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Cardiovascular disease (CVD) is the greatest cause of mortality, after cancer, 
in older adults (>60 years). CVD risk can be modulated by sedentary behaviour (SB) 
and physical activity (PA) however, research examining the effect of SB and PA on 
older adults’ cardiovascular/metabolic profile is lacking. This thesis aimed to 
address this gap in the literature. Ninety-three independently living older adults wore 
a thigh-mounted triaxial accelerometer for 7 consecutive days to assess habitual SB 
and PA engagement and patterns. Fasting blood samples to assess seven 
cardiometabolic marker concentrations and ultrasound to assess vascular structure 
and function were conducted. Engagement in light intensity PA (LIPA) decreased 
popliteal intima-media thickness (IMT) and further ageing of popliteal IMT. 
Replacing one hour of SB with LIPA decreased carotid artery diameter. Replacing 
an hour of any SB or PA with moderate to vigorous PA (MVPA, ≥10 mins bouts) 
reduced triglyceride concentration. Those with a ‘low’ triglyceride and ‘high’ 
lipoprotein lipase concentration engaged in 48% and 11% more MVPA (≥10 mins 
bouts) than the entire sample population, respectively. Patterns of SB, specifically 
W50% was associated with an increase in popliteal IMT and resting heart rate. 
Furthermore, participants with a ‘high’ procollagen 3 N-terminal peptide 
concentration had a larger W50% than the ‘low’ group. For SB, patterns of 
engagement appeared to be better predictors of older adults’ 
cardiovascular/metabolic status than total engagement time. LIPA is suggested to 
be a useful replacer of SB time due to their high co-dependence. MVPA (≥10 min 
bouts) engagement, which is already recommended in government PA policies, was 
a strong mediator of cardiometabolic markers. Overall, this thesis suggested that 
government PA policies should also include objective recommendations for SB and 
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The 2008 Health Survey for England found 39% of males and 29% of females 
aged 16.0 years (yrs) and over met the recommended physical activity (PA) 
guidelines (Craig et al., 2009). However, the average self-reported time spent 
performing sedentary behaviour (SB) was still 2.8±0.03 hrs·day-1 (Craig et al., 2009). 
Whilst these surveys provide valuable information, they have their limitations, as 
they are highly reliant on the participant’s recall ability. Indeed, it is now thought that 
the prevalence of SB and physical inactivity (not meeting PA recommendations) is 
even higher than previously reported, with accelerometer-derived survey data 
proposing that adults engage in SB for 9.91±0.04 hrs·day-1  and less than 10.0% 
meeting the recommended PA guidelines (Craig et al., 2009). SB is associated with 
an increased risk of developing factors associated with cardiovascular disease 
(CVD) (Healy et al., 2008a), such as  type 2 diabetes mellitus (Oggioni et al., 2014) 
and atherosclerosis (Laufs et al., 2005). 
Government health interventions have focused on improving physical health 
status by increasing bouts of moderate to vigorous physical activity (MVPA). The 
National Health Service (NHS) recommends 19.0 - 64.0+ yrs old adults should 
engage in 150 minutes (mins) of MVPA per week, which is commonly divided into 
five, 30.0 mins bouts a week (National Health Service, 2013a). However, individuals 
who meet the PA guidelines still display cardiometabolic risk factors associated with 
CVD and this is thought to be linked to their amount of SB, irrespective of the amount 
of MVPA undertaken (Healy et al., 2008a). Therefore, the research community has 
shifted focus towards PA and SB levels (collectively known as physical behaviour 
[PB] (Bussmann and van den Berg-Emons, 2013)) during the remaining 15.5 hours 
(hrs) of daily waking time (Hamilton et al., 2008). As the independent physiological 
characteristics of SB and MVPA have become apparent, a new PA population 
known as ‘active couch potatoes’ (ACP) has emerged (Gennuso et al., 2013; Healy 
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et al., 2008a; Peddie et al., 2013). The ACP population meet the PA guidelines for 
MVPA yet still spend the majority of their waking hours performing SB.  
Ageing is associated with an increase in SB (Harvey et al., 2013) and with 
life expectancy increasing, populations aged 60.0 yrs and older are projected to 
account for 25.0% of the UK population by the year 2035 (Office for National 
Statistics, 2012a). Therefore, studies examining the associations between SB and 
CVD risk are warranted as the prevalence of CVD cases in the UK is greatest in 
populations aged 65.0 yrs and over  (British Heart Foundation, 2014). 
This literature review aims to discuss the emergence of the ACP lifestyle, and 
how the independent effects of SB and MVPA on cardio-metabolic markers, 
associated with CVD, develop with ageing. 
 
Defining Sedentary Behaviour 
 
The definition of SB has been inconsistent throughout the literature due to 
different SB and the methods used to determine these. Most studies classify SB as 
<1.50 Metabolic Equivalent Tasks (METs) (Tremblay et al., 2010; Pate et al., 2008; 
Rowlands et al., 2014; Owen et al., 2010; Ainsworth et al., 2000) however; certain 
light intensity physical activities (LIPA) (standing) can elicit similar MET values 
(Ainsworth et al., 2000). ‘Sedentary’ originates from ‘sedere’, Latin for ‘to sit’. 
Therefore, the definition of SB should not only include the MET threshold (<1.50 
METs) but also acknowledge postural positions (sitting, lying, TV viewing, driving) 
(Tremblay et al., 2010).  
 Tremblay et al. (2010) further suggested that, similar to the measurement of 
PA using the acronym ‘FITT’ (frequency, intensity, time, type), SB should be 
recorded by using ‘SITT’ (SB frequency, interruptions in SB, time duration of each 
SB, type of SB). ‘SITT’ is recommended as SB does not have large variations in 
intensity and the number of interruptions in SB appears to be an important 





The Effects of Sedentary Behaviour Can Be Measured Independent of Those 
of Moderate to Vigorous Physical Activity 
 
Generally-speaking, PA may be considered as any activity of daily living that 
leads to the expenditure of energy, above the levels required for maintaining basal 
metabolic activities, with a threshold usually considered as anything at least 1.50 
times greater than the resting metabolic rate (RMR) (Mansoubi et al., 2015). The 
misclassification of SB under the umbrella of PA stems from the data collection 
methods of early epidemiological research. The Harvard Alumni study 
(Paffenbarger Jr et al., 1986) used self-reports to gain insight into PA levels by 
recording the frequency of stair climbing, city blocks (0.13 km) walked, and sports 
played. Individuals who failed to expend more than 2000 kcalweek-1 through these 
exercises were classed as sedentary even though there were no questions relating 
to SB. This assumption that too little MVPA equates to large amounts of SB may 
have come about through self-reports because it is easier for participants to recall 
more strenuous bouts of activity they have performed (Kriska, 2000), rather than 
how much time they have spent performing SB. Additionally, it can be difficult to 
quantify the frequency and length of SB when the focus of questions only relates to 
MVPA (e.g. “Ask only about activities that are at least the intensity of walking, but 
include walking.” - Stanford 7-day recall instructions (Sallis, 1985)). Therefore it is 
easy to understand how early PA research has influenced government health 
initiatives to focus on increasing MVPA to improve overall health, rather than aiming 
to reduce SB time. 
Conversely, SB and MVPA cause quantifiably different cardio-metabolic 
responses which do not correspond to the PA spectrum. SB was found to decrease 
lipoprotein lipase (LPL) activity (relative to ambulatory controls) by 55.0%, in 
oxidative muscle fibres. Whereas, voluntary running (56.0 mmin-1) caused no 
increase in relative LPL activity in oxidative muscle fibres (Bey and Hamilton, 2003). 
In the singular PA spectrum it would be expected that the decline in LPL from SB 
would be equally and oppositely matched by the benefits of MVPA. Therefore, in 
terms of physiological response, the PA spectrum should be bi-axial. The x axis 
should range from high SB to low SB and the y axis should range from insufficient 




In light of this independence between SB and MVPA, Healy et al. (2008a) 
found populations (47.3±13.1 yrs) that met the recommended PA guidelines still 
displayed associations between increased SB and CVD risk factors. This effect was 
more noticeable in their female sub-populations (triglyceride increase, from lowest 
to highest quartile of TV viewing hours: female 0.06 mmol·l-1 [95% confidence 
interval [95%CI] 0.04, 0.09], p<0.001, male, -0.001 mmol·l-1 [95%CI -0.03, 0.03], 
p=0.511). The greater association in female triglyceride concentration may be due 
to sex differences in fuel homeostasis, as a six day bed rest study caused female 
lipogenesis activity to increase by 570%, compared to no difference from baseline 
in males (Blanc et al., 2000b). In terms of similar observations in older persons, 
Bankoski et al. (2011) found that individuals aged 60.0 yrs and older were more 
likely to suffer from metabolic syndrome if they engaged in longer bouts of SB and 
had a greater percentage of time spent performing SB per day, independent of any 
PA they undertook in parallel. In aged ACP populations (74.6±6.5 yrs), positive 
associations between increased SB and fasting plasma glucose concentration, but 
no negative association between increased MVPA and fasting plasma glucose 
concentration or interaction between SB and MVPA plasma glucose concentration, 
was found (Gennuso et al., 2013). The lack of interaction between SB and MVPA 
highlights that the effects of SB and MVPA are independent of each other 
throughout the ageing process. 
The findings of Gennuso et al. (2013) are supported in acute environments 
as the ACP lifestlye appeared to elicit effects on glucose regulation that were similar 
to the effects of prolonged SB (Peddie et al., 2013). During a 9-hour period, young 
participants (18.0 – 40.0 yrs) consumed a glucose solution at three hour intervals. 
Participants engaged in either; 9 hrs of prolonged sitting, 30.0 mins of MVPA then 
8.50 hrs of sitting (ACP), or sitting interrupted every 30.0 mins by 1.00 mins 40.0 
seconds (s) of walking (LIPA). Overall, plasma glucose incremental area under the 
curve (iAUC) was similar for prolonged sitting and ACP groups (48.8 mmol·l-1·9h-1 
vs. 47.2 mmol·l-1·9h-1, respectivly) while interrupted sitting produced lower plasma 
glucose concentrations (29.9 mmol·l-1·9h-1) (Peddie et al., 2013). Consequently 
highlighting that the PA guidelines may not ameliorate the deleterious 
consequences of SB. The UK, Canada, and Australia have recently updated the PA 
guidelines to recommend a reduction in SB. Although evidence for the effects of SB 
is increasing (see table 1.1 for a summary), no guidance is given as to the maximum 
amount of daily SB, how often SB should be interrupted, and methods to reduce SB. 
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(**) 3.10 ↑ in 
metabolic syndrome 
development  Odds 
Ratio (OR) from 
lowest to highest 
quartile of % of SB 















(**) 4 mg·dL-1↑ from 
lowest to highest 
quartile of SB hours 
0.10 mg·dL-1 ↑ from 
lowest to highest 
quartile of SB hours 
Healy et al. 
(2008b) 








(**) r2=  0.14 with ↑ 
in SB breaks, 
(**) r2=  0.13 with ↑ 
in SB breaks 
(**) r2=  0.05 with ↑ 
in SB break 
(**) r2=  0.26 with ↑ 
in SB breaks 
(all independent of 
age) 
Dunstan et al. 
(2012) 





for 2 mins 
NA 2-h plasma 
glucose 
(N/A) LIPA ↓ 2-h 
plasma glucose by 
1.7 mmol·l-1, 
independent of age 
(N/A) MIPA ↓ 2-h 
plasma glucose by 
2.0 mmol·l-1, 
independent of age 
Healy et al. 
(2007) 










(**) Total SB time ↑ 
2-h plasma glucose 
(r2 = 0.18) , adjusted 
for age 
(**) Total LIPA time 
↓ 2-h plasma 
glucose (r2 = 0.17) , 
adjusted for age 
(**) Total MIPA time 
↓ 2-h plasma 
glucose (r2 = 0.18), 
adjusted for age 
Latouche et 
al. (2013) 





for 2 mins 
NA Dynein light 
chain 1 gene 
(N/A) 1.6 fold ↑ with 







Table 1.1 continued. 
Yamanouchi 






infusion rate 12.2%↓ 
in bed ridden 
compared to 
controls 
Carson et al. 
(2014) 







(**) 10 extra SB 
breaks per day: 0.01 
mmol·l-1 ↑ HDL-C 
3.72%↓ 
0.57%↓ 




69.8±3.8 6 months 
detraining 
Subjective Leptin (N/A) 0.4 ng·ml-1 ↑ 
above pre-training 
baseline 
 ** indicates that results were statistically significant after adjustment for MVPA. N/A indicates a 
study where the study design did not allow MVPA adjustments. NA indicates not applicable. ↑ 




The Benefits of Light Intensity Physical Activity 
 
Interrupting long bouts of SB appears to be an important determinant of 
physical well-being. Irrespective of total SB, MVPA time, and age, individuals (40.0 
– 87.0 yrs) who broke up SB on 673 occasions with LIPA (average break duration: 
4.50 mins), over five days of accelerometer wear time, had a 0.880 mmol·l-1 (p<0.05) 
lower in 2-hour plasma glucose concentration compared to individuals who only had 
506 breaks in SB. Reductions in triglycerides, body mass index (BMI), and waist 
circumference were also related to an increase in SB breaks (Healy et al., 2008b). 
This is further supported by a crossover study, which found 2-hour plasma glucose 
concentration, again independent of age, was decreased in middle-aged to older 
adults (45.0 – 65.0 yrs) when SB was interrupted every 20.0 mins with 2.00 mins of 
LIPA (1.70 mmol·l-1·1h-1 decline) or MVPA (2.00 mmol·l-1·1h-1 decline) compared to 
prolonged sitting (Dunstan et al., 2012). It appears that PA and SB plays an 
important role in the glucose-insulin axis as 53.0% of the variance in 2-hour plasma 
glucose concentration can be explained by SB (r2 = 0.18), LIPA (r2 = 0.17), and 
MVPA (r2 = 0.18) (Healy et al., 2007). Therefore, because LIPA can be easily 
accumulated and prevents the deleterious effects of SB on additional 
cardiometabolic markers (e.g. LPL) (Bey and Hamilton, 2003; Healy et al., 2008b), 
PA interventions should aim to interrupt SB with LIPA. 
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The optimum length of SB bouts and LIPA interruptions has not yet been 
determined. Beneficial associations with interruptions in SB and plasma glucose 
concentration were still visible in young persons (25.9±5.30 yrs) when SB bouts 
were increased to 30.0 mins and interruption length was decreased to 1.00 mins 
40.0 s (plasma glucose iAUC: interrupted, 29.9 mmol·l-1·9h-1, prolonged sitting, 48.8 
mmol·l-1·9h-1, ACP, 47.2 mmol·l-1·9h-1) (Peddie et al., 2013). This shows that 
benefits in SB breaks still exist with relatively increased SB time and decreased SB 
interruption length. However, Peddie et al. (2013) interruption intervention caused a 
lower plasma glucose iAUC per hour compared to Dunstan et al. (2012) (3.32 
mmol·l·1h-1, 5.10 mmol·l·1h-1, respectively), even though Dunstan et al. (2012) had 
shorter SB bouts and longer interruptions. This unexpected finding may be 
explained by Peddie et al. (2013) using a younger population than Dunstan et al. 
(2012) (25.9±5.3 yrs, 53.8±4.9 yrs, respectively) as glucose regulation declines with 
age (Gong and Muzumdar, 2012). As a result, PA guidelines may require different 
SB recommendations for different age groups. 
 
Sedentary Behaviour and Physical Activity: Impact on Glucose Regulation 
 
The interaction between SB and glucose regulation has been a popular topic 
due to the adverse effects hyperglycaemia has on the cardiovascular system. New 
recommended PA guidelines aimed at reducing SB by increasing LIPA could be 
crucial to the prevention of type 2 diabetes mellitus and subsequent CVD as SB and 
LIPA explain 35.0% of the variance in 2-hour plasma glucose concentration (Healy 
et al., 2007).  However, relationships between SB and fasting plasma glucose are 
not commonly found in both self-report and objectively measured PB studies (Healy 
et al., 2007; Healy et al., 2008b; Dunstan et al., 2007). This suggests SB influences 
glucose regulation through skeletal muscle related mechanisms as 2-hour plasma 
glucose is characterised as a measure of skeletal muscle insulin resistance. 
Whereas fasting plasma glucose is more reflective of hepatic insulin resistance with 
sustained skeletal muscle insulin sensitivity (Abdul-Ghani et al., 2006). 
It is thought that a reduction in facilitated glucose diffusion into skeletal 
muscle cells is brought about through a down-regulation of the glucose transporter, 
Glucose Transporter Type-4 (GLUT-4). In the vastus lateralis, ageing explains 
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7.80% and 26.0% of the variance in the decline of GLUT-4 concentration in males 
and females, respectively (Houmard et al., 1995). In addition, the ageing effect on 
GLUT-4 concentration also appears to be fibre type dependent, as a reduction in 
GLUT-4 is found with ageing in fast twitch fibres but not in slow twitch fibres of the 
vastus lateralis (Gaster et al., 2000). This decline in fast twitch GLUT-4 
concentration may, in fact, be due to decreased participation in free-living MVPA 
alongside an increased engagement in SB. In line with the above observations, 
moderate intensity PA (MIPA) in older populations is found to increase GLUT-4 
concentration, as it does in their younger counterparts (Cox et al., 1999). In support 
of the SB-GLUT-4 relationship, data shows that, seven young endurance runners 
aged 33.0 yrs, displayed a 17.5% reduction in gastrocnemius GLUT-4 concentration 
and a decrease in glucose disposal rates (1.90 mg·kg·FFM-1·min-1 decline),  despite 
an increased insulin concentration of 4.20 µm·ml-1, after six days of bed rest 
(Vukovich et al., 1996). Thus, the relationship between GLUT-4 and free-living SB, 
which has been exhibited in young populations is likely to be present in older 
persons, though the latter is yet to be demonstrated and requires further research. 
The evidence thus far suggests that longitudinal PA intervention in aged 
participants (60.0 - 72.0 yrs), causes an increase in vastus lateralis GLUT-4 
concentration (Biensø et al., 2015). It appears that this effect on GLUT-4 could also 
be found in acute SB breaks. Breaking up SB with LIPA or MIPA increased the 
expression of the gene that encodes dynein light chain 1 (DNLL1). DNLL1 plays a 
role in the transcription of GLUT-4 in middle aged to older adults (Latouche et al., 
2013) and is thought to be part of a mechanism for GLUT-4 induced reduction in 
plasma glucose during SB breaks.  
Insulin concentration may increase to compensate for the reduction in 
glucose uptake via the GLUT-4 pathway but consequently cause a decline in 
skeletal muscle insulin sensitivity. It should be noted that PA causes an increase in 
GLUT-4 translocation (Lund et al., 1995) and subsequently an increase in glucose 
clearance rate, independent of insulin (Lund et al., 1995). This increase in GLUT-4 
translocation with PA (seen in the study of Lund et al. (1995), may explain why 
interrupting SB with bouts of PA, was shown to lower plasma glucose concentrations 
compared with prolonged sitting in previous studies (Peddie et al., 2013; Healy et 
al., 2008b). On the other hand, 30.0 mins of MIPA followed by 8.50 hrs of prolonged 
sitting produced plasma glucose iAUC results that were similar to 9.00 hrs of 
prolonged sitting (Peddie et al., 2013). Based on the discussions above, this short 
10 
 
bout of MIPA should have increased GLUT-4 concentration and hence impacted on 
the iAUC. However, this single bout of PA may not have been enough to sustain an 
increased concentration of GLUT-4 over the remaining 8.50 hrs of SB as GLUT-4 is 
predicted to have a half-life of just 8.00 – 10.0 hrs (Host et al., 1998).  
Recently, Bailey and Locke (2014) found that SB breaks every 20.0 mins with  
2.00 mins of light intensity walking reduced postprandial plasma glucose 
concentration (iAUC 18.5 mmol·l-1·5h-1, reduction of 3.50 mmol·l-1·5h-1) compared 
to prolonged sitting in young persons (24.0±3.00 yrs). However, it was found that 
interrupting SB every 20.0 mins with 2.00 mins of standing (a LIPA) did not cause 
any beneficial decline in postprandial plasma glucose concentration (iAUC 22.2 
mmol·l-1·5h-1) compared to prolonged sitting (iAUC 22.0 mmol·l-1·5h-1). Therefore, 
PA interventions should aim to interrupt SB with a movement based LIPA. In 
addition, objective measures of PA should distinguish between breaks in SB caused 
by standing and walking to increase the validity of epidemiological studies 
examining the association between PB and cardio-metabolic health. 
Whilst glucose regulation declines with ageing (Gong and Muzumdar, 2012), 
PA interventions can protect against the ageing process. Bedridden, master 
athletes’ (62.0 - 87.0 yrs), and healthy older adults’ (76.0±2.00 yrs) glucose infusion 
rates were compared to that of healthy young individuals and young athletes 
(20.0±1.00 yrs). In ageing populations, glucose infusion rates were higher in master 
athletes and lower in bed ridden individuals than in healthy older adults. Compared 
to young individuals, the healthy older adult sub-populations had lower glucose 
infusion rates whereas master athletes had similar glucose infusion rates 
(Yamanouchi et al., 1992). Managing PA and SB is crucial in ageing populations to 
control glucose regulation, as the prevalence of diabetes mellitus is nearly seven 
fold greater in adults over 60.0 yrs compared to young populations (20.0 yrs) (Shaw 
et al., 2010). Although it is evident that frequent MVPA can protect against the 
effects of ageing on glucose control (Yamanouchi et al., 1992), it can be difficult for 
elderly populations to accumulate the recommended levels of MVPA. Therefore, 
future intervention studies, similar to the work of Peddie et al. (2013), Healy et al. 
(2008b), and Bailey and Locke (2014) should be conducted using ageing 
populations, whose waking hours are predominantly spent performing SB (Harvey 
et al., 2013), to examine the potential benefits of LIPA or sporadic MVPA (sMVPA, 
MVPA accumulated in bouts less than 10mins) breaks. 
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Sedentary Behaviour and Physical Activity: Impact on Cholesterol and 
Lipoprotein Lipase 
 
Low density lipids (LDL-C) (normative value: <3.00 mmol·l-1), high density 
lipids (HDL-C) (normative value: >1.00 mmol·l-1), and triglycerides (normative value: 
<1.70 mmol·l-1) are collectively known as total cholesterol (normative value: <5.00 
mmol·l-1) (National Health Service, 2013b). Decreasing LDL-C by 1.00 mmol·l-1 
reduces the relative risk of cardiovascular events by 22.0% in populations aged 65.0 
– 74.0 yrs, and by 16.0% in individuals over 75.0 yrs  (Baigent et al., 2010). In 
conjunction, a 0.78 mmol·l-1 decline in triglyceride concentration can decrease the 
relative risk of CVD by 15.0% in males, and 9.0% in females (50.8±6.70 yrs) (Cui et 
al., 2001). Meanwhile, HDL-C has been shown to have a protective effect, as a 0.55 
mmol·l-1 increase in HDL-C was associated with a decreased risk of coronary events 
by a factor of 1.70 and 1.95 in older adult (80.0±8.0 yrs) males and females, 
respectively (Aronow and Ahn, 1996). These findings are due to HDL-C role in 
transporting excessive cholesterol from peripheral tissues to the liver in a process 
known as reverse cholesterol transport (Sviridov and Nestel, 2002). LDL-C and 
triglycerides however, contribute to the pathogenesis of atherosclerosis. Increasing 
concentration of LDL-C can cause an accumulation within the arterial intimal space 
(Björnheden et al., 1996). These LDL-C particles become oxidised and bind to 
receptors on endothelial and smooth muscle cells causing apoptosis of smooth 
muscle cells (Björkerud and Björkerud, 1996), impaired nitric oxide (NO) synthesis 
(Keaney Jr et al., 1996) and oxidative stress (Cominacini et al., 2000). Macrophage 
secretion into the intimal space occurs to take up the oxidised LDL-C particles and 
consequently differentiate into foam cells (Rios et al., 2013). Triglyceride rich very-
LDL-C remnants, resulting from partial hydrolysis of triglycerides by LPL, bond to 
cholesterol esters from HDL-C via cholesterol ester transfer proteins. These 
cholesterol-enriched, triglyceride-poor species accumulate and are up taken by 
macrophages, subsequently forming foam cells (Talayero and Sacks, 2011). LPL 
not only interacts with triglycerides during the pathogenesis of atherosclerosis but 
also promotes retention of LDL-C within the intimal space by binding LDL-C to 
proteoglycans, found on smooth muscle cells. This retention allows more time for 
LDL-C particle modification and subsequently, promotes uptake by macrophages 
(Li et al., 2014). 
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 Whether LPL is antiatherogenic or proatherogenic is dependent on the 
cell/tissue that is expressing the enzyme (Mead and Ramji, 2002). Skeletal muscle, 
plasma and adipose tissue LPL is responsible for the clearance of lipoprotein 
particles and is therefore antiatherogenic, whereas endothelial LPL is 
proatherogenic (Mead et al., 1999; Mead and Ramji, 2002; Clee et al., 2000). 
Changes in LPL activity provides the best representation of the independence 
between MVPA and SB effect’s on cardio-metabolic markers of health status. As 
shown in Sprague-Dawley rats, 6.0 hrs of SB was found to decrease LPL activity 
(relative to ambulatory controls) by 55.0%, in postural oxidative muscle fibres 
(soleus) while HDL-C concentration declined by 22.0%. Whereas, voluntary running 
(56.0 mmin-1) caused no increase in relative LPL activity in oxidative muscle fibres. 
However, in glycolytic muscles (vastus lateralis), voluntary running caused an 
increase in relative LPL activity above that of ambulatory controls (Bey and 
Hamilton, 2003). The same authors (Bey et al., 2001) also reported a decrease in 
LPL activity in the soleus but not in the tibialis anterior with ageing in two strains of 
rat. It was stipulated that this ageing effect was visible in the soleus because it is a 
weight bearing muscle and LPL activity is dependent on muscle contractile activity 
(Hamilton et al., 1998). This apparent ageing effect on LPL activity in oxidative 
muscles was suggested to be due to a reduction in ambulatory movement with 
ageing and thus a reduction in postural muscle contractile activity (Hennig and 
Lømo, 1985). Therefore, the replacement of SB with LIPA may increase skeletal 
muscle LPL (antiatherogenic), subsequently reducing CVD risk.  
 In older adults (74.2±0.5 yrs), individuals who engaged in more than 5 
hrs·day-1 of LIPA had an average 0.23 mmol·l-1 (95%CI 0.07, 0.39, p=0.002) 
increase in HDL-C concentration and a lower ratio of total cholesterol to HDL-C (-
0.92 [95%CI -1.36, -0.48], p=0.003) with a trend towards lower concentrations of 
LDL-C and triglycerides (Pescatello et al., 2000). Assessment of PA in this study 
was done using the Yale Physical Activity Survey, which despite being validated for 
use with older adults (Dipietro et al., 1993), may not necessarily provide an exact 
quatitative measurement of PA. It is possible that the use of a direct and objective 
measure of PA might have produced greater data reliability and hence improved the 
degree of statistical significance, and/or greater associations between LIPA and 
HDL-C. Objective measures of PB from 4935 canadians (20.0 – 79.0 yrs) found an 
increase of 10 breaks in SB per day (break in SB were greater than 1.00 mins and 
classed as LIPA or MVPA) was associated with a 0.01 mmol·l-1 (95%CI 0.00, 0.02) 
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increase in HDL-C concentration and a 0.04 mmol·l-1 (95%CI -0.06, -0.01) decline 
in triglyceride concentration, indepentent of age. However, an increase in SB breaks 
was not associated with a decline in LDL-C. Conversely, a 0.21 mmol·l-1 (95%CI -
0.380, 0.040) decline in LDL-C was associated with an hourly increase in MVPA 
(Carson et al., 2014). As a result, reducing SB by increasing LIPA appears to be 
partly beneficial in the management of cholesterol and LPL. 
 
Sedentary Behaviour and Physical Activity: Impact on Ghrelin – Leptin – 
Adiponectin Axis 
 
Ghrelin, leptin, and adiponectin were once considered to be single action 
hormones, mediating metabolism and hunger. However, their role in vascular 
function has become apparent and may forge the link between obesity, SB, and 
CVD. Ghrelin (hunger hormone) and adiponectin (glucose regulation and fatty acid 
breakdown) appear to play a preventative role in CVD and type 2 diabetes mellitus 
risk (Spranger et al., 2003; Nagaya et al., 2004). Leptin, known as the satiety 
hormone, is a product of the OB gene and is a regulator of several physiological 
processes. Leptin is thought to play a role in the pathogenesis of atherosclerosis 
due to leptin receptor gene deficient rats becoming morbidly obese but immune to 
atherosclerosis (Nishina et al., 1994). Leptin has a positive association with body fat 
mass and obese individuals display an exponential rise in circulating plasma leptin 
concentrations, more than likely due to the onset of leptin resistance (Wang et al., 
2001). Normative values in normal weight populations (6.60 ng·ml-1 – 18.8 ng·ml-1) 
are lower than those of obese populations (28.6 ng·ml-1 – 34.8 ng·ml-1) highlighting 
the association between circulating plasma leptin concentration and fat mass in 
younger population (34.8±4.60 yrs) (Kazmi et al., 2013). Interestingly, older adult 
populations also display higher fasting serum leptin levels than their younger 
counterparts (4.30±1.90 ng·ml-1, 1.25±0.40 ng·ml-1, respectively, (Di Francesco et 
al., 2006)).   
Due to leptin regulating the differentiation of bone marrow osteoprogenitor 
cells it is thought that high concentrations of leptin binding to endothelial leptin 
receptors could cause calcification of the intimal wall (Parhami et al., 2001). A 10.0% 
rise in plasma leptin concentration was associated with a 1.50% decline in arterial 
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compliance, on the other hand, no association was found between leptin 
concentration and flow mediated dilation (FMD) in healthy, normal weight 
adolescents (Singhal et al., 2002).  This suggests endothelial dilators are not initially 
affected by increased leptin concentrations. However, leptin has also been 
associated with an increase in oxidative stress (Wang et al., 2013), which can cause 
nitric oxide synthase (eNOS) uncoupling and subsequently, downregulation of NO 
(Förstermann and Münzel, 2006). This mechanism may explain why negative 
associations between leptin concentration and endothelial dependent vasodilation  
exist in older adult populations (Gonzalez et al., 2013) due to oxidative stress being 
a mediator of declined FMD in populations older than 60.0 yrs (Taddei et al., 2001; 
Franzoni et al., 2005). Therefore, the effects of calcification appears to occur before 
the effects of oxidative stress in the development of vascular dysfunction and 
subsequently, CVD. 
 Taken together, both mechanisms could decrease vessel compliance and 
increase total peripheral resistance, which based on Darcy’s law, decreases blood 
flow. A decline in blood flow increases the likelihood of fatty plaque build-up leading 
to the formation of atherosclerotic lesions at arterial bifurcation sites (VanderLaan 
et al., 2004).  
 In a controlled study, SB was simulated through seven days of head down 
bed rest with 16 participants (32.4±1.90 yrs). The seven days of bed rest caused 
40.0% and 20.0% increase in male and female plasma leptin concentration, 
respectively (Blanc et al., 2000a). Similarly, in an intervention study, six months of 
detraining following a resistance training intervention in older adults (69.8±5.10 yrs) 
caused an increase in leptin concentrations that exceeded pre-LIPA and MIPA 
resistance training concentration. However, in vigorous intensity physical activity 
(VIPA) training group’s leptin concentration did not return to baseline levels which 
suggests a PA intensity threshold (Fatouros et al., 2005). Therefore, further studies 
are warranted to explore the possible relationship between SB, PA, plasma leptin, 









The body of literature surrounding SB is rapidly expanding and it has made 
the critical discovery that the cardio-metabolic effects of SB are distinct from MVPA. 
Therefore, individuals can be sufficiently active, based on the PA guidelines, but still 
sedentary for the remainder of the day. Epidemiological and crossover studies have 
shown a relationship between SB and cardio-metabolic markers associated with 
CVD. However, the objective measurement of PB is still a new concept. Future 
studies need to ensure that objective measurements of PB are able to distinguish 
sitting/lying from standing, and distinguish standing from LIPA that require 
movement. Although the use of pre-determined PA cut-off points, such as those 
derived by Freedson et al. (1998), are useful for between study comparisons, new 
research is needed to determine population-specific cut-off points, as no two 
populations are the same, physiologically. The need for population-specific cut-off 
points is especially important in ageing studies as most pre-determined thresholds 
were created using young or middle-aged adults and therefore, can cause 
misclassification of time spent in different PA intensities.  
A threshold between couch potato populations and ACP has been 
established. However, what is not known is when an ACP becomes sufficiently 
active to counteract the effects of SB. A maximum threshold of SB needs to be 
established where the effects of SB on CVD risk are greatly reduced in individuals 
who report levels of SB that are below this maximum threshold. In older adults, 
engaging in more than 7 hrs·day-1 of self-reported SB is associated with an 
increased risk of all-cause mortality (Chau et al., 2013). However, further 
confirmation of this possible threshold is required using more refined methodologies.  
Laboratory controlled interventions have shown that breaking up SB with 
LIPA is a successful method to control cardio-metabolic markers associated with 
CVD, such as glucose regulation. Further studies are warranted to establish links 
between SB breaks and other cardio-metabolic markers as well as determining the 
optimum length of SB bouts and SB breaks to reduce CVD risk. More importantly, 
intervention studies that use older adult populations are required as older adult 
individuals are likely to engage in a greater amount of SB time than their young 
counterparts.   
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Overall, SB research is still in the early stages of development, and more 
specifically, has not been implemented throughout the spectrum of ages, in 
particular the older segment of the population (e.g. populations aged 75.0+ yrs). It 
is important that future research has a strong methodological framework in both 
epidemiological and intervention studies before any conclusions are implemented 




Thesis Aims and Hypotheses 
 
Based on the findings of the literature review (chapter 01), the aims of this 
thesis were 1) to illustrate how and what PB(s) older adults should 
increase/minimise engagement in to improve their cardiovascular/metabolic profile 
and thus hopefully improve their health-related quality of later life. 2) determine 
whether cardiovascular/metabolic markers are affected by increasing age after the 
age of 60 years and whether PB(s) can mediate any apparent ageing effects. 
It was hypothesised that PB parameters representative of a greater 
engagement in SB would be detrimental to cardiovascular/metabolic parameters, 
whilst increased engagement in PA parameters would be beneficial to 
cardiovascular/metabolic parameters. Furthermore, it was hypothesised that a 






Chapter 02:  
Monitoring Physical Behaviour in 
Older Adults 
 
Part 1: ‘Overview for Developing Accelerometer 
Cut-off Points Specific to Older Adult 
Populations.’ 
 
Part 2: ‘Reliability and validity of the 
international physical activity questionnaire 
compared to calibrated accelerometer cut-off 
points in the quantification of sedentary 
behaviour and physical activity in older adults.’  
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Part 1: Overview for Developing Accelerometer 




 The GENEActiv Original (GENEA, Activinsights Ltd, Kimbolton, UK) triaxial 
accelerometer (43.0 mm x 40.0 mm x 13.0 mm, 16.0 g), previously validated for 
objective measures of free living physical behaviour (PB) patterns (Esliger et al., 
2011; Rowlands et al., 2014; Pavey et al., 2014), was chosen for objective 
measurement of older adult’s free-living PB in the current thesis.  
Twenty-four GENEA units underwent an initial static calibration process by 
recording the pull of gravity (9.81 m·s-2 or 1.00 G) for one minute through each axis 
(van Hees et al., 2014) to determine any unit falling outside a 5.00% variability limit 
(Esliger and Tremblay, 2006) (figure 2.1.1). Only one GENEA unit fell outside of this 
limit (0.051 difference) and therefore, it was not used for the thesis. The initial 
configuration of GENEA required each unit to undergo a three-hour charging period. 
This process has to be repeated every two months, during the data collection phase, 
to protect the longevity of the GENEA battery. 
 
Figure 2.1.1. The difference between actual force of gravity (1 G) and GENEA measured force of 
gravity in both directions of the x, y, and z axes. Dotted line represents the 5% variability limit 





To prepare a GENEA unit for a monitoring session, it was inserted into the 
Universal Serial Bus (USB) docking station (ActivInsights Ltd, Kimbolton, United 
Kingdom), which was connected to a ProBook 4320s laptop (Hewlett-Pickard, 
California, USA). Successful GENEA connection was confirmed by the unique 
GENEA unit code being displayed as a connect device in the GENEActiv Computer 
Software (ActivInsights Ltd, Kimbolton, United Kingdom). GENEA units were only 
used for monitoring if the battery status was ≥80%, as this was the minimum 
requirement for continuous weeklong monitoring. Within the ‘Config. Setup’ (figure 
2.1.2) Menu option, ‘Measurement Frequency’ was set at 60 Hertz (Hz) over a range 
of ± 8 Gravity (g) at a 12-bit (3.9 Milli-Gravity [mg]) resolution, as this allowed for a 
maximum of 12 continuous monitoring days. ‘Time Setup’ was always set as ‘Local 
PC Time’ and the same computer was always used for the GENEA configuration to 
ensure that time stamping within the raw data file reflected the actual time of day 
and was consistent between participants. ‘Recording Start Mode’ was set ‘At Future 
Time’ for 00:00 the following day to allow ease of automated analysis and between 
person comparisons. The unique identification code of the participant was inserted 
into the ‘Subject Code’, as multiple participants were monitored at the same time; 
this ensured that GENEA data was not matched to the wrong participant. ‘Body 
Location’ displayed which thigh the GENEA was placed on. This was the dominant 
leg of the participant, determined as the participant’s standing leg preference in a 
single leg postural balance attempt. It is pertinent to state that when the researcher 
removed the GENEA after the monitoring week, the thigh that the GENEA was 
placed on was again noted, to confirm that the ‘Body Location’ selected during the 
configuration was correct. Once the ‘Config. Setup’ information was completed, a 




Figure 2.1.2. ‘Config. Setup’ stage of the GENEActiv Computer Software, which was used to prepare 
a GENEA for monitoring. 
 
Fitting the Accelerometer 
 
 Pilot testing revealed that the GENEA can cause a degree of skin irritation 
during weeklong monitoring as a result of the sharp edges that are present on the 
back of the unit. To overcome this, a 35 × 55 × 7 mm soft sponge was attached to 
the back of the GENEA using two micropore strips (3M, Minnesota, USA) placed 
horizontally and vertically around the GENEA and sponge (figure 2.1.3). However, 
micropore tape did not cover the ‘gold prongs’, which are used to download the raw 
data, as residue from the tape may cause download errors when the GENEA is 
connected to the USB docking station. 
 




GENEA was mounted against the thigh of the dominant leg (anterior, 50% of 
femur length from greater trochanter to lateral femoral condyle) using two Tegaderm 
Films 1626W (100 mm x 120 mm) (3M, Minnesota, USA), which were placed 
horizontally and vertically over the GENEA. At this time, participants were asked to 
place a hand on either side of their thigh and pull downwards to stretch the skin, this 
allowed a better contact adhesion between the skin and the Tegaderm Films and 
minimised feelings of restriction during movement due to the attachment of GENEA. 
The gold ‘prongs’ of the GENEA facing downwards and the on/off light being visible 
confirmed correct orientation of the GENEA axes. A thigh-mounted accelerometer 
is considered the gold standard for sedentary behaviour (SB) time measurement (P. 
Kelly et al., 2016; Steeves et al., 2015; Edwardson et al., 2016) and therefore, was 
the chosen placement (as opposed to the wrist-worn option that GENEA was 
originally designed for). This is due to the change in thigh orientation that is common 
in the transition from standing to seated or reclined postures and vice versa. Using 
this knowledge, analysis software can determine posture relative to the Earth’s 
surface by examining the static acceleration of the GENEA axes (figure 2.1.4). 
 
Figure 2.1.4. The distinct orientation of the GENEA axes that allows posture to be identified through 






Accelerometer Care during the Monitoring Week 
 
In an attempt to reduce data skewing, GENEA surveillance was postponed 
until a later date if the participant had a ‘planned’ holiday or long journey that was 
not considered part of their ‘typical’ week. Participants were provided with two spare 
Tegaderm films in case the original films began to peel away from the skin. 
Participants were instructed not to remove the existing film as this could cause the 
GENEA to be disrupted. Instead, a spare film should have to be placed over the part 
of the existing film that was peeling away from the skin. If fluid began to accumulate 
within the air bubble that was present around the GENEA, participants were 
instructed to cut a small hole in the bottom of the air bubble to allow the fluid to drain 
and then place a spare film over the top to seal the air bubble once again. This was 
done purely for skin hygiene reasons, as the presence of fluid would not affect the 
GENEA. In the rare case that GENEA came away from the skin, participants were 
asked to write down on the sleep diary at what date and time they noticed the 
GENEA had been disturbed and at what date and time they reattached GENEA 
using the spare films. This allowed the researcher to then decide whether this period 
or day should be removed from the data analysis or whether a second monitoring 
week would be required.  
A sleep diary was provided to participants so they could self-report the time 
they woke up in the morning and what time they turned the lights off to go to sleep 
at night for each of the monitoring days. These times would then be used during the 
analysis of the GENEA data to help identify sleeping hours throughout the 
monitoring week. In cases where the sleeping diary had missing times, the epoched 
data was manually assessed to determine at what time prolonged SB occurred or 
ended. If this time point was similar to the self-reported ‘go to sleep time’ or ‘wake-
up time’ of other days then it was assumed, at the researcher’s discretion, that this 
was the ‘go to sleep time’ or ‘wake-up time’ for the respective day. 
 
Analysis of Accelerometer Data 
 
Following weeklong surveillance, the raw data was downloaded from the 
GENEA by connecting it to the GENEActiv Computer Software using the USB 
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docking station. Using the ‘Data Extractor’ stage, downloaded raw data was saved 
as a .bin file to the participant’s data folder. The download period normally lasted 
approximately 15 minutes. Successful download was confirmed with a pop-up 
message stating no errors had occurred. The .bin file was then smoothed in the 
‘Data Converter’ stage into 10-second (s) epochs. 10 s epochs were chosen over 
the commonly used 60 s epoch to increase the sensitivity to changes in a 
participant’s PB and allow for further smoothing, if needed for direct comparison with 
other studies (Atkin et al., 2012; Aguilar-Farías et al., 2014; Ayabe et al., 2013). 
Short epochs are recommended as a small accumulation of high intensity 
movement (counts per minute, G values, sum of vector magnitude) within an epoch 
that consists mostly of SB could cause a larger average output for the epoch and 
subsequently, lead to an over/underestimation of the PB intensity (Gabriel et al., 
2010; Ayabe et al., 2013). ‘Temperature Compensation’ was not applied to the data 
as it has shown to add no significant improvement to the calibration of GENEA in 
the United Kingdom (van Hees et al., 2014). The smoothed data files were saved 
as .csv files to allow analyses within Office Excel 2013 (Microsoft Corporation, 
Washington, USA). The Cheshire Algorithm for Sedentarism (CAS) (Wullems et al., 
2015) was used for off-line analyses of GENEA data (figure 2.1.5). 
 







The Cheshire Algorithm for Sedentarism 
 
The novel CAS software uses concepts that are similar to that of the 
‘Sedentary Sphere’ where the mean epoch G value of each x, y, and z axis were 
compared to one another to recognise posture (Rowlands et al., 2014). For 
example, if the y-axis G value was the lowest of the three axes (-1 G), the participant 
was standing up. If the z-axis G value was the lowest of the three axes (-1 G), the 
participant was sitting down or supine. If the x-axis G value was the lowest of the 
three axes (-1 G), the participant was lying sideways. Following posture 
identification (classified as SB or PA) the CAS then uses cut-off points that were 
locally validated against the energy expenditure of older adults (see Accelerometer 
Cut-off Point Development below) to determine physical activity (PA) intensity. 
Energy expenditure was represented as metabolic equivalent tasks (METs), which 
is the equivalent of oxygen utilisation (ml·kg·min-1) as a multiple of resting metabolic 
rate (RMR). The commonly applied METs denominator of 3.5 ml·kg·min-1, which 
represents the RMR of a 70 kg, 40 year old male (Byrne et al., 2005) was substituted 
for the participant’s RMR, within the current thesis, as this has been found to be 
lower than 3.5 ml·kg·min-1 in older adults (Ryan et al., 2015b). Therefore, using RMR 
derived METs should have reduced the likelihood of PA intensity misclassification 
and also account for individual difference in physical fitness (Ryan et al., 2015b; 
Ryan et al., 2015a). The summative G value used within the CAS software is 
referred to as Residual G, as it uses the standard deviations of the axes to determine 
overall movement. Residual G is similar to that of total movement (Onambele et al., 
2006) and is calculated using equation 2.1.1. The Residual G cut-off points of a 10 
s epoch for a mixed sex older adult population were 0.057 Residual G for SB – light 
intensity PA (LIPA) (1.50 METs, PA below this threshold was classified as standing) 
and 0.216 Residual G for LIPA – moderate to vigorous PA (MVPA) (3.00 METs). 
The CAS provided several parameters for both SB and PA. Details of these 







Equation 2.1.1. Residual G calculation. 
Residual G = √(SD x2 + SD y2 + SD z2) 
Where: x is the medio-lateral axis 
y is the vertical axis 
z is the anterior-posterior axis 
SD is standard deviation 
√ is square root 
 
Table 2.1.1. Definitions of the PB parameters provided by the CAS. 
 
Terminology Unit Definition 
Physical Behaviour   
Sedentary Behaviour (SB) hrs·day-1 
The mean amount of SB, of any length, that is 
accumulated in a 24hr day. 
Any waking behaviour characterised by a seated or 
reclined posture (Tremblay et al., 2010). 
Standing hrs·day-1 
The mean amount of standing, of any length, that is 
accumulated in a 24hr day. 
Any standing posture that elicits little to no movement 
and expends ≤1.50 METs of energy (Tremblay et al., 
2010). 
Light Intensity Physical 
Activity (LIPA) 
hrs·day-1 
The mean amount of LIPA, of any length, that is 
accumulated in a 24hr day. 
Any standing posture that elicits 1.50 - <3.00 METs 
(Tremblay et al., 2010). 
Sporadic Moderate to 
Vigorous Physical Activity 
(sMVPA) 
hrs·day-1 
The mean amount of MVPA, of any length, that is 
accumulated in bouts <10.0 mins in a 24hr day 
(Department of Health Social Services and Public 
Safety, 2011). 
Any standing posture that elicits ≥3.00 METs (Tremblay 
et al., 2010). 
≥10 Minute Moderate to 
Vigorous Physical Activity 
(10MVPA) 
hrs·day-1 
The mean amount of MVPA that is accumulated in bouts 
≥10.0 mins in a 24hr day (Department of Health Social 
Services and Public Safety, 2011). 
Any standing posture that elicits ≥3.00 METs (Tremblay 












SB Breaks n·day-1 
The mean amount of SB Breaks in a 24hr day. 
≥2.00 mins of continuous PA (Benatti and Ried-Larsen, 
2015) 
 that follows ≥1.00 of SB (Messinger‐Rapport et al., 2003).  
NB – Every day starts in a sedentary state. 
<5min SB Bout n·day-1 
The mean amount of SB bouts that consist of <5.00 mins in 
a 24hr day (Saunders et al., 2013). 
SB bout starts after ≥2.00 mins of PA is followed by ≥1.00 
mins SB and ends with an ‘SB Breaks’. Contains SB and 
<2.00 mins of PA. 
≥5min SB Bout n·day-1 
The mean amount of SB bouts that consist of ≥5.00 mins in 
a 24hr day (Saunders et al., 2013). 
SB bout starts after ≥2.00 mins of PA is followed by ≥1.00 
mins SB and ends with an ‘SB Breaks’.  Contains SB and 
<2.00 mins of PA. 




SB time (≥1.00 mins) between PA bouts of ≥ 2.00 mins are 
LOG transformed to normally distribute the data and then 
anti-logged to find the “True Mean” (Chastin et al., 2015c). 
Mean amount in a 24hr day. 
Alpha α·day-1 
How steeply the number of SB bouts decreases with 
increasing SB bout duration in a power-law distribution 
(Chastin et al., 2015c).  Mean amount in a 24hr day. 
W50% mins·day-1 
50% of SB time in a 24hr day is accumulated by SB bouts of 
this specific length or shorter (Chastin et al., 2015c). Mean 




The mean percentage of waking hours that is spent 











Accelerometer Cut-off Point Development 
 
A sub-population of the thesis participants who were recruited for chapter 03 
- 05 agreed to complete the GENEA cut-off point development study. Thus, 20 
participants (5 females <75.0 yrs, 5 females ≥75.0 yrs, 4 males <75.0 yrs, 6 males 
≥75.0 yrs) underwent laboratory controlled activities to produce PB cut-off points for 
the weeklong free-living data collection. The Manchester Metropolitan University 
Exercise and Sport Science Sub Committee granted ethical approval and 
participants signed informed consent forms prior to data collection. 
 Participants were fitted with a GENEA on both upper legs (anterior, 50% of 
greater trochanter to lateral femoral condyle length) and a heart rate monitor (Polar 





The mean amount of bouts that consist of ≥2.00 mins of 
continuous PA (Benatti and Ried-Larsen, 2015) followed by ≥1.00 
mins of continuous SB (Messinger‐Rapport et al., 2003) in a 24hr 
day. PA bout starts after ‘SB Breaks’ and ends with an SB bout. 
Contains PA and <1.00 mins of continuous SB. 
Daily Sum of 
PA Bout time 




PA time (≥2.00 mins) between SB bouts of ≥ 1.00 mins are LOG 
transformed to normally distribute the data and then anti-logged to 










The sum amount of ‘10MVPA Bouts’ time that is accumulated in a 




The mean percentage of waking hours that is spent performing 




The mean percentage of waking hours that is spent performing 




The mean percentage of waking hours that is spent performing 




The mean percentage of waking hours that is spent performing 
‘10MVPA’ in a 24hr day. 
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H7 monitor, Polar Electro, Kempele, Finland). The two GENEA units plus heart rate 
monitor were used as a reliability and validity measure. Video monitoring took place 
to assess the agreement between real-world behaviours and GENEA recognised 
PB intensity. Participants completed the protocol highlighted in figure 2.1.6 whilst 
wearing a mouthpiece connected to a Douglas bag, to collect exhaled gas samples.  
 
Figure 2.1.6. Cut-off points calibration protocol. Heart rate and two expired gas samples were 
collected during the last two minute of each four-minute stage. Ambulation required the participant 
to step 30 cm side to side at the pace of a 30 beats per minutes (30 steps per minute) metronome 
app (Logan Gauthier, Huntsville, USA), touching their feet together either side of the 30 cm line. 
Maximum walking speed for the final stage was set at 6.50 km·h-1 based on a previous protocol 
performed by a similar population (Miller et al., 2010). 
Two exhaled gas samples (one minute each) were collected in the last two 
minutes of each four minute stage using Douglas bags, and later analysed through 
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indirect calorimetry (Servomex 5200, Servomex, Crowborough UK). The mean 
oxygen utilisation of the two exhaled gas samples for each stage were divided by 
the lowest of the two oxygen utilisation readings from the seated stage (to represent 
RMR) to calculate MET conversion (referred to as measured METs). The lowest 
reading of the two seated oxygen utilisation samples was selected instead of the 
mean to account for hyperventilation, which is common within exhaled gas sample 
collection that uses a mouthpiece method (Scott, 1993). In a further attempt to 
reduce the likelihood of hyperventilation, participants were asked to wear the 
mouthpiece for five-minutes prior to the start of the four-minute supine stage so they 
could become accustomed to the unfamiliar procedure. Participant’s heart rate was 
monitored between each stage; only when their heart rate had returned to baseline 
(10% range) were they allowed to begin the next stage. This was done to protect 
against any fatiguing effect that could carry over into subsequent stages and thus, 
could influence both GENEA and oxygen utilisation readings. 
GENEA data was downloaded into Office Excel 2013 (Microsoft Corporation, 
Washington, USA) and time-matched to the heart rate and measured METs for each 
stage. Heart rate was used as a validity measure to ensure that any increase in 
GENEA Residual G or measured METs was a result of increasing physical task 
demand (figure 2.1.7). Residual G cut-off points were then determined, to represent 
the standard MET thresholds (SB-LIPA, 1.5 METs; LIPA-MVPA, 3.0 METs), using 




Figure 2.1.7. The mean heart rate of the participants’ during each physical behaviour stage. Blue 
bars represent mean heart rate. Error bars represent heart rate standard deviation per stage. Open 
circles represent the heart rate of each participant per stage. 
 
Equation 2.1.2. Accelerometer Cut-off Point Equation. 
Residual G = 0.0262 × Measured METs1.9204 
 
 Measured METs explained 89% of the variance in Residual G (figure 2.1.7), 
which was similar to that of other cut-off point development research (Matthew, 
2005) and therefore, deemed that GENEA Residual G was sufficient for quantifying 
energy expenditure in older adult populations. More importantly, the GENEA posture 
recognition and Residual G cut-off points could accurately classify the time spent 
engaging in SB and PA intensity as shown by a Cohen’s Kappa value of 1.00 (95% 
confidence interval [CI] 1.00, 1.00, p<0.001) and 0.89 (95%CI 0.49, 1.31, p<0.001), 
respectively. Therefore, this validation procedure increased the confidence that the 
results provided by the CAS were representative of the true PB(s) performed within 





Figure 2.1.8. The association between Measured METs and Residual G for each PB stage within the 
participants’ calibration protocols. Grey dotted line illustrates the power regression trend line. Blue 




Part 2: Reliability and validity of the international 
physical activity questionnaire compared to 
calibrated accelerometer cut-off points in the 
quantification of sedentary behaviour and physical 




The International Physical Activity Questionnaire (IPAQ) is used worldwide 
to indirectly evaluate an individual’s volumes of sedentary behaviour (SB) and 
physical activity (PA) throughout a seven-day week (Craig et al., 2003). Its potential 
use to measure SB and PA has become essential in recent years due to the 
emerging understanding of the independent effects of SB and moderate to vigorous 
PA (MVPA) on health-related factors (Bey and Hamilton, 2003; Bankoski et al., 
2011).  
Sedentary behaviour is defined as any seated or reclined posture (e.g. sitting, 
lying down, and driving) that expends 1.50 or less Metabolic Equivalent Tasks 
(METs), while MVPA is any activity that expends 3.00 or more METs (Tremblay et 
al., 2010). One MET is equal to Resting Metabolic Rate (RMR) or 3.50 ml·kg·min-1 
of oxygen utilisation, which is reported to reflect a 70 kg young person’s RMR (Byrne 
et al., 2005). In light of the independence between SB and MVPA, it is now possible 
to be highly sedentary whilst also being physically active (≥2.5 hrs·week-1 of MVPA 
accumulated in bouts ≥10 continuous minutes). Therefore, people can be 
categorised into four physical behaviour (PB) (Bussmann and van den Berg-Emons, 
2013) groups: highly sedentary and physically inactive (couch potato), highly 
sedentary but physically active (active couch potato, ACP), low sedentary and 
physically inactive (ambulator), and finally, low sedentary and physically active 
(active ambulator). 
MET thresholds are commonly applied to accelerometer data (Freedson et 
al., 1998; Miller et al., 2010) to allow for an objective measure of free-living SB and 
MVPA. Accelerometry is still a new concept within free-living monitoring, but is 
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deemed a valid determination of SB and MVPA (Montoye et al., 2014). 
Nevertheless, in large epidemiological studies, the use of accelerometers can be 
costly and time consuming.  
By contrast, self-report measures such as the IPAQ are readily available, 
very cost-effective and can generate large data sets. The IPAQ has previously 
undergone reliability and validity assessments in young to middle aged adults 
(n=2721, 54% female, 36.8±7.9 years) (Craig et al., 2003). Reliability is the extent 
to which results are consistent over time whilst validity determines whether a tool 
truly measures what it is intended to measure (Golafshani, 2003). However, few 
studies have assessed its validity of the IPAQ in populations over 60 years of age 
(Tomioka et al., 2011; Hurtig-Wennlöf et al., 2010; Cerin et al., 2012). These 
aforementioned studies used populations that ranged from 54 – 325 participants 
(49% - 58% female) to validate the IPAQ against waist mounted accelerometer 
measures, which may not be as accurate as thigh mounted accelerometers when 
determining posture (Edwardson et al., 2016). Sex differences have been reported 
within IPAQ data sets as well as in hip-mounted accelerometer measures (Tomioka 
et al., 2011), which suggests that the IPAQ results (Tomioka et al., 2011) were not 
due to sex differences in social desirability or approval (Hebert et al., 1997). To the 
author’s knowledge no study, to date, has investigated the reliability and validity of 
the self-administered IPAQ Long-Form, English (last 7 days format) against thigh-
mounted accelerometer derived data, using an older community-dwelling participant 
sample. Assessing the quality of the IPAQ across countries and age groups is 
essential to ensure the IPAQ is adaptable across different social, sex, and ethnic 
groupings. 
Therefore, the objectives of this study were to compare two IPAQ Long-Form, 
English (last 7 days format) data sets, collected a week apart, and to compare the 
results of the IPAQ to accelerometer measures of free-living SB and MVPA. The 
aim was to provide a reliability and validity record for IPAQ measures of SB and 
MVPA in middle-class (e.g. coming from a sub-region characterised by proximity to 
several universities, low claimant unemployment rate, high proportion of managerial 
and professional posts), semi-rural UK-based older-adults. It was hypothesised that: 
1. The IPAQ would be reliable. 2. Owing to a bias in the IPAQ to questions relating 
to PA rather than SB per se, the IPAQ may in fact underestimate SB and 
overestimate MVPA time. Thus, the second hypothesis was that the IPAQ may not 
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be valid in quantifying SB and MVPA time. 3. Sex bias would not occur in both the 




Eighty-nine community-dwelling retired (and/or in voluntary employment) 
older participants (73.7±6.3 years, 60 – 89 years, 54% female) who were 
independently mobile (i.e. no walking aids), did not suffer from an untreated 
cardiovascular disease, did not sustain an injury within the last three months, did 
not suffer from any mental impairment, and were deemed generally healthy, 
volunteered to participate in the study. These participants were recruited primarily 
from older adult community groups within the Cheshire East Borough, England. The 
Manchester Metropolitan University: Exercise and Sports Science Ethics Sub-
Committee granted ethical approval. Informed consent was obtained prior to 
participation in the study. On recruitment, it was made clear to the participants that 
their inclusion within the study would require their PB to remain habitual for at least 
the two weeks covered by the study protocol (see below). 
 
First Laboratory Visit 
 
During the first visit to the laboratory, 76 participants successfully completed 
the self-administered IPAQ Long-Form, English (last 7 days format), with the 
remaining participants returning incomplete questionnaires which were therefore not 
analysed. Participants’ demographics were collected and were then fitted with a 
commercially available thigh mounted (anterior aspect, at 50% of greater trochanter 
to femoral lateral condyle distance) triaxial accelerometer (GENEA, GENEActiv 
Original, Activinsights Ltd, Kimbolton, UK) on their dominant thigh, for a free-living 
week (7 consecutive days). Standing leg preference during a single leg balance 
exercise determined leg dominance. Two waterproof adhesive patches (3M 
Tegaderm Film, North Ryde, Australia) were used to mount GENEA. Height 
(precision: 0.01 m) and mass (precision: 0.1 kg) were measured with a stadiometer 
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(Harpenden, Holtain, Croswell, Wales) and electronic weighing scales (Salter, Kent, 
England). 
GENEA recorded at a 60.0 Hertz (Hz) frequency and data were smoothed 
using 10 second (s) epochs. The chosen GENEA output was Residual G (equation 
2.2.1), adapted from previous work on total movement analysis in older persons 
(Onambele et al. (2006) and termed the Cheshire Algorithm for Sedentarism (CAS, 
Chapter 02: Part 1) (Wullems et al., 2015).  
Equation 2.2.1. Residual G calculation. 
Residual G = √(SD x2 + SD y2 + SD z2) 
Where: x is the medio-lateral axis 
y is the vertical axis 
z is the anterior-posterior axis 
SD is standard deviation 
√ is square root 
 
Posture (SB or PA classification) was determined by comparing the mean 
epoch G values for the x, y, and z axes to one another (Rowlands et al., 2014). For 
example, if the y-axis G value was the lowest of the three axes (-1 G), the participant 
was standing up. If the z-axis G value was the lowest of the three axes (-1 G), the 
participant was sitting down or supine. If the x-axis G value was the lowest of the 
three axes (-1 G), the participant was lying sideways. The SB-light intensity PA 
(LIPA) (1.5 METs) Residual G cut-off point was 0.057 Residual G and the LIPA-
MVPA (3.0 METs) cut-off point was 0.216 Residual G. These cut-off points were 
derived from a systematic validation of the GENEA against expired gas samples of 
older adults collected during a laboratory-based activity calibration protocol, where 
nine PB functions (i.e. 1-supine, 2-sitting, 3-standing quietly, 4-self-selected ground 
walking, 5-brisk walk on treadmill, 6-3.5 km·hr-1 walk on treadmill, 7-self-selected 
walk on treadmill, 8-self-selected weighted-vest treadmill walking [at 15% of body 
weight], 9-repeated side-stepping) were monitored with concurrent gas analyses, 
heart rate, motion analysis and accelerometer output (Chapter 02: Part 1). There 
was a strong explained variance between Residual G and METs (r2=0.89, p<0.001). 
GENEA posture recognition, Residual G cut-off points and MET thresholds had a 
strong agreement in posture (Cohen’s kappa = 1.00, p<0.001) and PA intensity 
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(Cohen’s kappa = 0.81, p<0.001) identification (Chapter 02: Part 1). During in house 
calibration, it was found that normalising one MET to the RMR of the participant 
would help account for individual differences in physical fitness (Ryan et al., 2015a; 
Ryan et al., 2015b) and therefore make the Residual G cut-off points more 
ecologically valid.  
Second Laboratory Visit  
 
Following a week (uninterrupted 7 days of 24-hour-long accelerometer wear) 
of GENEA wear-time, 86 participants completed another self-administered IPAQ 
Long-Form, English (last 7 days format) within 8 – 11 days of the first laboratory 
visit. Scoring of the IPAQ was completed as described previously (IPAQ Research 
Committee, 2005). Due to older adults completing small amounts of MVPA (Craig 
et al., 2009), IPAQ measures of moderate PA and vigorous PA were combined to 
make 10MVPA (MVPA accumulated in bouts ≥10 continuous minutes).  
To allow direct comparison with the IPAQ, total week 10MVPA (hours over a 
week) as well as total week sporadic MVPA (sMVPA, accumulated in bouts <10 
continuous minutes, hours over a week), were used as the chosen output for 
GENEA. For SB, total week SB (hours over a week) was the chosen output of the 
IPAQ and GENEA, with the former including transport and other sitting time. For 
participants who had less than seven days of valid GENEA data (three participants 
[1 male and 2 females] only had 6 valid days [i.e. full 24 hour-long data set]), the 
mean daily engagement in SB, 10MVPA, and sMVPA of each participant’s six valid 
days was added to the sum of their valid days to complete their total week (7 day) 
SB, 10MVPA, and sMVPA data set. PB classification definitions are provided in 
table 2.2.1. Only waking hours (determined with self-reported sleeping hours, lights-
off time and wake-up time) are analysed for the purpose of this chapter. 
Table 2.2.1. Physical behaviour group classification. 
 
Total Week SB daily mean 
≥8 h·day-1 
Total Week SB daily mean 
<8 h·day-1 
Total Week 10MVPA 
<2.5 h·week-1 
Couch Potato Ambulator 
Total Week 10MVPA 
≥2.5 h·week-1 






SPSS Statistics 21 (International Business Machines Corporation, New York, 
USA) was used for statistical analyses. Those who were missing first or second visit 
IPAQ data were removed from the relative and absolute between day IPAQ 
reliability assessments. Meanwhile individuals only missing first visit IPAQ data were 
included in the concurrent validity and PB classification agreement assessments 
against GENEA data. For hypothesis one, related to between day IPAQ reliability, 
with the data being non-parametric (based on the outcome of the Kolgomorov-
Smirnov and Levene’s tests outcomes), Spearman rho correlations were used to 
examine the association between the first and second visit IPAQ data (for total week 
SB and total week 10MVPA). To illustrate the absolute reliability between first 
laboratory visit and second laboratory visit IPAQ data sets, Bland-Altman plots were 
used.  
For hypothesis two, related samples t-tests (or Wilcoxon Signed Rank tests 
for non-parametric data sets) and Spearman rho correlations were used to assess 
the validity of the IPAQ against GENEA measures of total week SB, total week 
10MVPA, and total week sMVPA. To illustrate the concurrent validity of the IPAQ 
against GENEA, Bland-Altman plots were used.  
For hypothesis three, independent samples t-tests (or Mann Whitney-U tests 
for non-parametric data sets) were used to examine sex differences in total week 
SB, total week 10MVPA, and total week sMVPA. These sex differences were carried 
out for both IPAQ and GENEA data sets. To identify sex differences in correlation 
coefficients and correlation slopes for reliability and validity assessments, Fisher’s 
z transformation tests were performed. Differences in the residuals within the 
systematic bias between sexes were assessed with independent samples t-tests (or 
Mann Whitney-U for non-parametric data sets). Cohen’s Kappa test was used to 
assess PB classification agreement between the IPAQ and GENEA. Whilst 
Pearson’s Chi Squared was used to assess the effect of sex on PB classification.  
Significance was set at p≤0.05. Explained variance was expressed as weak 
(<0.40), moderate (≥0.40), or strong (≥0.60). Data are presented as Mean ± 






Seventy-three participants (54% females) were included in the reliability 
assessment while 86 participants (52% females) were included in the validity 
assessment of the IPAQ (table 2.2.2). Two females were then excluded from the 
validity assessment due to GENEA data errors.  
Table 2.2.2. Participant demographics and breakdown of IPAQ completion. 
Group Male (n = 41) Female (n = 48) Pooled (n = 89) 
Completed (n = 33) (n = 40) (n =73) 
Age (yrs) 74.6 ± 6.0 72.8 ± 6.8 73.7 ± 6.5 
Height (m) 1.7 ± 0.1 1.6 ± 0.1 1.6 ± 0.1 
Mass (kg) 79.8 ± 11.0 71.4 ± 12.5 75.2 ± 12.5 
BMI (kg·m2) 27.6 ± 4.0 28.3 ± 5.0 28.0 ± 4.6 
Missing first visit IPAQ (n = 8) (n = 5) (n =13) 
Age (yrs) 76.1 ± 5.2 72.3 ± 5.7 74.3 ± 5.4 
Height (m) 1.70 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 
Mass (kg) 85.1 ± 8.9 70.0 ± 20.5 80.4 ± 15.6 
BMI (kg·m2) 28.5 ± 3.7 27.2 ± 8.7 27.9 ± 5.8 
Missing second visit IPAQ (n = 0) (n = 3) (n =3) 
Age (yrs)  69.0 ± 6.1 69.0 ± 6.1 
Height (m)  1.7 ± 0.1 1.7 ± 0.1 
Mass (kg)  85.3 ± 14.1 85.3 ± 14.1 
BMI (kg·m2)  31.1 ± 5.9 31.1 ± 5.9 
BMI Body mass index.    
 
 
Relative Reliability of the IPAQ 
 
Within the pooled population, a weak correlation between first and second 
visit IPAQ data was present for total week SB (figure 2.2.1a). For total week 
10MVPA, moderate correlations were found between first and second visit IPAQ data 
for the pooled population (figure 2.2.1b). Interestingly, the majority of data points 
were situated below the line of unity for total week SB and total week 10MVPA; 
suggesting that there was a trend for participants to report a lesser amount of time 
spent performing total week SB and total week 10MVPA in the second visit IPAQ 




Figure 2.2.1 a) Spearman rho correlation between first and second visit IPAQ total week SB. b) 
Spearman rho correlation between first and second visit IPAQ total week 10MVPA. * p≤0.05, ** 
p≤0.01, *** p≤0.001. 
 
Absolute Reliability of the IPAQ 
 
A Bland-Altman plot (figure 2.2.2a) of total week SB difference between first 
visit and second visit IPAQ for the pooled population showed small systematic bias 
(non-significant). However the 95% confidence intervals (95%CI) suggested large 
inter-individual random error (b=1.51±25.9 h·week-1). Systematic bias was similar 
as total week SB mean increased, suggesting no proportional bias (p=0.21).  
 For total week 10MVPA, a Bland-Altman plot (figure 2.2.2b) of total week 
10MVPA difference between first visit and second visit IPAQ for the pooled 
population showed systematic bias (b=6.37±22.7 h·week-1, p=0.025). It is notable 
that heteroscedasticity was present for the pooled population (Kolmogorov-Smirnov, 
p<0.001). Thus, proportional bias was present due to the difference between first 
and second visit IPAQ total week 10MVPA data increasing as the mean of first and 




Figure 2.2.2 a) Bland-Altman plot of the difference between First and Second Visit IPAQ data against 
the Mean of the First and Second Visit IPAQ data for total week SB. b) Bland-Altman plot of the 
difference between First and Second Visit IPAQ data against the Mean of the First and Second Visit 
IPAQ data for total week 10MVPA. Lines represent systematic bias and 95%CI for pooled, male, and 
female populations.  
 
Concurrent Validity of the IPAQ 
 
Total week SB measured by the IPAQ was 41% (p≤0.05) less than that of 
GENEA while total week 10MVPA measured by the IPAQ was 15.7 fold (p≤0.05) 
greater than that of GENEA. Interestingly, IPAQ total week 10MVPA was similar to 
GENEA sMVPA (21.6±19.4 h·week-1, Median 16.6(8.63) h·week-1, 18.5±5.63 




Figure 2.2.3. Comparison between IPAQ and GENEA measures of total week SB, total week 
10MVPA, and GENEA total week sMVPA. * p≤0.05. 
 
The pooled population showed a weak correlation between IPAQ and 
GENEA measures of total week SB (figure 2.2.4a). Additionally, the majority of data 
points were situated below the line of unity; suggesting a trend for the IPAQ to under 
report total week SB when compared to GENEA measures. This is also supported 
by a Bland Altman (figure 2.2.5a) plot that suggested all but two participants (11.4 
h·week-1, 30.8 h·week-1) under-reported their total week SB using the IPAQ (pooled: 
b=-27.6±26.5 h·week-1, p<0.001). Proportional bias was present in the pooled 
population (p≤0.001). 
No significant correlation (p>0.05) between IPAQ and GENEA measures of 
total week 10MVPA was found for the pooled population (figure 2.2.4b). 
Heteroscedasticity was present in total week 10MVPA data sets (p≤0.001). A Bland-
Altman revealed systematic bias that suggested the IPAQ over reported total week 
10MVPA compared to GENEA (figure 2.2.5b, b=20.3±19.6 h·week-1, p≤0.001). The 
presence of proportional bias suggested the difference between IPAQ and GENEA 
measures of total week 10MVPA increase as the mean of IPAQ and GENEA total 
week 10MVPA increase (p≤0.001).  
A weak correlation between IPAQ total week 10MVPA and GENEA total week 
sMVPA was present for pooled populations (figure 2.2.4c). Heteroscedasticity, the 
variance of the error in the IPAQ was predicted by a GENEA variable (Kaltenbach, 
2012), was present for both total week 10MVPA and sMVPA data sets (p≤0.001). 
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Interestingly, a Bland-Altman test suggested there was no systematic bias between 
IPAQ total week 10MVPA and GENEA total week sMVPA measures (figure 2.2.5c, 
b=3.13±17.5 h·week-1, p=0.11). However, proportional bias was present (p≤0.001). 
 
 
Figure 2.2.4 a) Spearman rho correlation between IPAQ and GENEA measures of total week SB. b) 
Spearman rho correlation between IPAQ and GENEA measures of total week 10MVPA. c) Spearman 
rho correlation between IPAQ total week 10MVPA and GENEA total week sMVPA. * p≤0.05, ** 












Figure 2.2.5 a) Bland-Altman plot of IPAQ and GENEA total week SB. b) Bland-Altman plot of IPAQ and GENEA 
total week 10MVPA. c) Bland-Altman plot of IPAQ total week 10MVPA and GENEA total week sMVPA. Lines 





A moderate and weak correlation was found between first and second visit 
IPAQ total week SB data sets for males and females, respectively (figure 2.2.1a). 
These correlations were not significantly different from one another (z=0.62, 
p>0.05). Additionally, male and female correlation slopes were similar (z=1.48, 
p>0.05). A Bland-Altman plot illustrated that the systematic bias between first and 
second visit IPAQ total week SB was non-significant for males and females 
(b=2.91±22.8 h·week-1, b=0.61±28.2 h·week-1, p>0.05, respectively). Proportional 
bias was not present for either group (figure 2.2.2a). There was no significant 
difference between the systematic bias of males and females (p=0.53). 
 Moderate correlations between first and second visit IPAQ total week 
10MVPA data sets were found for males and females (figure 2.2.1b). These 
correlations were not significantly different (z=0.02, p>0.05). However, male and 
female correlation slopes were significantly different (z=-2.20, p<0.05). A Bland-
Altman plot illustrated that the systematic bias between first and second visit IPAQ 
total week 10MVPA was non-significant within males and females (figure 2.2.2b, 
b=3.64±18.8 h·week-1, b=8.62±27.1 h·week-1, p>0.05, respectively). The systematic 
bias was not different between males and females (p=0.68). Proportional bias was 
present for females (p≤0.001) but not for males (p=0.08) (figure 2.2.2b). 
 No sex differences were present within measures of total week SB, 10MVPA, 
or sMVPA for second visit IPAQ and GENEA (figure 2.2.3). Differences between 
IPAQ and GENEA measures of total week SB, 10MVPA were found for males and 
females (p≤0.05). No difference between IPAQ total week 10MVPA and GENEA 
sMVPA was found for males and females (figure 2.2.3). 
 Weak correlations were found between IPAQ and GENEA total week SB 
within males and females (figure 2.2.4a), though there was no difference either 
between these correlations (z=-0.25, p>0.05) or male and female correlation slopes 
(z=0.22, p>0.05).  A Bland-Altman plot (figure 2.2.5a) illustrated that there was 
systematic bias between IPAQ and GENEA total week SB for males and females 
(b=-25.9±31.4 h·week-1, p<0.05, b=-29.3±20.7 h·week-1, p<0.05, respectively). No 
difference in systematic bias was found between sexes (p=0.25). Proportional bias 
was present for males (p≤0.001) but not females (p=0.32). 
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 No correlation was found between IPAQ and GENEA total week 10MVPA 
within males and females (figure 2.2.4b). The correlations coefficients and slopes 
did not differ between sexes (z=-0.07, p>0.05, z=-0.54, p>0.05, respectively). A 
Bland-Altman plot illustrated that systematic bias was present for the difference 
between IPAQ and GENEA total week 10MVPA within males and females (figure 
2.2.5b, b=19.3±19.8 h·week-1, p≤0.001, b=21.2±19.6 h·week-1, p≤0.001, 
respectively). Systematic bias was not different between sexes (p=0.44). 
Proportional bias was present for both sexes (p≤0.001). 
 Weak correlations between IPAQ total week 10MVPA and GENEA total week 
sMVPA were present for males and females (r2=0.18, p≤0.01, r2=0.22, p≤0.01). 
These correlations were not different between sexes (z=-0.09, p>0.05). Male and 
female correlation slopes were non-significantly different (z=-0.70, p>0.05). A 
Bland-Altman plot (figure 2.2.5c) illustrated no systematic bias between IPAQ total 
week 10MVPA and GENEA total week sMVPA for males and females (b=2.02±17.7 
h·week-1, p=0.47, b=4.17±17.4 h·week-1, p=0.12, respectively). Systematic bias was 
not different between sexes (p=0.41). Proportional bias was present for both sexes 
(p≤0.001). 
 The IPAQ and GENEA exhibited low agreement in the PB classification of 
the pooled (k=-0.01, p=0.55), male (k=-0.03, p=0.28), and female (k=0.01, p=0.69) 
populations (table 2.2.3). Only 2% of PB levels were correctly classified by the IPAQ 
in the pooled, male, and female populations (table 2.2.3). Sex was without effect on 












Table 2.2.3. Physical behaviour classification of the IPAQ compared against that of GENEA. 
IPAQ GENEA  





NC NC NC NC NC 
ACP 9 (7 M, 2 F) 1 (0 M, 1 F) NC NC 10 (7 M, 3 F) 
Ambulator 5 (2 M, 3 F) NC NC NC 5 (2 M, 3 F) 
Active 
Ambulator 
47 (19 M, 28 F) 10 (7 M, 3 F) 11 (5 M, 6 F) 1 (1 M, 0 F) 69 (32 M, 37 F) 
GENEA 
Total 
61 (28 M, 33 F) 11 (7 M, 4 F) 11 (5 M, 6 F) 1 (1 M, 0 F) 84 (41 M, 43 F) 
NC Not classified based on their IPAQ data, participants were not classified into the group in 




The objectives of this study were to compare two self-administered IPAQ 
Long-Form, English (last 7 days format) documents completed a week apart by a 
middle-class older adult UK population and to evaluate the results of the IPAQ to 
GENEA measures of free-living SB and MVPA. The aims were to 1) Assess the 
reliability and validity of the IPAQ for SB and MVPA in these comparatively older-
old, community-dwelling persons and 2) Determine any sex differences within the 
reliability and validity assessments. It was hypothesised that the IPAQ would provide 
a reliable (i.e. repeatable) measure of total week SB and 10MVPA in relatively older 
persons but may not provide acceptable levels of external validity (i.e. when 
absolute data are compared against GENEA data sets). Additionally, it was thought 
that sex differences would not influence reliability and validity assessments of the 
IPAQ. The results of the current study suggest that two hypotheses can be upheld: 
the IPAQ does not provide acceptable levels of validity when compared to GENEA 
measures of total week SB and 10MVPA in older persons. As expected, sex 
differences did not influence reliability and validity assessments of the IPAQ. In 
addition to these accepted hypotheses, the IPAQ showed low reliability/repeatability 





Reliability of the IPAQ 
 
Relative reliability of the IPAQ exhibited a significant repeated measures 
correlation coefficient (r =0.59; r2=0.26, p<0.001) for total week SB. This is lower 
than that reported in the relatively younger population (36.8±7.93 years) used in the 
original 12-country IPAQ study (Craig et al., 2003) (r=0.83±0.06, p≤0.05) and lower 
than the UK population (r=0.84, p≤0.05) used in the aforementioned study. Whether 
the geographical location and therefore socio-economic factors of the participants 
(current study: Cheshire East Borough, vs. Craig et al. (2003): Bristol) played a role 
in the differences between studies is unknown. It could be argued that, unlike the 
participants in the current study, the adults in the study of Craig et al. (2003) were 
still employed and therefore, had a predictable structure in their day-to-day lives. 
However, older adults have been shown to also have similarly predictable daily 
routines (Monk et al., 1992), which they highly value (Belza et al., 2004). 
Furthermore, the lack of systematic bias (figure 2.2.2a) in the difference between 
first and second visit IPAQ total week SB may be highlighting this predictability in 
daily routines (Monk et al. (1992). On the other hand, large 95%CI (b=1.51±25.9 
h·week-1) questions the reliability of the IPAQ. 
The IPAQ measure of total week 10MVPA also displayed a moderate relative 
reliability coefficient (r=0.69, r2=0.47, p<0.001) but showed systematic bias 
(b=6.37±22.7 h·week-1, p=0.025), thereby putting in question the reliability of the 
IPAQ for quantifying absolute MVPA in older persons. Unfortunately, the current 
study data cannot be compared with the 12-country IPAQ study as the previous 
study did not provide a suitable comparable measure of MVPA (Craig et al., 2003). 
However, the results of the current study are similar to previous IPAQ –Long Form 
reliability measures in Belgian older adults (r=0.63) (Van Holle et al., 2015) and 
outperformed the reliability of the IPAQ – Long Form, Chinese (7 day format), which 
found no significant between week correlation (Cerin et al., 2012). The presence of 
positive systematic bias (figure 2.2.2b) and the majority of data points below the line 
of unity for total week 10MVPA (figure 2.2.1b) may illustrate a learning effect 
following the completion of the first visit IPAQ or greater awareness of 10MVPA 
engagement. The greater awareness may be a result of a weeklong lifestyle 
surveillance by GENEA. However, is it hoped that the discrete and unrestrictive 
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placement of GENEA (mid-thigh) would minimise any effect on the participant’s 
awareness of lifestyle.   
 
Validity of the IPAQ 
 
For measurement of time spent performing SB or MVPA, accelerometry is 
considered the gold standard (P. Kelly et al., 2016). Moreover, thigh-mounted 
accelerometry is deemed the most suitable for SB measures due to the change in 
thigh orientation that is common to the transition from standing to seated or reclined 
postures (Steeves et al., 2015). A strength of the current study is that it used a thigh-
mounted triaxial GENEA that records the amount of static acceleration due to 
gravity. Using this knowledge, the in-house developed algorithm (CAS) (Wullems et 
al., 2015) can calculate thigh orientation relative to the Earth’s surface to accurately 
determine whether the participant is standing, sitting down, lying sideways, or prone. 
Furthermore, unlike earlier research that applied accelerometer cut-points, which 
were not validated for the population being studied, the CAS uses cut-off points 
validated against the energy expenditure (METs) of aged-matched older adults (in 
our laboratories, Chapter 02: Part 1) to determine the time spent performing different 
PA intensities. 
Participants had great difficulty in reporting total week SB using the IPAQ and 
often spent a few minutes formulating an answer. Although, significant correlations 
between IPAQ and GENEA for total week SB were present (figure 2.2.4a), 
differences in average time (figure 2.2.3) and systematic bias (figure 2.2.5a, 
27.6±26.5 h·week-1, p<0.001) revealed that the IPAQ underestimated total week 
SB by 41%. Only two participants over-reported their amount of total week SB 
(+11.4 and +30.8 h·week-1). This underestimation is consistent with another IPAQ 
validity study (hip mounted accelerometer) (b=27.4±3.46 h·week-1, p≤0.001) that 
used older adults (n=94, 65-85 years) (Cerin et al., 2012). Under-reporting is a 
common problem, qualitative research has shown that the sitting questions create 
confusion, as “sitting on a weekday?” does not provide details on which ‘day’ to 
report (Van Uffelen et al., 2011; Heesch et al., 2010). Sedentary behaviour is viewed 
as a negative lifestyle choice by older adults (Mcewan et al., 2016). Therefore, 
participants may have reported the day that had the least amount of SB to appear 
socially desirable. This is supported by the negative association found between 
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social desirability and self-reported SB in other populations (Jago et al., 2007). 
Alternatively, this difficulty in recall may also be due to the sporadic nature of SB 
and, unlike MVPA, engagement in other behaviours that occur at the same time as 
SB (e.g. eating, reading, and driving). Qualitative data was not the focus of this 
study; however, participant’s recollection of SB often came in the form of TV viewing 
therefore, SB such as eating may have been overlooked. 
For total week 10MVPA, a large systematic bias was also present as 
participant‘s IPAQ data over-reported by 20.3±19.8 h·week-1 (p<0.001) equivalent 
to, on average, 15.7 fold greater than total week 10MVPA time. This overestimation 
is consistent with previous IPAQ research that used accelerometry (hip mounted) in 
older adults (Cerin et al., 2012; Van Holle et al., 2015; Grimm et al., 2012). This, like 
SB, may be a result of social desirability as older adults view PA as a positive 
lifestyle choice (Belza et al., 2004). Alternatively, participants may be reporting 
MVPA bouts that were less than 10 continuous minutes in duration. The results of 
the current study revealed weak correlations between IPAQ total week 10MVPA and 
GENEA total week sMVPA (figure 2.2.4c, r2=0.19, p≤0.001). However, there was a 
small non-significant systematic bias between the two aforementioned variables 
(figure 2.2.5c, b=3.12±17.5, p=0.11) and no statistical difference between the 
population means of these two variables (figure 2.2.3). Heesch et al. (2010) 
suggested that the structure of the questions may be leading to this problem as the, 
"report activities lasting ≥ 10 minutes per session" instruction is included in the 
`number of days the activity was performedˊ question and not the following question 
relating to the duration of one of those activities. This could be interpreted that the 
10-minute criterion only relates to the frequency of the activity per week and not the 




There was only one incident of a sex difference in the reliability of PA 
measures. For the relative reliability of total week 10MVPA, males correlation slope 
was found to be greater than females (figure 2.2.1b, z=-2.20, p<0.05). Males and 
females had similar levels of GENEA measured total week 10MVPA, sMVPA, and 
SB (figure 2.2.3) therefore, it seems unlikely that one of the groups performed tasks 
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that were not as memorable during the monitoring week (Kriska, 2000). 
Unfortunately, participants did not wear GENEA prior to the completion of the first 
visit IPAQ. Therefore, we cannot be sure whether this suggested sex difference was 
a result of changeable memory within groups or actual inter-week behaviour change 
(P. Kelly et al., 2016). 
As a result of the IPAQ overestimating total week 10MVPA and 
underestimating total week SB, the majority of participants were placed into a higher 
PB classification than they actually were (table 2.2.3). A previous attempt to 
correctly classify older adults (66 – 85 years) as physically active had found an 81% 
(k=0.448, p<0.001) agreement between IPAQ and waist mounted accelerometer 
data (Hurtig-Wennlöf et al., 2010). For direct comparison, of the 12 participants that 
were physically active in the current study, based on GENEA data (ACP and Active 
Ambulator), 100% of those participants were correctly classified as physically active 
by the IPAQ.  However, an additional 62 participants were also classed as physically 
active by the IPAQ causing only 14% of participants to be classified as physically 
inactive by the IPAQ. Overall, the IPAQ was only able to correctly classify 2% (k=-
0.01, p=0.55) of the participants into one of the four PB groups for the pooled, male 
and female populations, causing no participants to be classed as a Couch Potato 
(table 2.2.3). In addition, sex had no effect on the ability of the IPAQ to correctly 




The age of the participants in our current study ranged from 60 – 89 years, 
which only has a 9 year overlap with population for whom the IPAQ was originally 
validated for (15 – 69 years) (Craig et al., 2003). Arguably, the reduced reliability of 
the IPAQ, could be partially assigned to this fact. Notably however previous studies 
have not made this distinction and have indiscriminately used the IPAQ in similarly 
much older population (Milanović et al., 2013) and yet have not reported any 
necessity to improve the uptake of the questionnaire through population stratification 
by decade of age, thereby supporting our current design that includes persons aged 






This is one of the first studies to use thigh-mounted accelerometry 
(considered the gold standard for SB and MVPA measurement) as a validator for 
the self-administered IPAQ – Long Form, English (last 7 days format) in older adults. 
The results of the current study suggest that use of the self-administered IPAQ – 
Long Form, English (last 7 days format) in the ‘older-old’ adults shows little relative 
and absolute reliability when re-tested in an 8 – 11 day window, even after 
accounting for the fact that there two weeks of monitoring where self-reporting as 
‘typical’. A Bland-Altman plot that revealed total week SB is underestimated by the 
IPAQ supports a weak correlation found between the IPAQ and GENEA measures 
of total week SB. This suggests that the IPAQ may not be suitable for quantitatively 
measuring SB in older adults. Similarly, the IPAQ overestimated the amount of total 
week 10MVPA and this was likely due to participants reporting MVPA bouts that were 
less than 10 continuous minutes, as there was no difference or systematic bias 
between IPAQ total week 10MVPA and GENEA total week sMVPA measures. 
Therefore, the IPAQ may not be suitable for measuring MVPA that consists of bouts 
at least 10 continuous minutes in duration. Due to underestimation of SB and 
overestimation of 10MVPA by the IPAQ, only 2% of participants were correctly 
categorised into one of the four PB groups. Interestingly, no difference in reliability 
or validity measures were found between sexes apart from correlation slope 
measures of total week 10MVPA reliability. Based on these results, it is suggested 
that the IPAQ should not be used as a monitoring technique to qualitatively classify 
or quantitatively measure habitual PB in older adults. Research aiming to monitor 
PB should use an objective measurement technique where possible. The objective 
of future research should be to increase the number and precision of the questions 
in the self-administered IPAQ Long-Form, English (last 7 days format), specifically 
addressing SB, to make it more relevant to older adults (e.g. changing examples of 





Segregating the distinct effects 
of sedentary behaviour and 
physical activity on older adults’ 
cardiovascular structures and 
functions. 
 
Part 1: ‘Linear regression analysis approach.’ 
 
Part 2: ‘Isotemporal substitution approach.’ 
 
Part 3: ‘3-Dimensional heat mapping approach.’  
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Cardiovascular related deaths in the UK increase ~1.8 fold per decade 
between the ages of 55 – 85+ years (yrs) (Townsend et al., 2015). This dramatic 
increase is likely to augment the socioeconomic burden as people over the age of 
60 are forecast to account for 25% of the population by the year 2035 (Office for 
National Statistics, 2012a). Physical activity (PA), more specifically moderate-
vigorous PA (MVPA), has been shown to be successful in the risk reduction and 
treatment of cardiovascular diseases (CVD) and therefore, is recommended in 
government policies. It is recommended by the UK government that older adults 
engage in bouts of at least 10 continuous minutes (mins) of MVPA that accumulate 
to a minimum of 150 mins over a seven-day week (Department of Health Social 
Services and Public Safety, 2011). In 2011, the government PA recommendations 
were updated to highlight the need to also avoid bouts of prolonged sedentary 
behavior (SB), in light of the increased awareness of the independent effects of SB 
on health (Bey and Hamilton, 2003; Gennuso et al., 2013; Gennuso et al., 2015). 
However, this initial recommendation was made in the absence of any clear 
evidence of the metabolic and/or circulatory consequences of prolonged SB in older 
adults. As such, it was not possible to provide a quantitative recommendation for 
SB time. Timely and recent evidence highlights the degree to which increments in 
SB time and other SB measures (e.g. breaks in SB) affect cardiovascular health 
independent of MVPA engagement (Thosar et al., 2014; Stamatakis et al., 2012; 
Gennuso et al., 2013; Gennuso et al., 2015; Rezende et al., 2016; García-Hermoso 
et al., 2015). Thus, it has been proposed that low intensity PA (standing, and light 
intensity PA [LIPA]) could be used to reduce SB time and improve heath (Bailey and 
Locke, 2014; Peddie et al., 2013), either directly or indirectly.   
With technological improvements, it is now possible to accurately quantify 
physical behaviour (PB) levels (SB and PA time). Thigh-mounted triaxial 
accelerometers are considered the gold standard for SB time quantification as 
posture can be determined through recognising the positional orientation of the 
upper leg relative to the Earth’s surface and monitoring can be carried out in real-
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time over a number of days. However, few key cardiovascular parameters have 
been mapped against this gold standard method of SB quantification (Brocklebank 
et al., 2015; Hajduk and Chaudhry, 2016).  
Therefore, the goal of the present study was to determine the degree of 
association between thigh-mounted accelerometer measures of habitual PB and 
key cardiovascular parameters in older adults. The objectives of this study were 
threefold: 1) determine whether measures of daily PB predict older adults’ 
cardiovascular profile; 2) determine which measures of PB patterns are better 
predictors of cardiovascular profile; 3) highlight any effects of SB on cardiovascular 
profile that are independent of MVPA and vice versa. The aim of this study was to 
provide an evidence-based recommendation for the parameter of PB that is the 
most prolific predictor of cardiovascular profile. It was broadly hypothesised that SB 
would be independently associated with certain cardiovascular parameters so that 
an objective lifestyle recommendation of SB may have to consider both amount and 
pattern of SB accumulation to ultimately improve health. In addition, it was 
hypothesised that PA, other than MVPA, could improve cardiovascular profile, thus 
creating an evidence-base for a recommendation for the spectrum of PA intensity 




Ninety-three older participants (73.8±6.23 yrs, 60 – 89 yrs, 55% female) 
whose screening questionnaire revealed as independently mobile (did not require a 
wheelchair or Zimmer frame), did not suffer from an untreated cardiovascular 
disease, had not sustained an injury within the preceding three months, had not 
ever/recently suffered from a neurological disease that impaired motor control or 
academic ability, and were not diabetic, were recruited for the study. These 
participants were recruited primarily from older adult community groups within the 
Cheshire East Borough, England. The local University (Manchester Metropolitan 
University) Ethics Sub-Committee granted ethical approval. Participant approval 
was acquired through written informed consent. Participants visited the laboratory 




First Laboratory Visit 
 
On the first visit participant demographics were collected (table 3.1.1) and 
test protocol familiarisation was conducted. Height and mass were measured with a 
stadiometer (Harpenden, Holtain, Croswell, Wales) and electronic weighing scales 
(Salter, Kent, England). Hydration was assessed during the second visit as outlined 
below (see Second Laboratory Visit). Participants were fitted with a commercially 
available thigh mounted (anterior aspect, at 50% of greater trochanter to femoral 
condyle distance) triaxial accelerometer (GENEA, GENEActiv Original, Activinsights 
Ltd, Kimbolton, UK) using two waterproof adhesive patches (3M Tegaderm Film, 
North Ryde, Australia) on their dominant leg, which remained in place for seven 
consecutive, free-living days. Standing leg preference during a single leg balance 
exercise, determined leg dominance. GENEA data (60.0 Hertz [Hz] frequency) were 
smoothed using 10 second (s) epochs. Residual G was selected as the GENEA 
output (equation 3.1.1), adapted from previous work on total movement analysis in 
older persons (Onambele et al., 2006) and termed the Cheshire Algorithm for 
Sedentarism (CAS, Chapter 02: Part 1). 
Table 3.1.1. Demographics for pooled, male, and female populations. Data presented as mean 
(standard deviation) unless stated otherwise. 
Variable Pooled Male Female 
Age (yrs) 73.8 (6.22) 74.9 (5.77) 72.8 (6.48) 
Height (m) 1.65 (0.08) 1.71 (0.07) 1.59 (0.06)*** 
Mass (kg) 75.9 (13.1) 81.1 (10.6) 71.7 (13.4)*** 
BMI (kg·m2) 27.9 (4.71) 27.6 (3.90) 28.1 (5.32) 
Primary CVD Meds (%)† 48.0 55.0 43.0 
(in)direct CVD Meds (%)‡ 59.0 55.0 63.0 
Hydration (%∙body mass-1) 50.6 (7.15)m 53.8 (5.08)m 46.4 (9.70)m*** 
† Participants are currently prescribed an amount of medication that reduces the risk or treats 
CVD (i.e. statins, warfarin). ‡ Participants are currently prescribed a medication that may affect 






  Equation 3.1.1. Residual G calculation. 
Residual G = √(SD x2 + SD y2 + SD z2) 
Where: x is the medio-lateral axis 
y is the vertical axis 
z is the anterior-posterior axis 
SD is standard deviation 
√ is square root 
 
The SB-LIPA (1.50 Metabolic Equivalent Tasks [METs]) cut-off point was 
0.057 Residual G and the LIPA-MVPA (3.00 METs) cut-off point was 0.216 Residual 
G. To obtain these cut-off points, a systematic validation of the GENEA against 
expired gas during a laboratory-based activity calibration protocol, was carried out 
in a sub-sample of older adults (n=20, Chapter 02: Part 1). Thus, nine PB functions 
(i.e. 1-lying down, 2-sitting, 3-standing quietly, 4-repeated side-stepping 5-self-
selected speed ground walking, 6-3.5 km∙hr-1 walk on treadmill, 7-self-selected 
speed walk on treadmill, 8-self-selected speed weighted-vest treadmill walking [at 
15% of body weight], 9-self-selected speed brisk walk on treadmill) were monitored 
with concurrent gas analyses, heart rate, motion analysis and accelerometer output. 
The scatter plot exhibited a strong explained variance between Residual G 
(GENEA) and METs (expired gas) (r2=0.89, p<0.001). Postural identification using 
accelerometer axes orientation, similar to that developed by Rowlands et al. (2014), 
showed perfect agreement with known time spent performing SB (6.00 mins) and 
PA (21.0 mins) (Cohen’s kappa=1.00 [95% confidence interval (CI) 1.0, 1.0], 
p<0.001). Residual G cut-off points and MET thresholds had a strong agreement for 
PB intensity identification (Cohen’s kappa=0.81 [95%CI 0.49, 1.31], p<0.001). To 
help account for individual differences in physical fitness, one MET was equal to the 
resting metabolic rate (RMR) of the participant. Participants were provided with a 
self-report sleep diary (wake-up time, lights-off, go to sleep time, naps not included) 
and were requested to complete it throughout the GENEA data collection week. 
GENEA outcome variables and definitions are provided in table 3.1.2. Previous 
GENEA findings have suggested that 6 days of accelerometer wear time are 
required to provide reliable estimates of PB (Dillon et al., 2016). Therefore, three 
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participants were removed from the analyses for not having sufficient accelerometer 
data (≥6 days).Hydration guidance was provided as participants were asked to 
arrive at the second laboratory visit in a fasted state (>8.00 hrs) but also hydrated 
as this could influence vascular parameters. 
Table 3.1.2. Definitions of the PB parameters provided by the CAS. 
Terminology Unit Definition 




The mean amount of SB, of any length, that is 
accumulated in a 24hr day. 
Any waking behaviour characterised by a seated or 
reclined posture (Tremblay et al., 2010). 
Standing hrs·day-1 
The mean amount of standing, of any length, that is 
accumulated in a 24hr day. 
Any standing posture that elicits little to no movement 






The mean amount of LIPA, of any length, that is 
accumulated in a 24hr day. 
Any standing posture that elicits 1.50 - <3.00 METs 
(Tremblay et al., 2010). 




The mean amount of MVPA, of any length, that is 
accumulated in bouts <10.0 mins in a 24hr day 
(Department of Health Social Services and Public 
Safety, 2011). 
Any standing posture that elicits ≥3.00 METs (Tremblay 
et al., 2010). 
≥10 Minute Moderate 
to Vigorous Physical 
Activity (10MVPA) 
hrs·day-1 
The mean amount of MVPA that is accumulated in bouts 
≥10.0 mins in a 24hr day (Department of Health Social 
Services and Public Safety, 2011). 
Any standing posture that elicits ≥3.00 METs (Tremblay 
et al., 2010). 
Patterns of PB   
SB Parameters   
SB Breaks n·day-1 
The mean amount of SB Breaks in a 24hr day. 
≥2.00 mins of continuous PA (Benatti and Ried-Larsen, 
2015) 
 that follows ≥1.00 of SB (Messinger‐Rapport et al., 





Table 3.1.2 continued. 
<5min SB Bout n·day-1 
The mean amount of SB bouts that consist of <5.00 
mins in a 24hr day (Saunders et al., 2013). 
SB bout starts after ≥2.00 mins of PA is followed by 
≥1.00 mins SB and ends with an ‘SB Breaks’. Contains 
SB and <2.00 mins of PA. 
≥5min SB Bout n·day-1 
The mean amount of SB bouts that consist of ≥5.00 
mins in a 24hr day (Saunders et al., 2013). 
SB bout starts after ≥2.00 mins of PA is followed by 
≥1.00 mins SB and ends with an ‘SB Breaks’.  Contains 
SB and <2.00 mins of PA. 
True Mean SB Bout 
 
mins·day-1 
SB time (≥1.00 mins) between PA bouts of ≥ 2.00 mins 
are LOG transformed to normally distribute the data and 
then anti-logged to find the “True Mean” (Chastin et al., 
2015c). Mean amount in a 24hr day. 
Alpha α·day-1 
How steeply the number of SB bouts decreases with 
increasing SB bout duration in a power-law distribution 
(Chastin et al., 2015c).  Mean amount in a 24hr day. 
W50% mins·day-1 
50% of SB time in a 24hr day is accumulated by SB 
bouts of this specific length or shorter (Chastin et al., 




The mean percentage of waking hours that is spent 





The mean amount of bouts that consist of ≥2.00 mins of 
continuous PA (Benatti and Ried-Larsen, 2015) followed 
by ≥1.00 mins of continuous SB (Messinger‐Rapport et 
al., 2003) in a 24hr day. PA bout starts after ‘SB Breaks’ 
and ends with an SB bout. Contains PA and <1.00 mins 
of continuous SB. 
Daily Sum of PA Bout 
time 
mins·day-1 
The mean amount of time that spent in ‘PA Bouts’ in a 
24hr day. 
True Mean PA Bout mins·day-1 
PA time (≥2.00 mins) between SB bouts of ≥ 1.00 mins 
are LOG transformed to normally distribute the data and 
then anti-logged to find the “True Mean” (Chastin et al., 
2015c). Mean amount in a 24hr day. 
10MVPA Bouts n·day-1 
The mean amount of bouts that consist of ≥10.0 mins 




Second Laboratory Visit  
 
Participants arrived for the second laboratory visit in a fasted, hydrated state. 
Where appropriate, participants were asked to refrain from taking medication until 
testing had been completed. All participants refrained from taking medication prior 
to the completion of the laboratory tests. A standardised meal (43.0% carbohydrate, 
43.0% protein, 14.0% fat) was provided to participants before commencing the 
testing session. 
  A three lead electrocardiogram (ECG) was fitted to participants to allow for 
R-gated artery analysis and resting heart rate measures. The skin was cleaned with 
an alcohol wipe prior to electrode (BlueSensor M, Ambu, Copenhagen, Denmark) 
placement. Participants began testing by resting in the supine position for 15.0 mins 
to minimise any impact of orthostatic changes. Room temperature and light intensity 
were maintained at 22.0°C and 20.0 lm·ft2 (Sekonic Studio Deluxe III L-398A Light 
Meter, Sekonic, Newcastle Under Lyme, UK), respectively, in order to minimise any 
impact of environmental ambience variations. Supine blood pressure (BP) (M2 
HEM-7121-F, OMRON, Hoofddorp, The Netherlands) was assessed three times to 
obtain an average systolic BP, diastolic BP, and pulse pressure. 
 Hydration was assessed using bioelectrical impedance analysis (BIA) 
(BodyStat 1500, BodyStat, Douglas, UK). The BIA assessed total body water as a 
percentage of total body mass using the manufacturer’s own algorithms that 
accounted for sex, age (yrs), height (cm), and body mass (kg). BIA has been shown 
Table 3.1.2 continued. 
Total Week 10MVPA hrs·week-1 
The sum amount of ‘10MVPA Bouts’ time that is 




The mean percentage of waking hours that is spent 




The mean percentage of waking hours that is spent 




The mean percentage of waking hours that is spent 




The mean percentage of waking hours that is spent 
performing ‘10MVPA’ in a 24hr day. 
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to be a reliable (Shanholtzer and Patterson, 2002) and valid (Ritz, 2001) method for 
hydration assessment. Participants were hydrated if total body water, as a 
percentage of total body mass, was 55.0% - 65.0% for males or 50.0% - 60.0% for 
females. 
 
Baseline Vascular Assessment 
 
Ultrasound assessments were performed using an echo Doppler ultrasound 
machine (model AU5; Esaote, Genova, Italy) with a 7.50 MHz broadband linear 
array transducer in brightness or B-mode with an angle of insonnation of 60.0° 
(Harris et al., 2010) (B gain: 75.0, Doppler gain: 49.0, CFM gain: 47.0, depth of 
penetration: 49.3 mm, depth of focus: 27.0 – 31.0). Live streaming of all 
assessments were collected on a Hewlett-Packard computer running video capture 
software (Premier 6.0, Adobe Systems, San Jose, USA) through an analogue to 
digital converter (Pinnacle, Corel Inc., Ottawa, Canada) at 25.0 Hz. The depth of the 
transducer penetration was noted to allow for video scaling during off-line analyses 
using Brachial Analyzer (no Bland-Altman bias in reliability, and low pixel error in 
synthetic data analysis (Sonka et al., 2002)) and Carotid Analyzer (Medical Imaging 
Application LLC, Iowa, USA), which has shown excellent validity compared to 
previous methods (r2=0.98, p<0.001, Bland-Altman bias 0.04, p=0.82) (Mancini et 
al., 2004). Participants were supine for left common carotid artery, right brachial 
artery, and prone for left popliteal artery baseline assessments. Video recordings 
were collected over ten cardiac cycles (Harris et al., 2010; Gill, 1985) for the 
assessment of systemic peak blood velocity, intima-media thickness (IMT), artery 
diameter, calculation of shear rate, and resistance index (RI) (table 3.1.3). All 
structural measures were obtained in a 10 mm region of interest (ROI), which was 
10 mm distal to the carotid bulb in the anterior (AL) and posterior longitudinal (PL) 
plane (figure 3.1.1) and 10 mm distal to the superior medial genicular bifurcation for 
the popliteal artery (Touboul et al., 2012). Artery diameter measures were filtered 
using automated R-gating to ensure artery diameter was measured during the end-
diastolic phase. Remaining frame-to-frame measurements were filtered from final 
analysis if they did not use at least 70% of the ROI to measure artery diameter 
and/or were more than one standard deviation (SD) from the mean artery diameter. 
All automated measures were assessed for errors by one researcher. Measurement 
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of carotid, popliteal and brachial IMT was performed on the far wall as this is shown 
to truly reflect anatomic intima-media layer (Wong et al., 1993; Pignoli et al., 1986). 
Previous validation of ultrasound showed 6.52% underestimation of carotid far wall 
IMT compared to histological measures whereas near wall IMT had a 25.3% 
overestimation in autopsies of 36 males (69.0±8.0 yrs) with an intraobserver error 
of 5.4±4.3% (Wong et al., 1993). These cardiovascular parameters were selected 
as they have previously been associated with CVD risk (Bots et al., 1997; Van Dijk 
et al., 2001; Padilla et al., 2009) and to distinguish any limb specific associations 
between PB and cardiovascular parameters. 
Table 3.1.3. Outline of dependent variables assessed using ultrasound. 
Variable Definition Equation 
Blood Velocity 
 
The mean peak speed of blood cell movement 




An estimate of shear stress, which does not 
account for blood viscosity.  
8 × ( Blood Velocity ÷ 
Artery Diameter [mm]) 
Resistance Index 
Represents the resistance of the vascular bed 
distal to the interrogated vessel. 
(Peak Systolic Velocity – 
End-Diastolic Velocity) ÷ 
Peak Systolic Velocity 
Intima-Media 
Thickness 
Distance from the lumen–intima interface to 
the media-adventitia interface of the far wall. 
N/A 
Artery Diameter 
Perpendicular measurement from the far wall 





Figure 3.1.1. Screenshot of Carotid Analyzer automated IMT analysis. Green box represents the 
region of interest, purple line represents the media-adventitia interface, and the yellow line represents 
the lumen-intima interface. 
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Intra-day and inter-day coefficient of variation (CV) were calculated from 
seven participants. Inter-day CV were 4.47%, 1.57%, and 5.33% for brachial, 
carotid, and popliteal artery diameter respectively, whilst intra-day CV were 4.97%, 
2.34%, and 4.03% for brachial, carotid, and popliteal artery diameter, respectively. 
Inter-day CV were 1.45%, 7.91%, and 11.3% for brachial, carotid, and popliteal IMT 
respectively, whilst intra-day CV were 3.04%, 3.40%, and 7.04% for brachial, 
carotid, and popliteal IMT, respectively. Artery diameter and IMT CV should be 
sensitive enough to detect PA related changes as three months of aerobic leg 
exercise caused a 9.0% increase in diameter and a 16.0% reduction in IMT 
(Dinenno et al., 2001). Blood Velocity CV was below 20.0% for inter-day and intra-
day measures of all three arteries. Baseline Shear Rate CV was below 16.0% for 
inter-day and intra-day measures off all three arteries. Both blood velocity and shear 
rate CV should be sensitive enough to detect changes caused by PA as MVPA has 
been shown to increase blood velocity and shear rate by 39.8% and 43.7%, 
respectively (Thijssen et al., 2009). Inter-day and intra-day CV was 5.75% and 
11.1% for carotid RI, respectively. RI CV could be sensitive enough to detect PA 
related changes as exercised individuals display a 6.94% lower RI compared to 
sedentary individuals (Azhim et al., 2007). 
 
Additional Measures: Flow Mediated Dilation  
 
Supine blood pressure was assessed three times (separated by 30.0 s) on 
the contralateral arm using an automated blood pressure sphygmomanometer (BP 
710, Omron, Kyoto, Japan). The highest systolic blood pressure was used as a 
reference pressure for the Flow Mediated Dilation (FMD) protocol. Participants were 
supine while the right arm was extended and abducted at an internal angle of 80.0° 
to keep the measurement area below heart level. The arm was supported under the 
elbow and hand by two cradles to keep the arm level with the body to minimise any 
effects of gravity (Harris et al., 2010). A manual blood pressure sphygmomanometer 
was placed around the forearm (20.0 mm distal of the antecubital fossa). To locate 
the brachial artery, the ultrasound transducer was placed distally, at 65.0% of upper 
arm length (acromion process to radial head) in the medial aspect. Once the brachial 
artery was located and artery walls were clearly identified, a mark was made on the 
skin using a waterproof pen, and the ultrasound transducer was secured in place 
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with a clamp manufactured by the university’s technical team at Cheshire (figure 
3.1.2). The variables outlined in table 3.1.3 were collected over ten cardiac cycles 
for the brachial artery prior to pressure cuff inflation as baseline measures. 
 
Figure 3.1.2. Flow mediated dilation equipment set-up. 
The manual blood pressure sphygmomanometer was inflated 25.0 mm Hg 
above maximum systolic blood pressure for 5.0 mins (Harris et al., 2010) to reduce 
blood flow to the hand and wrist. Due to the ultrasound equipment not possessing 
dual functionality, the ultrasound was changed to Doppler mode 10.0 s after 
pressure release to allow for the assessment of blood velocity at 15.0 s post 
deflation. Once five blood velocity waveforms were obtained the ultrasound was 
changed back to B-mode to capture the change in artery diameter (approximately 
30.0 s post deflation). Live stream recordings were captured for 2.0 mins post 
deflation when a final blood velocity measure was obtained. Off-line artery diameter 
analyses were performed using Brachial Analyzer (Medical Imaging Application 
LLC, Iowa, USA) as described above. FMD was subsequently calculated using 
equations 3.1.1 – 3.1.3.  
Equation 3.1.1. Unscaled FMD. 
Unscaled FMD = ([Peak artery diameter post pressure release – Baseline artery 






Equation 3.1.2. Allometrically Scaled FMD. 
Allometrically Scaled FMD = (([Peak artery diameter post pressure release – 
Baseline artery diameter0.87]-1) ÷ Baseline artery diameter) × 100 
Equation 3.1.3. FMD normalised to post deflation shear rate. 
FMD:SR = Unscaled FMD ÷ Shear rate 15.0 s post deflation 
 
 Flow Mediated Dilation data were removed from the main content of the 
chapter as many participants had a negative FMD (vasoconstriction) and the 
associations with PA parameters were questionable. Due to the questionable data, 





SPSS Statistics 22 (International Business Machines Corporation, New York, 
USA) was used for statistical analyses. Firstly, bivariate linear regression models 
were used to examine any association between PB (measured in hrs·day-1 only), 
covariables (including hydration status, amount of prescribed medication that 
primarily targets cardiovascular disease, total of prescribed medication that could 
(in)directly influence cardiovascular profile), and cardiovascular parameters. 
Hydration status was used as a covariate as this has been shown to effect artery 
diameter (Chen et al., 2007) whilst medication use was used as a covariate as it has 
been shown to effect cardiovascular parameters (Furberg et al., 1994; Williams et 
al., 2006; Dernellis and Panaretou, 2002). Hydration, primary CVD meds, and 
(in)direct CVD meds were used for covariate adjustment if a forced entry linear 
regression analysis had shown that that they are associated with the respective 
cardiovascular parameter. If two or more PB(s) or covariate parameters showed 
predictive qualities for a cardiovascular profile, a stepwise multivariate linear 
regression was used to assess the interactions between multiple PB(s) (measured 
in hrs·day-1 only) and/or covariate parameters and their combined association with 
cardiovascular parameters. Bivariate linear regression models were also used to 
examine the associations between patterns of PB and cardiovascular parameters. 
Cardiovascular variables were natural LOG transformed if they were non-normally 
distributed (Kolmogorov-Smirnov or Shapiro-Wilk, p≤0.05). 
66 
 
  GENEA outliers were identified using box and whisker plots and 
subsequently removed. The aforementioned statistical tests were then re-performed 
to determine whether the GENEA outliers were influencing the statistical outcomes.  
Statistical significance was set at p≤0.05. Data are presented as Mean (SD) 





Physical Behaviour Profile 
 
After discounting the participants with insufficient accelerometer data (<6 
days), the remaining participants’ PB(s) and patterns of PB parameters are outlined 
in table 3.1.4. 
Table 3.1.4. Physical behaviour and patterns of PB demographics for pooled, male, and female 











9.65 (1.46) 9.68 (1.30) 43. 5.24 
84. 13.9 
9.69 (1.47) 9.61 (1.47) 
Standingb 
(hrs·day-1) 
1.11 (0.44) 1.10 (0.40) 56. 2.89 1.11 (0.43) 1.12 (0.45) 
LIPAc 
(hrs·day-1) 
1.97 (0.63) - - 1.92 (0.65) 2.01 (0.61) 
sMVPAd 
(hrs·day-1) 




2.72 (0.80) 2.55 (0.76) 
10MVPAe 
(hrs·day-1) 





0.15 (0.31)m 0.05 (0.15)m 
SB Breaksi 
(n·day-1) 
22.1 (3.43) 22.6 (3.10) 62. 13.1 22.5 (3.86) 21.7 (3.39) 
<5min SB Boutj 
(n·day-1) 
6.38 (1.86) - - 6.54 (1.92) 6.22 (1.95) 
≥5min SB Boutk 
(n·day-1) 
16.5 (2.32) - - 16.8 (2.51) 16.2 (2.22) 
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Table 3.1.4 continued. 
True Mean SB 
Boutl 
mins·day-1 
29.8 (12.5)m 29.4 (11.8)m 13. 53.9 
62. 70.3 
84. 67.5 
30.0 (7.76)m 32.1 (16.1)m 
Alpham 
(α·day-1) 
1.44 (0.03) - - 1.44 (0.03) 1.44 (0.03) 
W50%n 
(mins·day-1) 
51.9 (19.2)m 52.7 (17.5) 8. 94.6 51.0 (19.2)m 53.1 (23.0)m 
PA Boutso 
(n·day-1) 
22.1 (3.43) 22.6 (3.10) 62. 13.1 22.5 (3.86) 21.7 (3.39) 
Daily Sum of PA 
Bout Timep 
(mins·day-1) 
344 (94.8) - - 340 (155)m 341 (137)m 
True Mean PA 
Boutq 
mins·day-1 
15.9 (4.96) 15.3 (4.25) 43. 33.3 16.0 (5.04) 16.1 (4.84) 
10MVPA Boutsr 
(n·day-1) 














0.81 (1.93)m 0.41 (1.08)m 
SB%t 
(%·waking hrs·day-1) 
62.2 (9.57) - - 61.8 (9.78) 62.2 (9.68) 
Standing%u 
(%·waking hrs·day-1) 
7.20 (2.83) 7.06 (2.39) 56. 18.6 
73. 15.0 
7.07 (2.74) 7.24 (2.90) 
LIPA%v 
(%·waking hrs·day-1) 
12.6 (3.90) - - 12.2 (3.97) 12.9 (3.82) 
sMVPA%w 
(%·waking hrs·day-1) 





17.3 (4.94) 16.5 (5.05) 
10MVPA%x 
(%·waking hrs·day-1) 





0.98 (1.82)m 0.40 (1.00)m 
c, j, m, p, t, v Did not have outliers. ‡ Subscript numbers represents which participant had outlier data. † 







Cardiovascular characteristics are outlined in table 3.1.5. Measurement of 
carotid PL and popliteal variables was performed on a sub-population (n=45, age: 
73.6(7.17) yrs, male: 22, female: 23). 
Table 3.1.5. Cardiovascular parameter demographics for pooled, male, and female populations. Data 
presented as mean (SD), unless stated otherwise. 
Variable Pooled Male Female 
Systolic BP (mmHg) 139 (17.0) 137 (16.1) 140 (17.8) 
Diastolic BP (mmHg) 71.4 (11.8)m 72.0 (8.98) 73.5 (8.46) 
 4.28 (0.11) 4.26 (0.11) 4.29 (0.11) 
Pulse Pressure (mmHg) 66.5 (12.8) 65.4 (12.4) 67.4 (13.3) 
Heart Rate (bpm) 63.4 (8.92) 62.0 (9.27) 64.6 (8.53) 
Brachial    
Baseline Diameter (mm) 4.14 (0.71) 4.60 (0.67) 3.77 (0.51)*** 
Baseline Blood Velocity (mm·s-1) 309 (113)m 301 (137) 323 (107) 
 5.73 (0.28) 5.75 (0.27) 5.72 (0.28) 
Baseline Shear Rate (·s-1) 602 (262)m 558 (286)m 645 (213)m* 
 6.41 (0.32) 6.32 (0.30) 6.49 (0.33)* 
IMT (mm) 0.51 (0.11)m 0.59 (0.14)m 0.46 (0.19)m* 
 -0.67 (0.36)m -0.52 (0.27)m -0.77 (0.39)m* 
Carotid    
AL Artery Diameter (mm) 7.32 (0.85) 7.70 (0.85) 6.99 (0.71)*** 
AL IMT (mm) 0.76 (0.15)m 0.76 (0.18)m 0.77 (0.13)m 
 -0.25 (0.15) -0.24 (0.15) -0.26 (0.15) 
AL Blood Velocity (mm·s-1) 351 (120)m 372 (116)m 335 (95.2)m 
 5.87 (0.27) 5.92 (0.27) 5.83 (0.26) 
AL Shear Rate (·s-1) 412 (122) 411 (118) 412 (127) 
AL RI 0.71 (0.11)m 0.73 (0.09) 0.72 (0.08) 
 -0.32 (0.11) -0.31 (0.14)m -0.33 (0.15)m 
PL Artery Diameter (mm) 7.21 (0.54) 7.37 (0.35) 7.09 (0.64) 
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Table 3.1.5 continued. 
PL IMT (mm) 0.80 (0.13) 0.81 (0.10) 0.80 (0.15) 
Popliteal    
Artery Diameter (mm) 6.35 (1.21) 6.84 (2.18)m 6.14 (1.28)m** 
IMT (mm) 0.78 (0.14) 0.80 (0.16) 0.76 (0.11) 
Blood Velocity (mm·s-1) 255 (79.1)m 265 (71.7)m 240 (122)m 
 5.60 (0.32) 5.58 (0.27)m 5.48 (0.42)m 
Shear Rate (·s-1) 334 (168)m 312 (173)m 360 (240)m 
 5.85 (0.38) 5.73 (0.33) 5.97 (0.39)* 
m Median (IR). Bold data has been natural LOG transformed. BMI Body mass index. BP Blood 
pressure. IMT Intima media thickness. AL Anterior longitudinal plane. PL Posterior longitudinal 
plane. * p≤0.05, ** p≤0.01, *** p≤0.001. 
 
Physical Behaviour Predicted Cardiovascular Profile  (Bivariate) 
 
SB showed no predictive qualities for cardiovascular parameters. Meanwhile 
PA variables showed a number of associations (4 out of 19) with cardiovascular 
parameters (table 3.1.6). Notably, an hour per day increase in low intensity PA 
(Standing, and LIPA) is sufficient to stimulate vascular adaption of popliteal artery 
diameter (Standing: -0.75 [95%CI -1.41, -0.09] mm) and IMT (LIPA: -0.09 [95%CI -
0.15, -0.03] mm). In addition, an hour increase in sMVPA was also sufficient to 
reduce popliteal IMT (-0.06 [95%CI -0.12, 0.002] mm) and resting heart rate (-3.36 










Table 3.1.6. Bivariate and multivariate stepwise linear regressions between PB, covariates and 
cardiovascular parameters. 
Variable Model b -95% CI +95% CI p r2 adj. P. Corr. 
Systolic BP SBa -0.39 -2.85 2.06 0.75 -0.01  
Standingb -1.27 -9.38 6.82 0.75 -0.01  
LIPAc -0.75 -6.45 4.94 0.79 -0.01  
sMVPAd 1.02 -3.58 5.64 0.65 -0.01  
10MVPAe 1.44 -11.7 14.6 0.82 -0.01  
Hydrationh -0.65 -1.14 -0.17 0.01 0.06  
LOG 
Diastolic BP 
SBa 0.001 -0.01 0.01 0.93 -0.01  
Standingb -0.03 -0.09 0.01 0.15 0.01  
LIPAc -0.01 -0.05 0.02 0.39 -0.003  
sMVPAd 0.01 -0.01 0.04 0.37 -0.002  
10MVPAe -0.01 -0.10 0.08 0.81 -0.01  
Hydrationh -0.004 -0.007 0.00 0.03 0.04  
Pulse 
Pressure 
SBa -0.45 -2.31 1.39 0.62 -0.01  
Standingb 1.54 -4.56 7.64 0.61 -0.01  
LIPAc 0.61 -3.68 4.91 0.77 -0.01  
sMVPAd 0.17 -3.30 3.65 0.92 -0.01  
10MVPAe 2.48 -7.44 12.4 0.62 -0.01  
Hydrationh -0.39 -0.75 -0.02 0.03 0.03  
Heart Rate SBa 1.10 -0.16 2.37 0.08 0.02  
Standingb -5.59 -9.67 -1.52 0.01 0.06  
LIPAc -2.74 -5.67 0.18 0.06 0.02  
sMVPAd -3.36 -5.67 -1.05 0.01 0.07  



























       
SBa 0.002 -0.10 0.10 0.97 -0.01  
Standingb 0.08 -0.26 0.43 0.63 -0.01  
LIPAc 0.02 -0.22 0.26 0.88 -0.01  
sMVPAd 0.05 -0.14 0.25 0.59 -0.01  
10MVPAe 0.02 -0.54 0.58 0.94 -0.01  
Primary CVD 
Medsf 
0.09 0.01 0.19 0.03 0.03  
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Table 3.1.6 continued. 
LOG Blood 
Velocity 
SBa -0.01 -0.04 0.03 0.80 -0.01  
Standingb -0.06 -0.14 0.12 0.92 -0.01  
LIPAc -0.03 -0.12 0.06 0.50 -0.01  
sMVPAd 0.04 -0.03 0.11 0.28 0.002  
10MVPAe 0.03 -0.18 0.25 0.75 0.001  
LOG Shear 
Rate 
SBa -0.002 -0.05 0.04 0.94 -0.01  
Standingb -0.04 -0.20 0.11 0.58 -0.01  
LIPAc -0.04 -0.15 0.06 0.41 -0.004  
sMVPAd 0.02 -0.06 0.11 0.57 -0.01  
10MVPAe 0.01 -0.24 0.27 0.91 -0.01  
LOG IMT SBa 0.01 -0.02 0.03 0.77 -0.01  
Standingb 0.04 -0.06 0.16 0.37 -0.002  
LIPAc 0.01 -0.06 0.09 0.68 -0.01  
sMVPAd 0.003 0.06 0.06 0.92 -0.01  
10MVPAe -0.06 -0.24 0.11 0.48 -0.01  
Carotid        
AL Artery 
Diameter 
SBa 0.07 -0.05 0.19 0.26 0.003  
Standingb -0.12 -0.54 0.28 0.53 -0.01  
LIPAc -0.22 -0.50 0.06 0.12 0.01  
sMVPAd 0.01 -0.22 0.23 0.96 -0.01  
10MVPAe 0.33 -0.33 1.00 0.32 0.00  
Primary CVD 
Medsf 
0.11 0.003 0.22 0.04 0.03  
LOG AL IMT SBa 0.001 -0.02 0.02 0.91 -0.01  
Standingb 0.05 -0.02 0.12 0.17 0.01  
LIPAc 0.01 -0.03 0.07 0.50 -0.01  
sMVPAd 0.002 -0.04 0.04 0.91 -0.01  




SBa -0.02 -0.05 0.02 0.32 0.00  
Standingb -0.003 -0.13 0.12 0.95 -0.01  
LIPAc 0.03 -0.05 0.12 0.47 -0.01  
sMVPAd 0.04 -0.03 0.11 0.25 0.004  
10MVPAe 0.11 -0.10 0.32 0.30 0.001  
AL Shear 
Rate 
SBa -9.64 -27.4 8.16 0.28 0.002  
Standingb 2.95 -56.4 62.3 0.92 -0.01  
LIPAc 21.8 -19.8 63.5 0.30 0.001  
sMVPAd 14.5 -18.9 48.1 0.38 -0.003  
10MVPAe 20.7 -76.2 117 0.67 -0.01  
LOG AL RI SBa 0.001 -0.01 0.01 0.90 0.00  
Standingb 0.02 -0.03 0.07 0.42 -0.004  
LIPAc 0.01 -0.03 0.04 0.74 -0.01  
sMVPAd -0.01 -0.04 0.02 0.45 -0.01  
10MVPAe -0.05 -0.14 0.03 0.24 0.004  
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Table 3.1.6 continued. 
PL Artery 
Diameter 
SBa 0.07 -0.06 0.20 0.28 0.01  
Standingb -0.07 -0.42 0.27 0.65 -0.02  
LIPAc -0.17 -0.46 0.13 0.25 0.01  
sMVPAd -0.19 -0.48 0.09 0.17 0.03  
10MVPAe 0.27 -0.77 1.32 0.59 -0.02  
PL IMT SBa -0.01 -0.05 0.01 0.24 0.01  
Standingb -0.01 -0.09 0.07 0.88 -0.03  
LIPAc 0.02 -0.05 0.09 0.52 -0.02  
sMVPAd 0.01 -0.05 0.08 0.64 -0.02  
10MVPAe 0.10 -0.15 0.35 0.41 -0.01  
Popliteal        
Artery 
Diameter 
SBa 0.14 -0.10 0.40 0.24 0.01  
Standingb -0.75 -1.41 -0.08 0.02 0.08  
LIPAc -0.35 -0.91 0.20 0.21 0.01  
sMVPAd 0.18 -0.37 0.74 0.51 -0.01  
10MVPAe 0.89 -1.19 2.98 0.39 -0.01  
IMT SBa 0.02 -0.003 0.05 0.07 0.05  
Standingb -0.06 -0.15 0.01 0.11 0.03  
LIPAc -0.09 -0.15 -0.03 0.004 0.15  
sMVPAd -0.06 -0.12 -0.002 0.04 0.07  
10MVPAe -0.07 -0.32 0.17 0.54 -0.01  
MRc -0.09 -0.15 -0.03 0.004 0.15  
LOG Blood 
Velocity 
SBa 0.03 -0.03 0.10 0.36 -0.004  
Standingb -0.12 -0.31 0.06 0.18 0.01  
LIPAc -0.06 -0.22 0.08 0.37 -0.01  
sMVPAd -0.08 -0.23 0.06 0.25 0.01  
10MVPAe -0.51 -1.06 0.03 0.06 0.05  
Hydrationh -0.01 -0.02 -0.01 0.002 0.19  
LOG Shear 
Rate 
SBa 0.01 -0.07 0.08 0.90 -0.02  
Standingb 0.01 -0.21 0.22 0.96 -0.02  
LIPAc -0.01 -0.18 0.17 0.95 -0.02  
sMVPAd -0.11 -0.28 0.06 0.20 0.01  
10MVPAe -0.66 -1.29 -0.03 0.04 0.07  
Hydrationh -0.01 -0.03 -0.004 0.01 0.12  
MRh -0.01 -0.03 -0.004 0.01 0.12  
Bold font highlights significant (p≤0.05) bivariate and multivariate stepwise linear regression 
models. Hydration Change per percent increase in total body water. Primary CVD Meds 
Change per one unit increase in the number of medications directly targeting CVD risk. 
(in)direct CVD Meds Change per one unit increase in the number of medications (in)directly 
targeting CVD risk. MR Multivariate stepwise linear regression model. Superscript letters 
represent which, and what order PB variables are included in the multivariate model. b Change 
in cardiovascular variable per unit increase in GENEA variable. -95%CI Negative 95% 
confidence interval. +95%CI Positive 95% confidence interval. p Significance value. r2 adj. 




When GENEA outliers were removed from the data (table 3.1.7), SB was 
found to be a predictor of heart rate (1.58 [95%CI 0.17, 2.99] bpm) (thus predicting 
1 out of 19 cardiovascular parameters). Standing was also found to be a predictor 
of popliteal IMT (-0.13 [95%CI -0.22, -0.03] mm) with the removal of outliers (thus 
predicting 3 out of 19 cardiovascular parameters). LIPA as a predictor had no 
outliers (1 out of 19 predictions for cardiovascular parameters). sMVPA was no 
longer a predictor of popliteal IMT when outliers were removed (thus now predicting 
1 out of 19 cardiovascular parameters). 10MVPA was no longer a predictor of 
popliteal shear rate following the removal of outliers (thus predicting no 
cardiovascular parameters. 
Table 3.1.7. Change in bivariate and multivariate stepwise linear regressions models following the 
removal of PB outliers. 
Variable Model b -95% CI +95% CI p r2 adj. P. Corr. 
Heart Rate SBa 1.10 -0.16 2.37 0.08 0.02  
Standingb -5.59 -9.67 -1.52 0.01 0.06  
LIPAc -2.74 -5.67 0.18 0.06 0.02  
sMVPAd -3.36 -5.67 -1.05 0.01 0.07  
























SBa 1.58 0.17 2.99 0.02 0.04  
Standingb -6.77 -11.2 -2.28 0.004 0.08  
LIPAc -2.74 -5.67 0.18 0.06 0.02  
sMVPAd -4.69 -7.54 -1.84 0.002 0.10  
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Table 3.1.7 continued. 
Brachial        
Artery 
Diameter 
SBa 0.002 -0.10 0.10 0.97 -0.01  
Standingb 0.08 -0.26 0.43 0.63 -0.01  
LIPAc 0.01 -0.22 0.26 0.88 -0.01  
sMVPAd 0.05 -0.14 0.25 0.59 -0.01  
10MVPAe 0.02 -0.54 0.58 0.94 -0.01  
Primary CVD 
Medsf 
0.09 0.01 0.19 0.03 0.03  














SBa -0.01 -0.13 0.10 0.77 -0.01  
Standingb -0.04 -0.42 0.34 0.82 -0.01  
LIPAc 0.01 -0.22 0.26 0.88 -0.01  
sMVPAd 0.12 -0.12 0.37 0.30 0.001  
10MVPAe 0.20 -1.25 0.84 0.69 -0.01  
Primary CVD 
Medsf 
0.08 -0.01 0.18 0.07 0.02  
Hydrationh 0.02 0.003 0.04 0.02 004  
MRh 0.02 0.001 0.04 0.03 0.04 0.23 
Excludedf 0.22   0.06  0.22 
Popliteal        
IMT SBa 0.02 -0.003 0.05 0.07 0.05  
Standingb -0.06 -0.15 0.01 0.11 0.03  
LIPAc -0.09 -0.15 -0.03 0.004 0.15  
sMVPAd -0.06 -0.12 -0.002 0.04 0.07  
10MVPAe -0.07 -0.32 0.17 0.54 -0.01  
MRc -0.09 -0.15 -0.03 0.004 0.15  
SBa 0.02 -0.01 0.06 0.10 0.03  
Standingb -0.13 -0.22 -0.03 0.01 0.14  
LIPAc -0.09 -0.15 -0.03 0.004 0.15  
sMVPAd -0.06 -0.13 0.004 0.06 0.05  
10MVPAe 0.01 -0.27 0.28 0.96 -0.02  
MRc -0.11 -0.17 -0.04 0.001 0.21  
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SBa 0.01 -0.07 0.08 0.90 -0.02  
Standingb 0.01 -0.21 0.22 0.96 -0.02  
LIPAc -0.01 -0.18 0.17 0.95 -0.02  
sMVPAd -0.11 -0.28 0.06 0.20 0.01  
10MVPAe -0.66 -1.29 -0.03 0.04 0.07  
Hydrationh -0.01 -0.03 -0.004 0.01 0.12  
MRh -0.01 -0.03 -0.004 0.01 0.12  
SBa 0.01 -0.07 0.08 0.90 -0.02  
Standingb 0.01 -0.21 0.22 0.96 -0.02  
LIPAc -0.01 -0.18 0.17 0.95 -0.02  
sMVPAd -0.11 -0.28 0.06 0.20 0.01  
10MVPAe -0.65 -1.39 0.08 0.08 0.04  
Hydrationh -0.01 -0.03 -0.004 0.01 0.12  
Bold font highlights significant (p≤0.05) bivariate and multivariate stepwise linear regression 
models. Orange shading highlights regression models following outlier removal. Hydration Change 
per percent increase in total body water. Primary CVD Meds Change per one unit increase in the 
number of medications directly targeting CVD risk. (in)direct CVD Meds Change per one unit 
increase in the number of medications (in)directly targeting CVD risk. MR Multivariate stepwise 
linear regression. Superscript letters represent which, and what order PB variables are included 
in the multivariate model. b Change in cardiovascular variable per unit increase in GENEA 
variable. -95%CI Negative 95% confidence interval. +95%CI Positive 95% confidence interval. p 
Significance value. r2 adj. Adjusted explained variance. P. Corr. Partial Correlation. 
 
Physical Behaviour Predicted Cardiovascular Profile (Multivariate)  
 
Resting heart rate had the most PB predictors, excluding only LIPA from the 
model. Standing and sMVPA each explained 12.2% of the variance in heart rate 
whilst controlling for the other PB parameters in the model. This was the largest 
partial correlation of the PB parameters included in the prediction of heart rate. 
There were no other cardiovascular parameters that could be predicted using 
multiple PB parameters (table 3.1.6). 
 With the removal of GENEA outliers, SB and 10MVPA were removed from the 




Patterns of Physical Behaviour Predict Cardiovascular Profile  
 
The predictive quality of cardiovascular parameters using patterns of PB are 
displayed in table 3.1.7. W50%, SB%, and alpha appear to be the most common 
predictors within the SB category, showing predictive qualities for three, two, and 
two cardiovascular parameters (out of 19), respectively (table 3.1.8). Within the PA 
category, daily sum of PA bout time showed predictive qualities for two 
cardiovascular markers (out of 19), with PA bouts, true mean PA bout, Standing%, 
LIPA%, sMVPA%, and 10MVPA% all showing predictive qualities for one 
cardiovascular parameter (out of 19) (table 3.1.8). Please note that only significant 
associations are displayed in table 3.1.7 to reduce its size. The complete results 















Table 3.1.8. Bivariate linear regressions models between patterns of PB and cardiovascular 
parameters. Note that neither Systolic BP, Pulse Pressure, Brachial; Artery Diameter, LOG Blood 
Velocity, LOG Shear Rate, LOG IMT, Carotid; AL Artery Diameter, LOG AL IMT, LOG AL Blood 
Velocity, LOG AL Shear Rate, LOG AL RI, and PL Artery Diameter showed any significant model 
with the 16 patterns of PB of interest and hence these models are not shown. Note that only 
significant models between patterns of PB and cardiovascular variables are shown. 
Variable Model b -95% CI +95% CI p r2 adj. 
LOG 
Diastolic BP 
Alpha 0.73 0.10 1.37 0.02 0.04 
Heart Rate SB Breaks -0.63 -1.13 -0.13 0.01 0.05 
 <5min SB 
Bout 
-1.34 -2.27 -0.40 0.01 0.07 
 True Mean 
SB Bout 
0.17 0.01 0.35 0.04 0.03 
 W50% 0.19 0.17 0.31 0.001 0.10 
 PA Bouts -0.63 -1.13 -0.13 0.01 0.05 
 
Daily Sum of 
PA Bout 
Time 
-0.03 -0.05 -0.01 0.001 0.10 
 SB% 0.27 0.08 0.46 0.01 0.07 
 Standing% -0.80 -1.45 -0.15 0.01 0.05 
 sMVPA% -0.41 -0.78 -0.04 0.02 0.04 
Carotid       
PL IMT Alpha 1.60 0.29 2.90 0.01 0.14 
Popliteal       
Artery 
Diameter 
Standing% -0.12 -0.22 -0.01 0.02 0.09 
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Table 3.1.8 continued. 
IMT W50% 0.003 0.00 0.01 0.04 0.07 
 
Daily Sum of 
PA Bout 
Time 
-0.001 -0.001 0.00 0.001 0.13 
 True Mean 
PA Bout 
-0.01 -0.01 -0.001 0.02 0.09 
 SB% 0.01 0.001 0.01 0.01 0.11 
 LIPA% -0.01 -0.02 -0.004 0.01 0.13 
LOG Blood 
Velocity 
W50% 0.01 0.00 0.01 0.03 0.07 
LOG Shear 
Rate 
10MVPA% -0.10 -0.20 -0.001 0.04 0.06 
Significant bivariate linear regressions (p≤0.05). b Change in cardiovascular variable per unit 
increase in GENEA variable. -95%CI Negative 95% confidence interval. +95%CI Positive 
95% confidence interval. p Significance value. r2 adj. Adjusted explained variance. 
 
 After the removal of outliers (table 3.1.9), W50%, SB%, and alpha remained 
the best predictors of cardiovascular parameters within the SB category (three, two, 
and two out of 19, respectively), showing no change in prediction quality.  Within the 
PA category, true mean PA bout,  daily sum of PA bout time, and total week 10MVPA 
showed the most predictive qualities for cardiovascular parameters (two each), 
followed by PA bouts, 10MVPA bouts, Standing%, LIPA%, and sMVPA% (one each) 





Table 3.1.9. Change in bivariate linear regression models between patterns of PB and cardiovascular 
parameters after patterns of PB outliers were removed. 
Variable Model b -95% CI +95% CI p r2 adj. 
Heart Rate True Mean 
PA Bout 
-0.30 -0.68 0.07 0.11 0.01 
-0.41 -0.82 -0.01 0.04 0.03 
Popliteal       
Artery 
Diameter 
Standing% -0.12 -0.22 -0.01 0.02 0.09 
-0.11 -0.24 0.02 0.10 0.03 
IMT Standing% -0.01 -0.02 0.004 0.17 0.02 





-0.07 -0.15 0.01 0.06 0.05 





-0.15 -0.34 0.03 0.10 0.03 





-0.09 -0.18 0.001 0.05 0.06 
-0.13 -0.22 -0.03 0.01 0.14 
LOG Shear 
Rate 
10MVPA% -0.10 -0.20 -0.001 0.04 0.06 
-0.09 -0.21 0.01 0.09 0.04 
Bold font highlights significant (p≤0.05) bivariate linear regressions. Orange shading 
highlights regression models following outlier removal. b Change in cardiovascular 
variable per unit increase in GENEA variable. -95%CI Negative 95% confidence interval. 





The purpose of the current study was to address three objectives: 1) 
determine whether measures of daily PB predict older adults’ cardiovascular profile; 
2) determine which measures of PB patterns are better predictors of cardiovascular 
profile; 3) highlight any effects of SB on cardiovascular profile that are independent 
of MVPA and vice versa. It was broadly hypothesized that a number of 






Physical Behaviour Predicts Cardiovascular Parameters  
 
A lack of predictive qualities of PB relative to brachial and carotid parameters 
suggests that the effects of PB may either be site specific or indicative of a 
remodeling process, which masks any adaptation to changes in PB in older adults. 
Interestingly, predictive qualities relative to popliteal parameters were seen with low 
intensity PA (standing and LIPA), suggesting that low intensity PB could reduce 
popliteal parameters that are associated with CVD (Burke et al., 1995). Within 
bivariate regression models both an hour increase in standing and LIPA led to a 
0.14 and 0.09 mm reduction in popliteal IMT, respectively, whilst LIPA was the only 
PB variable included in the multivariate stepwise regression model that suggested 
popliteal IMT would decrease by 0.112 mm per hour increase in LIPA. This finding 
is consistent with a training study that found popliteal IMT decreased by 0.038 mm 
over 12 weeks (18 hours) of LIPA (30% heart rate reserve), which equated to a 
0.002 mm reduction in popliteal IMT per hour of LIPA (Green et al., 2010). The 
results of the current study would have strong implications in older adults who 
struggle to accumulate sufficient 10MVPA, as they may find it easier to accumulate 
LIPA. 
 
Which Physical Behaviour Pattern is the Best Predictor of Cardiovascular Profile? 
 
With improvements in the objective measurement of SB, the focus of 
research has shifted to the patterns in which SB is accumulated rather than total SB 
time per se. In particular, SB breaks has become a heavily researched parameter 
(Carson et al., 2014; Chastin et al., 2015a) especially in acute interventions (Peddie 
et al., 2013; Bailey and Locke, 2014; Dunstan et al., 2012; Holmstrup et al., 2014). 
Within the current data, SB breaks only had predictive qualities for resting heart rate, 
whilst other patterns of SB, W50% and alpha showed more predictive qualities for 
cardiovascular parameters (three and two, respectively). W50% and alpha were first 
introduced by Chastin and Granat (2010) to create a more sensitive measure of 
change in SB accumulation as SB breaks can be similar when W50% and alpha are 
significantly different between the pre and post phases of an intervention, or 
between groups (Chastin et al., 2015c; Ryan et al., 2016). W50% is the usual SB 
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bout length that would accumulate 50.0% of total SB time if all of the SB bouts of 
that length and shorter/greater were accumulated (Chastin and Granat, 2010). 
W50% had predictive qualities for popliteal IMT as every minute increase in W50%, 
increased popliteal IMT by 0.003 mm, which may have CVD implications as those 
with a history of CVD have exhibited a 0.04 (95% CI 0.03, 0.04) mm increase in 
popliteal IMT than those with no history (Burke et al., 1995). Thus, as little as a ten-
minute increase in W50% could lead to CVD complications. 
 Alpha is a unit-less power-law distribution that displays the increase in SB 
bouts as SB bout duration decreases (Chastin et al., 2015c). Diastolic BP and 
carotid PL IMT showed predictive associations with alpha while W50% did not in the 
current study. The direction of these predictive models suggested that an increase 
in alpha (more SB bouts, shorter duration) would result in an increase in diastolic 
BP and carotid PL IMT. This is opposite to what would be intuited as brachial 
diastolic BP has been found to be similar between supine and orthostatic postures 
(Gemignani et al., 2012). On the other hand, orthostatic posture increases carotid 
circumferential wall tension, compared to supine posture, and is associated with an 
increase in carotid plaque formation, which can be expressed as an increased IMT. 
This suggests that the association between alpha and carotid PL IMT may be a 
result of more PA (orthostatic posture) due to a reduction SB bout length. The large 
95%CI (0.29, 2.90 mm) in the current data may highlight the need for further data to 
confirm or otherwise, the reported association between alpha and carotid PL IMT 
since a 0.10 mm increase in IMT can increase the relative risk of stroke by 18.0% 
(Lorenz et al., 2007). The increase in diastolic BP with increasing alpha may hold 
true as more bouts of a shorter duration would indicate that the older person causes 
this offset by engaging in more PA, where the arms are likely hanging by their side 
(as may be the case in gentle strolling or even chair-based exercise). In other words, 
there may have been PA not captured by the thigh-mounted accelerometer in the 
current study. This may cause a hydrostatic pressure that would subsequently 
increase blood pressure (Padilla et al., 2009). However, the lack of association 
between standing and diastolic BP within the current data does not support this idea.  
 The current findings suggest that W50% should be the preferred SB pattern 
of PB parameter for predicating cardiovascular risk because it has the most 
predictive qualities (three). In addition, W50% is presented in minutes, which can be 
easily understood and explained in a ‘real-world’ therapeutic (clinical or lifestyle) 
intervention settings.  
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 Within PA patterns of PB, true mean PA bout length (Chastin and Granat, 
2010), showed the most predictive qualities for cardiovascular parameters (two) 
where ‘true mean’ refers to the mean duration of a PA bout succeeding anti-log 
transformations of previously LOG transformed non-normally distributed PA bout 
lengths (Chastin and Granat, 2010). This adds strength to the argument that it is not 
the number of SB breaks that is the most important, but the complex interaction 
between those SB breaks and the duration of individual SB breaks. The predictive 
qualities of total week 10MVPA (two) and the number of 10MVPA bouts (one) within 
the current study support the government’s use of a total 10MVPA recommendation 
accumulated in, at least, ten minute bouts within their PA guidelines for older adults 
(Department of Health Social Services and Public Safety, 2011). 
  
Independent Physiological Effects of Sedentary Behaviour and Moderate 
to Vigorous Physical Activity  
 
The basis of SB physiology stems from the apparently independent effects 
of SB and MVPA on health status (Bey and Hamilton, 2003; Gennuso et al., 2013). 
Prior to the removal of outliers, MVPA (sMVPA or 10MVPA) showed predictive 
qualities for resting heart rate, popliteal IMT, and popliteal LOG shear rate, whereas 
SB did not within bivariate regression models. After the removal of outliers, sMVPA 
only showed predictive qualities for heart rate however, SB now displayed predictive 
qualities for heart rate too. This could infer that the effects of SB and MVPA on heart 
rate may not be independent. Furthermore, SB is excluded whilst sMVPA is included 
in the multivariate predictive model for heart rate suggesting SB does not add any 
further strength to the predictive model for heart rate, this could infer that SB and 
sMVPA use the same mechanistic pathways to affect heart rate. MVPA is known to 
reduce resting heart rate through increases in stroke volume (Hagberg et al., 1983) 
and reduction in peripheral resistance (Hambrecht et al., 2000) whilst SB does the 
opposite (Spaak et al., 2005; Levine et al., 1997). The results of the current study 
support the idea that SB and MVPA effect resting heart rate indirectly by impacting 
on stroke volume and total peripheral resistance. 
 The predictive qualities of W50% and alpha were just as prevalent as those 
of true mean PA bout length, daily sum of PA bout time, and total week 10MVPA. Of 
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the six cardiovascular markers these patterns of PB parameters predicted, three of 
them were only associated with one pattern of PB variable. This may infer that SB 
and PA parameters are physiologically independent and as such, warrants the need 
for future studies to include multiple PB parameters to be able to fully assess the 
effect of PB on health. 
 The main strength of this study is the use of a thigh-mounted accelerometer, 
which allows for accurate posture classification. However, one PB variable this study 
did not measure is seated/reclined PB eliciting >1.50 METs (as would occur in 
seated exercise training programs for instance, a modality of exercise of particular 
prevalence in frail older persons (Yates and Dunnagan, 2001). Arguably, it is 
unlikely that this classification of PB would be prevalent within independent living 
older adults and therefore its absence from our current PB stratification would be 
minimal in this type of population. It is however notable that owing to the age group 
of our study participants, the sample was skewed towards low adherence to 10MVPA 





The purpose of this study was to determine which measures of PB display 
predictive qualities for cardiovascular variables so future research could justify the 
use of specific PB parameters as dependent variables within intervention studies. 
The main strength of this study is the use of a thigh-mounted accelerometer, which 
allows for accurate posture classification. Overall, the present study displayed that 
all PB measures (hrs·day-1), excluding 10MVPA, showed predictive qualities for at 
least one cardiovascular variable (figure 3.1.3). Within patterns of PB, W50% and 
total week MVPA, daily sum of PA time, and true mean PA bout length were the 
best predictors of cardiovascular parameters (figure 3.1.3). The results suggest 
patterns of PB are more prolific predictors of cardiovascular health status than total 
PB measured in hours per day. SB and MVPA PB measures showed different and 
unique predicative qualities for cardiovascular parameters. This observation further 
supports the notion that both SB and MVPA engagements need to be considered in 
future PB research and/or lifestyle recommendations. Finally, increasing standing 
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and LIPA engagement showed predictive qualities for popliteal IMT reduction. We 
propose this to be one of the most clinically relevant findings from our current work 
as it suggests that older adults do not have to engage in MVPA (which they have, 








Figure 3.1.3. Summary of significant (p≤0.05) bivariate linear regressions displaying the SD change 
in cardiovascular parameter z-score per SD increase in PB parameter z-scores. Black lines indicate 
-95%CI, beta coefficient, and +95%CI from centre to outer perimeter. - indicates a negative 
association. + indicates a positive association. Graph is standardised to stack the regression models 
on top of the preceding model. E.g. the +95%CI line for the W50% and popliteal LOG blood velocity 
model also represents the -95%CI for the W50% and resting heart rate model. Data in brackets 
represents the standard deviation for the respective parameter. Models created using GENEA 








It is becoming evident that sedentary behaviour (SB) affects a number of 
physiological parameters independent of the amount of moderate to vigorous 
intensity physical activity (MVPA) engagement (Gennuso et al., 2013; Bey and 
Hamilton, 2003). With time being finite within a day (i.e. 24 hour endpoint), 
engagement in one physical behaviour (PB) (Bussmann and van den Berg-Emons, 
2013) will offset the amount of time that can be spent performing another. Standard 
regression modelling fails to recognise the time constraints and therefore the use of 
multiple measures of PB within a regression model will not account for the time that 
is displaced by engaging in a specific bout of PB.  
Isotemporal substitution modelling (ISM) recognises that time is finite by 
including a measure of total PB (e.g. sum of waking hours SB and physical activity 
[PA]), which is kept constant and therefore, provides the opportunity to substitute 
one PB for another, thereby reflecting the realities of daily life (Mekary et al., 2013). 
Rather than prediction, per se, ISM reflects the decisions people have made (e.g. 
prolonged SB) and offers an extrapolation of what would happen should they 
decided to do something different (e.g. MVPA). Therefore, this analysis may be 
more advantageous to public health PB action plans, as it clearly illustrates what will 
happen to markers of health if habitual PB levels and/or patterns are changed. In 
older adult populations, ISM has mainly been used to assess the effect on cardio-
metabolic (van der Berg et al., 2017; Yates et al., 2015; Hamer et al., 2014) rather 
than cardiovascular parameters (Wellburn et al., 2015). However when 
cardiovascular parameters have been assessed, it has demonstrated promising 
results, for instance, suggesting the substitution of SB for light intensity PA (LIPA) 
would reduce the relative risk of cardiovascular disease (CVD) prevalence within 
older adult cohorts (Wellburn et al., 2015). Light intensity PA is a promising 
intervention to reduce SB for older adult populations as it can arguably prove to be 
easier  (in comparison to MVPA) to comply with, and can be accumulated to consist 
the greater majority of a 24-hour simplex (Craig et al., 2009).  
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The ten-minute minimum threshold for an MVPA bout (10MVPA), highlighted 
in the PA guidelines (Department of Health Social Services and Public Safety, 
2011), to show clinically beneficial outcomes, has not been examined using ISM. If 
sporadic MVPA (sMVPA, MVPA accumulated in bouts of less than 10 continuous 
minutes) has beneficial effects on cardiovascular profile, this alternative mode of 
accumulating MVPA would likely allow older adults to improve their health within 
their physical capacities, and maintain this PB profile in the long term. Therefore, 
the objective of this study was to simulate the degree to which the substitution of SB 
and lower intensity PA for MVPA would have positive effects on cardiovascular 
profile markers and vice versa, in older adults. The aim was to provide a time-
constrained, alternative to bivariate/multivariate regression modelling tool, to predict 
how changes in PB may affect the cardiovascular profile of older adults. It was 
hypothesised that substituting SB for any intensity of PA would improve 
cardiovascular parameters and that substituting a PB for a higher intensity would 
improve cardiovascular profile. It was also hypothesised that substituting SB for 





 This methods section follows that of Chapter 03 Part 1, using the same 
participants and data collection procedures. The descriptives of the measured 
parameters are outlined in table 3.2.1 as a reminder of the assessed cardiovascular 










Table 3.2.1. Demographics, cardiovascular, and PB parameters of the sample population. 
Variable Pooled 
Age (yrs) 73.8 (6.22) 
Height (m) 1.65 (0.08) 
Mass (kg) 75.9 (13.1) 
BMI (kg·m2) 27.9 (4.71) 
Primary CVD Meds (%)† 48.0 
(in)direct CVD Meds (%)‡ 59.0 
Hydration (%) 50.6 (7.15)m 
Systolic BP (mmHg) 139 (17.0) 
Diastolic BP (mmHg) 71.4 (11.8)m 
 4.28 (0.11) 
Pulse Pressure (mmHg) 66.5 (12.8) 
Heart Rate (bpm) 63.4 (8.92) 
Brachial  
Baseline Diameter (mm) 4.14 (0.71) 
Baseline Blood Velocity (mm·s-1) 309 (113)m 
 5.73 (0.28) 
Baseline Shear Rate (·s-1) 602 (262)m 
 6.41 (0.32) 
IMT (mm) 0.51 (0.11)m 
 -0.67 (0.36)m 
Carotid  
AL Artery Diameter (mm) 7.32 (0.85) 
AL IMT (mm) 0.76 (0.15)m 
 -0.25 (0.15) 
AL Blood Velocity (mm·s-1) 351 (120)m 
 5.87 (0.27) 
AL Shear Rate (·s-1) 412 (122) 
AL RI 0.71 (0.11)m 
 -0.32 (0.11) 
PL Artery Diameter (mm) 7.21 (0.54) 





Table 3.2.1 continued. 
Popliteal  
Artery Diameter (mm) 6.35 (1.21) 
IMT (mm) 0.78 (0.14) 
Blood Velocity (mm·s-1) 255 (79.1)m 
 5.60 (0.32) 
Shear Rate (·s-1) 334 (168)m 
 5.85 (0.38) 
Physical Behaviour  
SB (hrs·day-1) 9.68 (1.30) 
Standing (hrs·day-1) 1.10 (0.40) 
LIPA (hrs·day-1) 1.95 (0.60) 
sMVPA (hrs·day-1) 2.58 (0.66) 
10MVPA (hrs·day-1) 0.08 (0.18)m 
Total PB (hrs·day-1) 15.4 (4.77)m 
m Median (Interquartile Range). † Participants are currently prescribed an amount of 
medication that reduces the risk or treats CVD (i.e. statins, warfarin). ‡ Participants are 
currently prescribed a medication that may affect the cardiovascular system either 
directly or as a side effect. Bold data has been natural LOG transformed. BMI Body 
mass index. BP Blood pressure. IMT Intima media thickness. AL Anterior longitudinal 
plane. PL Posterior longitudinal plane. SB Sedentary behaviour, LIPA Light intensity 
physical activity, sMVPA Sporadic moderate to vigorous intensity physical activity 
(accumulated in bouts < 10 mins), 10MVPA 10 minute moderate to vigorous intensity 
physical activity (accumulated in bouts ≥ 10 mins), Total PB Total physical behaviour, 




SPSS version 22 (IBM, New York, USA) was used for statistical analyses. 
Pearson correlation was used to assess multicollinearity between PB parameters 
and total PB, no adjustment was made to the data if multicollinearity was present. 
Isotemporal substitution regression modelling (forced entry) was implemented to 
examine the impact of one hour of PB substitution (Mekary et al., 2013). Isotemporal 
substitution modelling is performed by removing the substitution PB from the forced 
entry linear regression model (i.e. substitute SB model: Intercept + (ẞ1 х Standing) 
+ (ẞ2 х LIPA) + (ẞ3 х sMVPA) + (ẞ4 х 10MVPA) + (ẞ5 х Total PB) + Covariates + Error). 
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Significant PB predictors within the ISM illustrate that replacing one hour of the 
substituted PB (as data is measured in hrs·day-1) with the significant PB would have 
an effect on the respective cardiovascular parameter (magnitude of unit change 
illustrated by beta coefficient and 95% confidence intervals [95%CI]). Including total 
PB at the end of the ISM represents the time-constrained hours within a waking 
hours day, which standard linear regression modelling does not account for. 
Partition regression modelling (forced entry) was used to examine the effect of 
adding PB to the prediction model. Both ISM and partition models were conducted 
without (Model 1) and with (Model 2) adjustment for covariates to determine how 
hydration status and medication affect the relationship between PB and 
cardiovascular profile. Hydration status was used as a covariate as this has been 
shown to effect artery diameter (Chen et al., 2007) whilst medication use was used 
as a covariate as it has been shown to effect cardiovascular parameters (Furberg 
et al., 1994; Williams et al., 2006; Dernellis and Panaretou, 2002). Hydration, 
primary CVD meds, and (in)direct CVD meds were used for covariate adjustment if 
a forced entry linear regression analysis had shown that that they are associated 
with the respective cardiovascular parameter. Cardiovascular data were natural 
LOG transformed if they violated normal distribution. Data are presented as beta 




Isotemporal Substitution Modelling 
 
Isotemporal substitution showed that changes in PB levels would significantly 
affect three out of the 19 assessed cardiovascular parameters (Appendix Chapter 
03 table A3.2.1-19), these being resting heart rate, carotid AL artery diameter, and 








Figure 3.2.1 Significant PB ISM and their impact on cardiovascular parameters. Markers indicate (left 
to right) -95%CI, beta coefficient, and +95%CI. * Normalised for Primary CVD Medication. SB 
Sedentary behaviour, LIPA Light intensity PA, sMVPA Sporadic moderate to vigorous intensity PA 
(accumulated in bouts <10 mins), 10MVPA 10 minute moderate to vigorous intensity PA (accumulated 
in bouts ≥10 mins), Carotid AL artery diameter Carotid anterior longitudinal plane artery diameter. 
Blue circles indicate a positive effect on cardiovascular profile. Orange circle indicates a negative 
effect on cardiovascular profile. 
 
Substitution of SB with Standing and sMVPA was suggested to reduce 
resting heart rate (figure 3.2.1, -6.20 [-12.1, -0.22] bpm, -3.72 [-7.01, -0.44] bpm, 
respectively) which, is clinically relevant as a 5 bpm increase in resting heart rate 
increases the risk of cardiovascular mortality by 3% (2.0, 4.0) (Li, 2015). After the 
substitution of SB with LIPA, carotid AL artery diameter was predicted to reduce 
(figure 3.2.1, -0.54 [-1.00, -0.07] mm) and vice versa (figure 3.2.1, 0.54 [0.08, 1.00] 
mm), which is clinically relevant as a 0.78 mm increase is associated with a 2.1 (1.3, 
3.3) hazard ratio risk of all-cause mortality (Van Dijk et al., 2001). Substitution of 
Standing with sMVPA (figure 3.2.1, 1.31 [0.11, 2.51] mm) would increase popliteal 
artery diameter and vice versa (figure 3.2.1, -1.52 [-2.83, -0.22] mm). This result is 
clinically relevant as an 8-week interval training program increased popliteal artery 
diameter by 0.14 mm per hour of training (Madsen et al., 2015) as well as the 
popliteal artery diameter of healthy controls being 0.6 mm (p=0.11) lager than those 
with coronary artery disease (males aged 40 – 70 years) (Angerer et al., 2001). 
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 Within model 2, the results for all cardiovascular variables remained the same 
after covariate adjustment suggesting that co-variates had no effect on the 




Interestingly, engagement in Standing (-8.08 mmol·l-1 [-14.26, -1.90]) would 
reduce resting heart rate by a greater magnitude compared to engagement in 
sMVPA (-5.60 mmol·l-1 [-9.70, -1.49]) (Appendix Chapter 03 table A3.2.1-19).  
Increasing levels of SB and Standing would increase carotid AL IMT by 1.05 
(1.00, 1.11) mm and 1.13 (1.01, 1.26), mm, respectively (Appendix Chapter 03 table 




The largest correlation coefficient within the multicollinearity matrix was 
between SB, LIPA and sMVP (r=-0.69) whilst the remaining variables only had weak 
correlations suggesting low influence of collinearity on the results (table 3.3.2). 
Table 3.2.2. Collinearity statistics for PB parameters. 
 SB Standing LIPA sMVPA 10MVPA Total PB 
SB - -0.58*** -0.69*** -0.69*** -0.23* 0.32** 
Standing  - 0.64*** 0.35** 0.01 0.24* 
LIPA   - 0.45*** -0.02 0.13 
sMVPA    - 0.19 0.23* 
10MVPA     - 0.05 
Pearson Correlations. *** p≤0.001, ** p≤0.01, * p≤0.05. 
SB Sedentary behaviour, LIPA Light intensity PA, sMVPA Sporadic moderate to vigorous 
intensity PA (accumulated in bouts <10 mins), 10MVPA 10 minute moderate to vigorous 








The objective of this study was to determine whether the substitution of SB 
and lower intensity PA with MVPA would have positive effects on cardiovascular 
health and vice versa, in older adults. The aim was to provide a time-constrained, 
alternative to bivariate/multivariate regression modelling, to simulate how changes 
in PB would affect the cardiovascular profile of older adults. It was hypothesised that 
substituting SB with any intensity of PA would improve cardiovascular parameters 
and that substituting a PB with a higher intensity would improve cardiovascular 
profile. It was also hypothesised that substituting SB with 10MVPA would have a 
greater effect on cardiovascular parameters than seen with sMVPA substitutions.  
Heart rate is controlled by the central nervous system, which is compromised 
of the sympathetic and parasympathetic pathways. The simulation of the 
replacement of SB with Standing or sMVPA reduced resting heart rate. 
Physiologically, this could be achieved through improved baroreceptor function, 
which naturally declines with age (Gribbin et al., 1971). Given that six weeks of yoga 
(consisting mainly of static postures [and breathing exercises]) has been reported 
to improve high frequency baroreceptor sensitivity, and to reduce resting heart rate 
in older adults (whereas prolonged aerobic training did not) (Bowman et al., 1997), 
a similar effect may be at play in the Standing PB within our current modelling. High 
frequency baroreceptors represent the sympathetic nervous system, suggesting 
that vasoconstriction response was improved to counteract the natural fall in blood 
pressure with standing activities (Hill, 1895). Subsequently, increased 
vasoconstriction would increase venous return and stroke volume, which would 
result in the need for a lower heart rate to maintain resting cardiac output. On the 
other hand, the modelling of reduction in heart rate through increased sMVPA may 
be achieved via improvements in the parasympathetic pathway. Interval training 
consisting of nine, 5-minute repeated bouts at 65% of maximum heart rate (MVPA) 
over 14 weeks improved markers of  parasympathetic activity (PNN50 [percentage 
of successive normal sinus RR intervals >50.0 ms] and RMSSD [root mean square 
of the successive normal sinus RR interval difference]) and subsequently decreased 
24-hour mean heart rate within older adults (Pichot et al., 2005). Therefore, the 
simulations from real data in our current study suggest that reducing SB with PA, 
such as Standing (arguably easy to accumulate, due to the increased perceived 
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barriers to exercise that occur with increasing age (O'Neill and Reid, 1991)), could 
yield health benefits. However, engagement in MVPA is also important, as it would 
appear that different pathways are targeted by the two distinct PA intensities. 
The reduction in resting heart may also be a result of vascular remodelling 
within compliant blood vessels such as the carotid and popliteal arteries, but not the 
stiffer brachial artery. With ageing, artery diameter increases as elastin stiffness 
decreases causing the load bearing to shift to collagen fibres within the vascular 
smooth muscle (O’rourke and Hashimoto, 2007). This structural change may not be 
due solely to ageing but also due to increased SB, as the substitution of LIPA with 
SB increased carotid AL artery diameter in our modelling. The opposite association 
was shown when the reverse substitution between SB and LIPA was made. These 
inferences are in line with previous older adult research which found an increase 
and decrease in carotid-femoral pulse wave velocity with increased engagement in 
LIPA and SB, respectively (Gando et al., 2010).  
The increase in arterial stiffness with ageing is also a determinant for the fall 
in orthostatic blood pressure, which begins before baroreceptor mediated reflexes 
(Gross, 1970). Orthostatic posture increases lower limb blood pressure, which 
subsequently leads to an increase in total peripheral resistance and declined cardiac 
output. With the substitution of standing with sMVPA, popliteal artery diameter 
increased. This, in line with Poiseuille’s Law of flow, would decrease local blood 
pressure and thus total peripheral resistance. However, sMVPA engagement would 
also acutely increase blood flow (Krustrup et al., 2004). Blood flow declines with age 
in the legs due to increased sympathetic activity (Dinenno et al., 1999), the latter 
which could increase total peripheral resistance. Training interventions within 
physically inactive have shown that the acute vascular responses to interval training 
(MVPA bouts <10 mins, representative of sMVPA) stimulates baroreceptor activity 
(Pichot et al., 2005) and increased artery diameter (Madsen et al., 2015), 
subsequently leading to improved popliteal endothelial function and distensibility 
(Rakobowchuk et al., 2008). Overall, our results suggest that older adults who 
cannot sustain MVPA for 10 continuous minutes can still attain vascular adaptions 
(reduced resting heart rate and increased popliteal artery diameter) that mediate 







The ISM of the current study suggested that an accumulation of MVPA bouts, 
that are shorter than the recommended 10-minute minimum, would improve 
cardiovascular parameters (including resting heart rate and popliteal artery 
diameter), with lower intensity PA also influencing cardiovascular parameters. Our 
findings are therefore a promising avenue for lifestyle interventions in older adults 
in order to reduce the ageing effects on cardiovascular health, especially those end-
users who cannot engage or sustain sufficient MVPA to be classed as physically 
active. The replacement of SB with PA influenced two of the 19 (resting heart rate, 
and carotid AL artery diameter) whilst the replacement of sMVPA with a lower 
intensity PB influenced one (popliteal artery diameter) cardiovascular parameter(s). 
The current findings suggested that the reduction of SB is just as important as the 
need to be physically active for older adults.  
Finally, the current study illustrates the usefulness of ISM in simulating the 
different effects (and/or physiological pathways) that a PB outcome of interest, may 
have on a unique (or a set of) cardiovascular parameter(s), dependent on the PB it 
is displacing. This is the first study, to the authors’ knowledge, to demonstrate 
changes in cardiovascular structure within an isotemporal substitution model for an 
older adult cohort.  
Intervention studies are needed to determine the time course of the 









Since 2003, it has become increasingly evident that sedentary behaviour 
(SB) has physiological effects that are independent from those of moderate to 
vigorous physical activity (MVPA) (Bey and Hamilton, 2003), resulting in an  
approximate 20.0% per annum increase in SB research (PubMed, key word: 
sedentary behaviour, date accessed: 02 February 2, 2017). In particular, SB 
appears to be a strong mediator of cardiovascular disease (CVD), as recent meta-
analysis have suggested that increased SB carries a 71% (95% confidence interval 
[CI] 8.0, 148) increase in the relative risk of CVD mortality (Wilmot et al., 2012). 
Predictive models have mainly focused on using MVPA as a covariate for SB 
however, few have used light intensity physical activity (LIPA) (Buman et al., 2010; 
Healy et al., 2007; Fanning et al., 2016), which is hypothesised to be a method of 
SB reduction (Bailey and Locke, 2014), as a covariate. Recently, it has been argued 
that different intensities of physical behaviour (PB) (Bussmann and van den Berg-
Emons, 2013) should be considered as co-dependents, rather than independents, 
as engagement in one form of PB will offset the amount of time that can be engaged 
in other forms of PB within a day (Rosique-Esteban et al., 2017). Furthermore, the 
physiological effects of SB independent from MVPA (Gennuso et al., 2013) may be 
altered by other PB engagement within the remaining hours of the day, that are not 
considered in traditional statistical analyses and therefore, these do not represent a 
‘real-world’ environment (Chastin et al., 2015b). Currently, the UK government does 
not recommend a threshold for the maximum amount of time an adult should engage 
in SB. Critically, further investigation is therefore required to determine the complex 
interaction between SB and the different intensities of physical activity (PA) on 
health parameters. These studies are integral to the formulation and prescription of 
meaningful and/or justifiable health recommendations. For older adults, the 
inclusion of quantitative SB and LIPA advice in the government PA 
recommendations is essential as less than 5.0% of older adults attain sufficient 
MVPA (Craig et al., 2009) therefore, other avenues to improve health need to be 
highlighted which, may be more attainable for frail older adults.  
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 The objectives of the current study are to examine whether; 1) any SB effects 
on older adult cardiovascular profile are present after accounting for LIPA and 
10MVPA (MVPA accumulated in bouts of ≥10 minutes [mins]). 2) there is consistently 
one or several PB profiles that display unfavourable measures of cardiovascular 
parameters. 3) greater engagement in one PB can offset the cardiovascular effects 
caused by other PB parameters. 
The overarching aim was to propose a visual mapping of the interplay 
between PB (mainly SB, LIPA, and 10MVPA) and cardiovascular parameters, so that 
the end-user (i.e. health workers, carers, older persons) may have an easy to 
understand evidence-based point of reference. 
 Based on the evidence from Chapter 03 Part 1 and Part 2, it was 
hypothesised that the way in which one engages in one PB or another, would be 
evident on the resultant cardiovascular profile markers. In addition, it was 
anticipated that the combination of SB, LIPA, and 10MVPA would show the strongest 
(physiologically explainable) relationship with cardiovascular variables. Indeed, 
previous analysis using combinations that included sMVPA, and total week 10MVPA 
(hrs∙week-1) did not show strong patterns with cardiovascular health (Appendix 




The methods of data collection follow that of Chapter 03 Part 1 (n=93, 
73.8±6.2 years [yrs], female 54%). Sedentary behaviour, LIPA, and 10MVPA were 
used as measures of PB (table 3.3.1). Of the 19 cardiovascular parameters 
assessed in Chapter 03 Part 1 and 2, 11 (including body mass index [BMI]) were 
selected for 3-dimensional heat mapping analyses. Participants were grouped for 
each cardiovascular parameter based on government or peer-reviewed research 
recommended threshold health values (table 3.3.2). If no threshold recommendation 






Table 3.3.1. Physical behaviour parameters and definitions. 
 
  
Terminology Unit Definition 
Sedentary Behaviour 
(SB) 
hrs·day-1 The mean amount of SB, of any length, that is accumulated 
in a 24hr day. 
Any waking behaviour characterised by a seated or reclined 
posture (Tremblay et al., 2010). 
Light Intensity Physical 
Activity (LIPA) 
hrs·day-1 The mean amount of LIPA, of any length, that is 
accumulated in a 24hr day. 
Any standing posture that elicits 1.50 - <3.00 METs 
(Tremblay et al., 2010). 
≥10 Minute Moderate to 
Vigorous Physical 
Activity (10MVPA) 
hrs·day-1 The mean amount of MVPA that is accumulated in bouts 
≥10.0 mins in a 24hr day (Department of Health Social 
Services and Public Safety, 2011). 





Table 3.3.2. Thresholds for cardiovascular parameters and the distribution of participants 
between the thresholds.  
Cardiovascular Parameter Thresholds n 
BMI (kg·m2) 





Obese I: 30.0-34.9 
Obese II: 35.0-39.9 







Systolic BP (mmHg)  
(Mancia et al., 2007) 
Healthy: ≤120 
High Healthy: 121-139 
High I: 140-159 





Diastolic BP (mmHg)  
(Mancia et al., 2007) 
Healthy: ≤80 
High Healthy: 81-89 
High I: 90-99 





Pulse Pressure (mmHg)  
(Glynn et al., 2000) 
Healthy: <53 
High Healthy: 53-62 
High I: 63-76 





Carotid AL Artery Diameter (mm) 







Carotid Far Wall IMT (mm)  
(Bots et al., 1997) 
Healthy: <0.75 
High Healthy: 0.75-0.821 
High I: 0.822-0.907 





Resting Heart Rate (bpm)  
(Li, 2015) 
Healthy: <50 
Moderate Healthy: 50-60 








































Q Represents quartile thresholds. BMI Body mass index. BP Blood pressure. AL 









XLSTAT (Addinsoft, New York, USA) add-in for Excel 2013 (Microsoft Inc., 
Washington, USA) was used to create 3-dimensional surface heat maps. The 
various colours represent different health groupings in terms of the magnitude of 
specific cardiovascular parameters, with red, orange, yellow and green generally 




The average engagement in PB intensities and pooled cardiovascular 
parameters can be found in Chapter 03 Part 1, table 3.1.4 and 3.1.5. 
 
Body Mass Index 
 
The majority of participants were classified as overweight (40 out of 93) or 
healthy (27 out of 93). Engagement in low levels (below average engagement in 
LIPA, 10MVPA <0.5 hrs∙day-1) of LIPA (<0.85 hrs·day-1), 10MVPA (<0.20 hrs·day-1) 
and a range of SB from 2.50 – 12.5 hrs·day-1 characterised participants as obese 
III. As engagement in LIPA increased there was a trend for SB to decrease, when 
10MVPA remained at <0.05 hrs·day-1, which led to a decrease in participant’s BMI 
into the obese I/overweight categories. Increasing 10MVPA (>0.20 hrs·day-1) whilst 
LIPA (1.31 hrs·day-1) and SB (11.4 hrs·day-1) were held constant led to a movement 
from obese III into the overweight category. However, to be categorised as healthy 
BMI, participants also had to engage in >2.40 hrs·day-1 of LIPA, whilst 10MVPA was 
>0.20 hrs·day-1 and SB was <7.5 hrs·day-1. Overall, to be classed as a healthy BMI, 
it appears that targeting an increase in LIPA, as it tends to mirror a decrease in SB, 
may be the best intervention as long as participants engage in >0.20 hrs·day-1 of 






Figure 3.3.1. The combined influence of SB, LIPA, and 10MVPA on BMI in older adults. Colours 
represent thresholds of BMI category (kg·m2). 
 
Systolic Blood Pressure 
 
Over 50% of the participants were classified as having a (high) healthy 
systolic blood pressure (BP). However, there was no discernible influence of the 
combined PB, or changing PB, on systolic BP (figure 3.3.2). 
 
Figure 3.3.2. The combined influence of SB, LIPA, and 10MVPA on Systolic BP in older adults. 
Colours represent thresholds of Systolic BP (mmHg). 
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Diastolic Blood Pressure 
 
Engagement in low levels of LIPA (<0.85 hrs·day-1), 10MVPA (<0.20 hrs·day-
1) and a range of SB from 2.50 – 12.5 hrs·day-1 characterised participants with pre-
hypertensive diastolic BP. An increase in both LIPA and/or 10MVPA from these low 
levels was characterised with participants displaying a healthy diastolic BP (≤80.0 
mmHg) (figure 3.3.3), which additionally, was present in more than three quarters 
of participants. 
 
Figure 3.3.3. The combined influence of SB, LIPA, and 10MVPA on Diastolic BP in older adults. 




There was no clear association between engagement in SB, LIPA, 10MVPA, 
and pulse pressure (figure 3.3.4). A high pulse (63 – 76 mmHg) pressure was the 








Figure 3.3.4. The combined influence of SB, LIPA, and 10MVPA on pulse pressure in older adults. 
Colours represent thresholds of pulse pressure (mmHg). 
 
Carotid Artery Diameter 
 
The distribution of participants across the three categories of carotid AL 
artery diameter was fairly even (Table 3.3.2). High SB (>11.5 hrs·day-1) and low 
10MVPA (<0.2 hrs·day-1) characterized participants with large carotid AL artery 
diameter (7.57 – 11.0 mm). Artery diameter remained large as LIPA increased until 
participants accumulated >2.0 hrs·day-1 of LIPA, after which participants were 
characterized with a healthy artery diameter (<6.92 mm). In participants completing 
<2.0 hrs·day-1 of LIPA, increasing 10MVPA reduced artery diameter to a moderate 
level, regardless of SB engagement. Low SB (<8.00 hrs·day-1), high 10MVPA (>0.5 
hrs·day-1), and high LIPA (>2.0 hrs·day-1) had a trend for participants to display a 









Figure 3.3.5. The combined influence of SB, LIPA, and 10MVPA on carotid AL artery diameter in older 
adults. Colours represent thresholds of carotid AL artery diameter (mm). 
 
Carotid Intima-Media Thickness 
 
Low 10MVPA (<0.2 hrs·day-1) and high SB (>10.0 hrs·day-1) was 
characterised with moderately sized IMT (0.75 – 0.821 mm), even as LIPA 
increased. Increasing 10MVPA above 0.20 hrs·day-1, independent of change in SB 
or LIPA was generally characterized with a healthy IMT (figure 3.3.6), which was the 
most prevalent category (41 out of 90) for the older adult’s IMT. 
 
Figure 3.3.6. The combined influence of SB, LIPA, and 10MVPA on carotid AL far wall IMT in older 
adults. Colours represent thresholds of carotid AL far wall IMT (mm). 
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Resting Heart Rate 
 
All participants fell within the normal resting heart rate range (40 – 100 bpm). 
There appeared to be a relationship between LIPA and 10MVPA time trade-off, and 
participant’s heart rate falling above and below the 60 bpm ‘ideal’ threshold. If 
participants engaged in no 10MVPA, they needed to engage in >2.00 hrs∙day-1 of 
LIPA to have a resting heart rate <60 bpm. However, as 10MVPA engagement 
increased, less LIPA engagement was required to have a heart rate below 60 bpm 
(e.g. 10MVPA: 0.44 hrs∙day-1, LIPA: 1.39 hrs∙day-1, heart rate: 57 bpm). SB appeared 
to have little to no influence on resting heart rate, as participants either side of this 
LIPA-10MVPA threshold line had similar SB engagement (figure 3.3.7). 
 
Figure 3.3.7. The combined influence of SB, LIPA, and 10MVPA on resting heart rate in older adults. 
Colours represent boundaries of resting heart rate (bpm). 
 
Brachial Artery Diameter 
 
Those with low 10MVPA (<0.20 hrs·day-1) tended to exhibit a brachial artery 
diameter in the upper two quartiles, even with increasing LIPA. Those with the 
highest levels of SB (>11.0 hrs·day-1) tended to exhibit an artery diameter in the 
upper quartile. Individuals with moderate engagement in 10MVPA (0.20 – 0.50 
hrs·day-1) commonly had an artery diameter within the lowest quartile. However, 
occasions where SB engagement was >11.0 hrs·day-1, participants displayed an 
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increased artery diameter. Interestingly, physically active participants (10MVPA: 
>0.50 hrs·day-1) also had a trend to have an increase artery diameter (figure 3.3.8). 
 
Figure 3.3.8. The combined influence of SB, LIPA, and 10MVPA on brachial artery diameter in older 
adults. Colours represent quartiles of brachial artery diameter (mm). 
 
Brachial Intima-Media Thickness 
 
There appeared to be an optimal range for LIPA (1.00 – 2.50 hrs·day-1), 
10MVPA (0.10 – 0.50 hrs·day-1, and SB (<11.0 hrs·day-1) engagements for 
participants to fall within the lowest quartile of IMT. Interestingly, high LIPA (>3.50 
hrs·day-1) and 10MVPA (>0.50 hrs·day-1) was characterized with IMT in the upper 





Figure 3.3.9. The combined influence of SB, LIPA, and 10MVPA on brachial far wall IMT in older 
adults. Colours represent quartiles of brachial far wall IMT (mm). 
 
Popliteal Artery Diameter 
 
Participants with <2.00 hrs·day-1 of LIPA, high SB (>9.00 hrs·day-1), and were 
physically inactive (10MVPA: <0.50 hrs·day-1) were characterized with an artery 
diameter in the upper two quartiles. However, those with high LIPA (>3.50 hrs·day-
1) or were physically active (10MVPA: >0.50 hrs·day-1) fell within the lowest quartile 
of artery diameter (figure 3.3.10). 
 
Figure 3.3.10. The combined influence of SB, LIPA, and 10MVPA on popliteal artery diameter in older 
adults. Colours represent quartiles of popliteal artery diameter (mm). 
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Popliteal Intima-Media Thickness 
 
Participants with LIPA engagement >2.00 hrs·day-1 were characterized within 
the lowest quartile of IMT. There was a trend for those with low LIPA (<2.00 hrs·day-
1) and high SB (>9.00 hrs·day-1) to have a greater IMT, if their 10MVPA was <0.50 
hrs·day-1). Participants who were physically active (10MVPA: ≥0.50 hrs·day-1) fell 
within the lowest quartile of IMT, regardless of LIPA and SB engagement (figure 
3.3.11). 
 
Figure 3.3.11. The combined influence of SB, LIPA, and 10MVPA on popliteal far wall IMT in older 




The objectives of the study were: 1) to illustrate any SB effect on older adults’ 
cardiovascular health after accounting for LIPA and 10MVPA, 2) to illustrate whether 
there is consistently one or several PB profiles that display unfavourable measures 
of cardiovascular parameters, 3) to illustrate whether a greater engagement in one 
PB can offset the cardiovascular effects caused by other PB parameters. 
The overarching aim was to propose an end-user (i.e. health workers, carers, 
older persons) friendly visual representation of the interaction between absolute 
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Within older adults, BMI follows a U-shaped relationship with mortality risk 
(Winter et al., 2014). Thus, overweight older adults have a lower hazard ratio risk of 
all-cause mortality than those with a healthy BMI (23.5 kg∙m2) (Winter et al., 2014). 
Increased risk of death does not occur with increasing BMI until 33.5 kg∙m2 (Winter 
et al., 2014), which is Obese I within the current study. Based on being classified as 
obese I, the present findings suggest that leading a high sedentary (>12.0 hrs∙day-
1), low physical activity (low LIPA [<1.0 hrs∙day-1], low 10MVPA [<0.1 hrs∙day-1]) 
lifestyle may be associated with an increased risk of death. In order to improve BMI 
status to a healthy classification, it is recommend based on our data that older adults 
should reduce SB (<7.5 hrs∙day-1) and increase LIPA (>3.5 hrs∙day-1) without 
needing to increase 10MVPA. This may be a more palatable message for high 
sedentary, low MVPA older adults to engage with, as most LIPA, as with SB, can 
be performed in conjunction with other activities, such as playing cards, bingo, and 
social group meetings and therefore, may not require routine adjustment, which is 
likely to occur when asked to increase 10MVPA engagement. Within the UK, a lack 
of provision for non-sedentary behaviour and an expectation that older adults 
must/want to sit is highlighted as a determinant for prolonged sitting within 




 The risk of CVD death increases 6% per 10 bpm increase in resting heart 
rate (Li, 2015). The results of the current study suggested two possible targets for 
intervention, increasing LIPA or 10MVPA. For participants to have a heart rate below 
60 bpm, they either engaged in no 10MVPA and >2.0 hrs∙day-1 of LIPA or they 
engaged in >0.44 hrs∙day-1 of 10MVPA and >1.39 hrs∙day-1 of LIPA. Participants who 
were below these LIPA and 10MVPA thresholds tended to display a resting heart 
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rate within the 61-70 or 71-80 bpm groupings suggesting an increased risk of CVD 
death. Interestingly, the LIPA and 10MVPA showed no associations with resting 
heart rate in Chapter 03 Part 1 and Part 2 which, is probably a result of the statistics 
not being suitable to extract this complex trade-off between LIPA and 10MVPA thus 
warranting the need to also visualise data where possible. 
 A 0.78 mm increase in carotid artery diameter is associated with a 2.0 (95%CI 
1.3, 3.3) hazard risk of mortality over a 6.6 year follow up in older adults (Van Dijk 
et al., 2001). The average artery diameter of those who died during follow-up in the 
aforementioned study of Van Dijk et al. (2001) was 7.57±0.91 mm. The current study 
suggested that those who are highly sedentary and engage in little PA (LIPA and 
10MVPA) will tend to have a carotid artery diameter above 7.57 mm. There was a 
trend for artery diameter to reduce as LIPA and 10MVPA increased and SB 
decreased. This is consistent with isotemporal substitution models from Chapter 03 
Part 2, which found carotid artery diameter, would decrease by 0.54 mm with the 
replacement of one hour of SB with LIPA. It appeared that older adults needed to 
engage in 10MVPA for at least 0.4 hrs∙day-1 and 4.0 hrs∙day-1 of LIPA with <8.0 
hrs∙day-1 of SB to have the best chance of being characterised with a healthy carotid 
artery diameter, as other accumulation patterns were sporadic in artery diameter. 
 Participants who engaged in <0.2 hrs∙day-1 of 10MVPA tended to be 
characterised with a carotid IMT between 0.75 – 0.821 mm or >0.907 mm, which 
are suggested to carry a 2.28 and 4.21 increased odds ratio for stroke events, 
respectively, compared with those with an IMT <0.75 mm (Bots et al., 1997). For 
participants to likely be classified with an IMT <0.75 mm within the current study, 
the data suggested that older adults needed to engage in at least 0.2 hrs∙day-1 of 
10MVPA, which equates to one 10-minute bout of MVPA per day. However, this bout 
of MVPA may need to be of a vigorous intensity as previous evidence has shown 
reductions in IMT with vigorous intensity PA (Kozàkovà et al., 2010) but not 
moderate intensity PA (Tanaka et al., 2002; Rakobowchuk et al., 2008). 
 There is a trend for brachial artery diameter to increase with age (Green et 
al., 2010). The current findings suggested that low levels of 10MVPA resulted in 
participants displaying a brachial artery diameter >3.6 mm. As 10MVPA increased 
above 0.2 hrs∙day-1, an artery diameter <3.6 mm was most prevalent. Interestingly, 
high engagement in SB appeared to attenuate this observation. Suggesting that SB 
may influence artery diameter independent of 10MVPA. Furthermore, those 
111 
 
participants who were physically active (>0.5 hrs∙day-1 of 10MVPA) had larger 
brachial artery diameters. This may suggest a U-shaped continuum for brachial 
artery diameter and 10MVPA. As gradual increases in 10MVPA may attenuate age 
related increases in brachial artery diameter however, as 10MVPA engagement 
exceeds 0.5 hrs∙day-1, it becomes sufficient to stimulate healthy arterial remodelling 
(Green et al., 2010). In fact, further analysis supported this hypothesis as brachial 
artery diameter tended to be smaller in participants that engaged in 0.21 – 0.49 
hrs∙day-1 of 10MVPA compared to participants with ≤0.2 hrs∙day-1 of 10MVPA 
engagement. Meanwhile, those who were physically active (≥0.5 hrs∙day-1 of 
10MVPA) had the largest brachial artery diameter (Appendix Chapter 03 figure 
A3.3.29). 
 Interestingly, the current study suggested that engaging in the upper levels 
of PB (SB: ≥11 hrs∙day-1, LIPA: >2.5 hrs∙day-1, 10MVPA: ≥0.5 hrs∙day-1) 
characterised participants with a brachial IMT in the upper two quartiles (>0.51 mm). 
This does not support previous findings that suggested older adult’s brachial IMT 
(baseline: 525±18.7 μm) reduces after 12 weeks of LIPA (488±17.9 μm) and then 
further reduces after an additional 12 weeks of 10MVPA (454±15.5 μm) (Green et 
al., 2010). In addition, neither Chapter 03 Part 1 nor Part 2 showed any associations 
between PB and brachial IMT, therefore the visual pattern in the current study would 
need further research to try to explain the patterns described. 
 Similar to the brachial artery, popliteal artery diameter increases with age 
(Green et al., 2010). An enlarged popliteal artery in older adults can be a sign of an 
impending aneurysm, which is particularly important to diagnose, as approximately 
one-third of patients will have an abdominal aortic aneurysm (Dawson et al., 1997), 
which carries an estimated in-hospital mortality rate of 65.9% in the United Kingdom, 
if rupture occurs (Karthikesalingam et al., 2014). The current study suggested that 
those who engaged in >2 hrs∙day-1 of LIPA and <9 hrs∙day-1 of SB would likely be 
characterised with a popliteal artery diameter in the lowest quartile. In addition, 
physically active (10MVPA: ≥0.5 hrs∙day-1) participants also had popliteal artery 
diameters that were in the lowest quartile of size, regardless of SB engagement. It 
seemed that these levels of LIPA and 10MVPA might be sufficient to negate the 
effects of SB, which appeared to push participants into the upper two quartile of 
artery diameter if they engaged in >12 hrs∙day-1 of SB. In contrast, Chapter 03 Part 
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1 and Part 2 displayed no association between SB, LIPA, 10MVPA and popliteal 
artery diameter. 
 Popliteal IMT increases with age (Green et al., 2010) and is a common site 
for atherosclerotic disease. The current study suggested that participants who are 
not physically active (10MVPA: <0.5 hrs∙day-1) need to engage in >2 hrs∙day-1 of LIPA 
and <12 hrs∙day-1 of SB to fall within the lowest IMT quartile. High engagement in 
SB appeared to not effect popliteal IMT if participants were physically active 
(10MVPA: ≥0.5 hrs∙day-1), suggesting older adults could offset the impact of 
prolonged SB. It was highly apparent however, that a highly sedentary, physically 
inactive, and low LIPA lifestyle carries a high likelihood of an enlarged popliteal IMT. 
This observation is in-line with Chapter 03 Part 1, which also highlighted that 
increasing LIPA would decrease popliteal IMT as well as a trend for popliteal IMT to 




It is apparent that there are complex interactions between PB intensities and 
their subsequent effect on cardiovascular health markers. The improvement in some 
cardiovascular variables with increasing LIPA is a promising observation from the 
current study. This suggests that older adults may be able to improve their health 
through a greater engagement in activities that are within their physical capability 
and can be completed with limited logistical requirements. In addition, an 
engagement in >2.0 hrs·day-1 of LIPA appeared to improve cardiovascular 
parameters and to be associated with a reduction in SB, which is also an important 
PB to limit prolonged engagement in, as the current study suggested SB above 8 – 
11 hrs·day-1 could negatively affect cardiovascular profile. Finally, this study added 
further support to maintaining a physically active lifestyle, if capable, as there was a 
clear improvement in profile for some cardiovascular markers when 10MVPA 
exceeded 0.5 hrs∙day-1.  
 Overall, the current study suggests that older adults should aim to be 
physically active and reduce SB engagement. If a physically active lifestyle is not 
possible, or physically inactive older adults aim to improve their health, then 
increasing engagement in LIPA may be a useful starting point (especially where 

















As life expectancy increases, the 60 year-old and above age group are 
predicted to account for 25.0% of the UK population by the year 2035 (Office for 
National Statistics, 2012a). This may cause a socio-economic imbalance, 
particularly in the National Health Service (NHS), as average annual inpatient 
healthcare spending per person increases exponentially after the age of 50 years 
(50 year-old male: £605, 70 year-old male: £1,834, 89 year-old male: £5,198) (E. 
Kelly et al., 2016). With adults over the age of 65 years only expected to spend 
55.0% of their remaining years of life in ‘good’ health (Office for National Statistics, 
2016) the question becomes: can changes in older adults’ lifestyle offset the natural 
ageing process and subsequently increase healthy life expectancy? Cardiovascular 
disease (CVD) is the leading causes of death in older adults after cancer (Townsend 
et al., 2015) but its mortality risk can be adjusted through changes in physical 
behaviour (PB) (Bussmann and van den Berg-Emons, 2013). Physically active 
adults (150 mins∙wk-1 of moderate-vigorous intensity physical activity [MVPA], 
accumulated in bouts ≥10.0 mins [10MVPA] (Department of Health Social Services 
and Public Safety, 2011))  are predicted to reduce their risk of CVD mortality by 
35.0% (95% confidence interval [CI] 30.0, 40.0) (Nocon et al., 2008) compared to 
the physically inactive whereas, sedentary behaviour (SB) can increase CVD 
mortality risk by 90.0% (95%CI 36.0, 166) (Wilmot et al., 2012). Although life 
expectancy at age 65 years (yrs) has increased year on year in the UK (1.43 yrs 
increase between 2001 – 2008 (Office for National Statistics, 2013)), healthy life 
expectancy has increased at a much slower rate (0.65 yrs increase between 2001 
– 2008 (Office for National Statistics, 2012b)). Therefore, to inform how the gap 
between life expectancy and healthy life expectancy can be reduced, PB research 
should further investigate the impact on morbidity using CVD markers, such as 
common carotid artery diameter, which increases with age (r2=0.14, p<0.001, age: 
73.3±5.8 yrs) (Polak et al., 1996) and is positively associated with multiple CVD risk 
factors in adults aged 55 years (Jensen-Urstad et al., 1999). Chapter 03 has shown 
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that isotemporal substitution modelling suggest that older adults’ carotid artery 
diameter can be reduced by 0.54 (95%CI 1.00, 0.07) mm with the replacement of 
one hour of SB with light intensity PA (LIPA). As well as total PB time, patterns of 
PB are also predicators of cardiovascular health status (Healy et al., 2008b; 
O’Donovan et al., 2017; Chastin et al., 2015a). An increase in accumulated 
sedentary time using bouts ≥10 mins is associated with an increase in carotid intima-
media thickness (IMT) (García-Hermoso et al., 2015), which is a predictor of stroke 
in old age (72.5±5.5 yrs) (O'Leary et al., 1999) (1.49 [95%CI 1.37, 1.62] relative risk 
per 0.20 mm carotid IMT increase) and also increases with age (10 – 69 years) 
(Farro et al., 2012), suggesting SB engagement could accelerate the ageing 
process.  
Although the distribution of the population is shifting to an increased older 
adult population and life expectancy has increased, the majority of ageing research 
has investigated the transition between young (18 – 30 yrs) to middle (40 – 60 yrs) 
or middle to old (60 – 80 yrs) age groups (Celermajer et al., 1994; Black et al., 2009; 
Dinenno et al., 1999; Dinenno et al., 2000; Eigenbrodt et al., 2006; Green et al., 
2010; Moreau et al., 2006; Pierce et al., 2011; Tanaka et al., 2002; Van den 
Munckhof et al., 2012; van der Heijden-Spek et al., 2000). Few studies have 
investigated the transition from old age to older (80+ yrs) age populations (Ferrara 
et al., 1997; Fritze et al., 2012) i.e. further ageing. Therefore, the aims of this study 
are to determine which cardiovascular profile markers are affected by further ageing 
in older adults aged ≥60 yrs and to recommend what and/or how PB profile can be 
optimized to offset these further ageing effects. The objectives are to highlight 
changes in cardiovascular profile with further ageing with and without adjustment 
for total PB time and patterns of PB. It is hypothesised that physical activities may 
attenuate the effect of further ageing on cardiovascular profile (Skoumas et al., 
2003) whereas SB may accelerate the further ageing process (García-Hermoso et 
al., 2015). In addition, as patterns of PB appear to be stronger predictors of 
cardiovascular profile (Chapter 03), they may also be the strongest adjusters of 
further ageing. Using a cross-sectional study design, participants will be grouped 
per lustrum of older age in order to capture greater details of the further ageing 







Ninety-three older adults were recruited and grouped based on their age (60 
– 65 yrs: n=10, 66 – 71 yrs: n=21, 72 – 77 yrs: n=35, 78 – 83 yrs: n=20, 84+ yrs: 
n=7). Participant recruitment and data collection follows that of the methods of 
Chapter 03. A brief methods is outlined below. 
 
First Laboratory Visit 
 
Participants were fitted with a thigh mounted triaxial accelerometer (GENEA, 
GENEActiv Original, Activinsights Ltd, Kimbolton, UK) on the dominant leg (anterior 
aspect, at 50% of greater trochanter to femoral condyle distance) using a waterproof 
adhesive patch (3M Tegaderm Film, North Ryde, Australia), for seven consecutive 
free-living days. Leg dominance was determined from leg preference for a single 
leg balance exercise. GENEA Residual G PB intensity cut-off points were developed 
against concurrent expired gas analysis (Metabolic Equivalent Tasks [METs]) of a 
sub-population of 20 participants during ten different PB(s) (r2=0.89, p<0.001). SB-
LIPA (1.50 METs) cut-off point was 0.057 Residual G, while the LIPA-MVPA (3.00 
METs) cut-off point was 0.216 Residual G. SB and Standing posture allocation was 
determined using methods similar to that of the ‘Sedentary Sphere’ (Rowlands et 
al., 2014). Intensity was classed as Standing if posture was classed as standing but 
Residual G was below the SB-LIPA cut-off point. This analysis used 10.0 second 
(s) epoch GENEA data (60.0 Hertz [Hz]) and was labelled as The Cheshire 
Algorithm for Sedentarism (CAS). Sleeping hours data was triangulated using a self-
reported Sleep Diary (wake-up time, lights-off go to sleep time, naps not included) 
throughout the monitoring week. In brief, Total PB variables are displayed as the 
average daily engagement over seven days of monitoring. Patterns of PB variables 
are displayed as the average daily amount of bouts or average duration of bouts. 
The more complex calculations of patterns of PB variables are outlined in table 4.1. 
A complete list of definitions for PB variables within the current study can be found 
in Chapter 02 Part 1. Height, mass, body mass index (BMI), and medication use 





Table 4.1. Brief definitions of GENEA variables. 
GENEA Variable Definition 
Alpha  
(α∙day-1) 
How steeply the number of SB bouts decreases with 
increasing SB bout duration in a power-law distribution. 
= 1 + n(1 ÷ Ʃ ln(SB bout length ÷ smallest SB bout length)) 
(Chastin and Granat, 2010). 
W50%  
(mins∙day-1) 
50% of SB time in a 24hr day is accumulated by SB bouts of 
this specific length or shorter.  
= (Ʃ SB bout lengths > median SB bout length) ÷ total SB 
engagement. (Chastin and Granat, 2010) 
NB. Median SB bout length criteria can be changed (increase 
or decrease SB bout length) until the equation equals 0.5 
(50%). This criterion SB bout length is the W50%. 
True Mean SB Bout 
(mins∙day-1) 
SB time (≥1.00 mins) between PA bouts of ≥ 2.00 mins are 
LOG transformed to normally distribute the data and then anti-
logged to find the “True Mean” (Chastin et al., 2015c). 
True Mean PA Bout 
(mins∙day-1) 
PA time (≥2.00 mins) between SB bouts of ≥ 1.00 mins are 
LOG transformed to normally distribute the data and then anti-
logged to find the “True Mean” (Chastin et al., 2015c). 
 
Second Laboratory Visit  
 
Participants arrived in an overnight fasted, hydrated state and were provided 
a standardised meal (49.0% carbohydrate, 38.5% protein, 12.5% fat) before the 
testing session started.  
 A three lead electrocardiogram (ECG), to measure heart rate and the 
diastolic phase of the cardiac cycle, was fitted to participants before resting in the 
supine position for 15.0 minutes (mins). Light intensity (20.0 lm·ft2) and room 
temperature (22.0 ºC) were kept constant throughout testing. Hydration status, as a 
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percentage of total body mass, was determined using bioelectrical impedance 
(BodyStat 1500, BodyStat, Douglas, UK). 
 An echo Doppler ultrasound (model AU5; Esaote, Genova, Italy) using a 7.50 
MHz broadband linear array transducer was used for vascular assessment (angle 
of insonnation: 60.0, B gain: 75.0, Doppler gain: 49.0, CFM gain: 47.0, depth of 
penetration: 49.3 mm, depth of focus: 27.0 – 31.0). Live streamings were recorded 
on a Hewlett-Packard computer running video capture software through an 
analogue to digital converter (Pinnacle, Corel Inc., Ottawa, Canada) at 25 Hz. Left 
common carotid artery and right brachial artery assessments were performed in the 
supine position whilst left popliteal artery assessments were in the prone position. 
Ten cardiac cycles were used to assess baseline IMT and artery diameter for all 
three arteries. Assessments took place within a 10 mm region of interest (ROI), 10 
mm distal of the carotid bulb in the anterior longitudinal (AL) plane, 65% of upper-
arm length (acromion process to lateral radial head) distal of the glenohumeral joint 
for the brachial artery, and 10 mm distal of the superior medial genicular bifurcation 
of the popliteal artery (Harris et al., 2010; Altın et al., 2005; Burke et al., 1995; 
Touboul et al., 2012; Naqvi and Lee, 2014).  
Offline analysis of artery diameter measures for all arteries was performed 
using Brachial Analyzer (Medical Imaging Application LLC, Iowa, USA) whilst 
Carotid Analyzer (Medical Imaging Application LLC, Iowa, USA) was used for IMT 
measures. Data was then R-gated to ensure artery diameter and IMT was measured 
during the diastolic phase only. R-gated frame-to-frame measurements that did not 
use 70.0% of the ROI and/or were more than one standard deviation (SD) from the 
mean artery diameter were filtered from final analysis. All automated processes 
were checked for error by one researcher. Inter/Intra-day coefficients for variation 




Statistical analyses were performed using SPSS Statistics version 22 (IBM, 
New York, USA). A 1×5 one way Analysis of Variance (ANOVA) (or Kruskal-Wallis 
for non-parametric data, violation of Kolmogorov-Smirnov and/or Levene’s test) was 
used to determine whether cardiovascular profile markers changed with further 
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ageing. Simple contrast analysis (Mann-Whitney U for non-parametric data) was 
used post-hoc to determine at which age cardiovascular markers became 
significantly different from that of the youngest age group. Two Analysis of 
covariance (ANCOVA) tests were used to determine if total PB(s), or patterns of 
PB(s), influenced the rate of further ageing. Once again, simple contrast analysis 
was used post-hoc to determine whether the cardiovascular markers were 
significantly different from that of the youngest age group after PB engagement had 
been considered. PB parameters were considered covariates if they displayed 
predictive qualities for the aforementioned cardiovascular markers within Chapter 
03 Part 1. Covariates were added into the ANCOVA model in order of highest to 
lowest adjusted explained variance from Chapter 03 Part 1. One non-significant 
covariate was removed from the model (from lowest explained variance to highest) 
at a time until the ANCOVA model was stable (only significant covariables included).  
A 1×5 one way ANOVA (or Kruskal-Wallis for non-parametric data, violation of 
Kolmogorov-Smirnov and/or Levene’s test) was used to determine whether 
demographics were different between age groups. Bonferroni tests (Mann-Whitney 
U for non-parametric data) were used post-hoc to highlight which age group’s 
demographics were significantly different from one another. Natural LOG 
transformed cardiovascular parameter data is presented if all age groups became 
parametric following LOG transformation of non-parametric data. Parametric data is 
presented as Mean ± SD and non-parametric data as Median (Interquartile Range 




Ninety-three community-dwelling older adults (60-89 yrs) participated in the 








Table 4.2. Participant demographics and PB profiles 
  Age Group 
 Demographics 60-65 66-71 72-77 78-83 84+ 
n 10 21 35 20 7 
Female (%) 90 48 57 50 43 
Height (m) 1.66±0.09 1.62±0.06 1.65±0.09 1.69±0.07 1.66±0.10 
Mass (kg) 71.6±13.7 72.9±14.3 76.9±12.8 77.4±12.6 82.4±10.6 
BMI (kg·m2) 30.9±6.44 27.8±4.81 26.9±4.43a 27.5±3.19 29.8±5.75 
Daily Medication Use 
(%) 
70 80 77 90 71 
Total PB      
SB (hrs∙day-1) 9.81±1.30 9.24±1.38 9.72±1.25 9.73±1.47 10.1±1.15 
Standing (hrs∙day-1) 1.19±0.30 1.16±0.41 1.09±0.40 1.06±0.44 0.93±0.49 
LIPA (hrs∙day-1) 2.11±0.49 1.93±0.61 1.99±0.60 1.98±0.73 1.80±0.87 
sMVPA (hrs∙day-1) 2.68±0.58 2.89±0.57 2.56±0.54 2.39±0.77b 2.11±0.71b 
10MVPA (hrs∙day-1) 0.06(0.16) 0.17(0.28) 0.06(0.17)b 0.09(0.26) 0.00(0.05)bd 
Patterns of PB      
SB Breaks (n∙day-1) 21.3±2.57 23.6±2.73 21.9±3.85 21.6±4.16 22.2±3.03 
<5min SB Bout 
(n∙day-1) 
6.01±1.56 6.52±1.33 6.61±2.22 5.79±2.02 6.94±2.34 
≥5min SB Bout 
(n∙day-1) 
16.0±1.49 17.9±2.10a 16.1±2.29b 16.2±2.97b 16.1±1.42 
True Mean SB Bout 
(mins∙day-1) 
36.1(19.0) 26.2(7.00)a 31.7(11.2)b 29.9(19.4) 28.9(9.79) 
Alpha (α∙day-1) 1.43±0.04 1.45±0.03 1.44±0.04 1.44±0.05 1.44±0.04 
W50% (mins∙day-1) 57.3±12.6 46.5±11.3a 55.8±13.7b 55.5±18.5b 61.6±9.88b 
PA Bouts (n∙day-1) 21.3±2.57 23.6±2.73 21.9±3.85 21.6±4.16 22.2±3.03 
Daily Sum of PA Bout 
Time (hrs∙day-1) 
6.16±1.09 6.21±1.46 5.82±1.57 5.48±1.73 4.56±1.86ab 
True Mean PA Bout 
(mins∙day-1) 
18.0±3.23 16.4±5.14 15.9±4.61 15.7±4.22 12.1±4.02abc 
10MVPA Bouts 
(n∙day-1) 
0.29(0.29) 0.57(0.86) 0.14(0.64)b 0.43(0.82) 0.00(0.14)b 
Total Week 10MVPA 
(hrs∙wk-1) 
0.41(3.18) 1.05(1.54) 0.42(1.28) 0.60(1.56) 0.00(0.34)ab 
SB% (%∙waking hrs-1) 60.8±6.78 59.3±8.58 61.7±9.52 63.7±10.5 69.7±10.7bc 
Standing% 
(%∙waking hrs-1) 
7.36±1.83 7.05±2.10 7.01±2.51 6.85±2.73 6.00±3.06 
LIPA% 
(%∙waking hrs-1) 
13.1±2.80 12.3±3.67 12.7±3.86 12.9±4.47 11.7±5.17 
sMVPA% 
(%∙waking hrs-1) 
16.7±3.94 18.6±3.64 16.4±3.37 15.5±4.80b 15.2±2.49 
10MVPA% 
(%∙waking hrs-1) 
0.89±1.21 1.32±1.05 0.71±0.87b 1.04±1.07 0.30±0.59b 
a Significantly different from 60-65 age group. b Significantly different from 66-71 age group. c 





Physical Behaviour Profiles 
 
There was no consistent pattern for changes in PB with lustrum of age 
increase (table 4.2). With that being said, SB were higher, and PA were lower in the 
oldest lustrum for a number of outcome measures compared to 66-71, and 72-77 
year old groups (e.g. SB%, 10MVPA, Daily Sum of PA Bout Time, table 4.2, all 
p<0.05). Similarly, there are a number of lower SB and higher PA measures in the 
66-71 year group, compared to the other lustrum groups (e.g. W50%, SB bout 




Further ageing did not affect systolic BP (figure 4.1), diastolic BP (figure 4.2), 
or pulse pressure (figure 4.3) and there were no PB covariates for these parameters. 
Further ageing did not affect resting heart rate, even after adjustment for sMVPA 
and Standing, and Daily Sum PA Bout Time and SB% (figure 4.4). 
 
Figure 4.1. The effect of further ageing on systolic BP. Age data and error bars are presented as 
median and interquartile range. There were no Total PB or Patterns of PB covariates. Open circles 




Figure 4.2. The effect of further ageing on diastolic BP. Age data and error bars are presented as 
median and interquartile range. There were no Total PB or Patterns of PB covariates. Open circles 
represent individual participants’ diastolic blood pressure within their respective age group. 
 
 
Figure 4.3. The effect of further ageing on pulse pressure. Age data and error bars are presented as 
mean and standard error. There were no Total PB or Patterns of PB covariates. Open circles 





Figure 4.4. The effect of further ageing on resting heart rate. Age data and error bars are presented 
as mean and standard error. Age+Total PB data and error bars are presented as covariate adjusted 
mean and standard error. Age+Patterns of PB data and error bars are presented as covariate 
adjusted mean and standard error. Total PB covariates: sMVPA and Standing. Patterns of PB 
covariates: Daily Sum PA Bout Time and SB%. Open circles represent individual participants’ pulse 




Common carotid AL artery diameter did not increase with further ageing 
(figure 4.5) however, carotid AL far wall IMT was largest in the 60-65 age group, 
resulting in all older age groups displaying a smaller IMT compared to the former 
(excluding 84+ group). Interestingly, there was a trend for IMT to increase in size as 
age increased from 66-71 to 84+ (figure 4.6). Notably, there were no PB covariates 




Figure 4.5. The effect of further ageing on common carotid AL artery diameter. Age data and error 
bars are presented as mean and standard error. There were no Total PB or Patterns of PB 
covariates. Open circles represent individual participants’ carotid AL artery diameter within their 
respective age group. 
 
 
Figure 4.6. The effect of further ageing on common carotid AL far wall IMT. Age data and error bars 
are presented as mean and standard error. There were no Total PB or Patterns of PB covariates. 
Dashed series Significantly different from 60-65 year old group, p≤0.05. Open circles represent 
individual participants’ carotid AL far wall IMT within their respective age group. 
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Interestingly the brachial artery diameter of participants between the age of 
78 - 83 yrs was larger than that of participants aged 60-65 yrs old (figure 4.7). 
Meanwhile, brachial artery far wall IMT did not increase with further ageing (figure 
4.8).  
 
Figure 4.7. The effect of further ageing on brachial artery diameter. Age data and error bars are 
presented as mean and standard error. There were no Total PB or Patterns of PB covariates. Dashed 
series Significantly different from 60-65 year old group, p≤0.05. Open circles represent individual 





Figure 4.8. The effect of further ageing on brachial far wall IMT. Age data and error bars are 
presented as mean and standard error. There were no Total PB or Patterns of PB covariates. Open 
circles represent individual participants’ brachial far wall IMT within their respective age group. 
 
Popliteal artery diameter did not increase with further ageing even after 
adjustment for the Total PB covariate, Standing (figure 4.9). Popliteal IMT of 
participants aged 84+ years old was larger than participants aged 60-65 years old. 
Interestingly, this further ageing effect on popliteal IMT was somewhat attenuated 





Figure 4.9. The effect of further ageing on popliteal artery diameter. Age data and error bars are 
presented as mean and standard error. Age+Total PB data and error bars are presented as covariate 
adjusted mean and standard error. Total PB covariate: Standing. Open circles represent individual 
participants’ popliteal artery diameter within their respective age group. 
 
 
Figure 4.10. The effect of further ageing on popliteal far wall IMT. Age data and error bars are 
presented as mean and standard error. Age+Total PB data and error bars are presented as covariate 
adjusted mean and standard error. Age+Patterns of PB data and error bars are presented as 
covariate adjusted mean and standard error. Total PB covariate: LIPA. Patterns of PB covariates: 
LIPA%. Dashed series - significantly different from 60-65 year old group, p≤0.05. Open circles 








The aims of this study are to determine which cardiovascular health markers 
are affected by further ageing in older adults aged ≥60 yrs and recommend what 
and/or how PB profile can be optimized to offset any further ageing effects. The 
objectives were to highlight changes in cardiovascular health per lustrum of old age 
with and without adjustment for total PB time and patterns of PB. 
 Ageing research primarily investigates the transition between young (18 – 30 
yrs) to middle (40 – 60 yrs) or middle to old (60 – 80 yrs) age groups (Celermajer et 
al., 1994; Black et al., 2009; Dinenno et al., 1999; Dinenno et al., 2000; Eigenbrodt 
et al., 2006; Green et al., 2010; Moreau et al., 2006; Pierce et al., 2011; Tanaka et 
al., 2002; Van den Munckhof et al., 2012; van der Heijden-Spek et al., 2000). Few 
studies have investigated the transition from old age to older (80+ yrs) age 
populations (Ferrara et al., 1997; Fritze et al., 2012). Due to the increasing 
percentage of older adults in the UK population (Office for National Statistics, 2012a) 
and the increasing life expectancy (Office for National Statistics, 2013), ‘further 
ageing’ research, such as the current study, is essential to ensure the disease 
prevention and treatment methods provided to the older old age population is 
appropriate to maintain quality of life. 
 The presence of further ageing related changes in cardiovascular parameters 
within the current study highlights that older adults, to a degree, are an amorphous 
group, which would indicate a requirement for adequately individualized treatments 
dependent on their age category. In this context, LIPA had the most notable effect 
on popliteal IMT ageing whilst other PB(s) displayed no effect on cardiovascular 
ageing. However, given that the greater majority of the cardiovascular parameters 
showed no further ageing effect would suggest that a generic lifestyle intervention 
would be effective across the spectrum of the 60 – 90 yr old population. 
 
Peripheral Arteries the Target of Further Ageing 
 
Age related increases in popliteal IMT have previously been reported in a 
comparison of young (26±2 yrs) and older (72±1 yrs) adults (0.46±0.03, 0.73±0.05 
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mm, respectively) (Nishiyama et al., 2008). Our results add further evidence, 
suggesting that popliteal IMT continues to increase into older old age. However, the 
most notable finding from the current study was the trend for an attenuation of further 
ageing related increases in popliteal IMT following adjustment for LIPA and LIPA%. 
Although not statistically significant, participants within the 84+ age group had an 
average engagement in LIPA that was lower than the 60 - 65 age group (1.80±0.87, 
2.11±0.49 hrs∙day-1, respectively). This observation is supported by a 12-week LIPA 
(30% heart rate reserve) intervention, which reduced popliteal IMT by 5.30% in 
middle/older adults (59±2 yrs) (Green et al., 2010). Furthermore, it supports the 
paradigm that LIPA can elicit health benefits, which has been a common finding in 
Chapter 03 Part 1 - 3 and adds to the body of evidence that LIPA should be included 
in the older adult’s government recommendations for PA. 
 The current study observed a gradual increase in brachial artery diameter 
with further ageing, with a statistically significant difference between the 60 – 65 vs. 
78 – 83 age groups. Previous findings have observed an age related change in 
brachial artery diameter in the comparison between young (mid 20’s) and middle-
older (late 50’s – mid 70’s) adults (Green et al., 2010; Black et al., 2009; Van den 
Munckhof et al., 2012). One hypothesis for the age associated increase in artery 
diameter is to compensate for the increase in IMT, which occurs with age and plaque 
formation, to maintain lumen diameter (Polak et al., 1996; Labropoulos et al., 1998). 
The current study does not support this hypothesis, as the increase in popliteal IMT 
with further ageing was not accompanied by a commensurate increase in popliteal 
artery diameter. Additionally, the observed further ageing effect on brachial artery 
diameter was not replicated for brachial IMT. Therefore, our findings would tend to 
support the breakdown of elastin content and recoil properties (Fritze et al., 2012; 
van der Heijden-Spek et al., 2000; O’rourke and Hashimoto, 2007) as the proposed 
mechanism for this observed increase in artery diameter with ageing. The current 
study demonstrates that this increase in brachial artery diameter continues into older 
old age and therefore, suggests that older adults should continue to take steps to 






A Plateau in the Impact of Ageing? 
 
Of significant (and positive) note, is the fact that we did not observe a further 
ageing effect on blood vessel diameter for either the carotid or the popliteal arteries, 
which have previously been reported to be influenced by age (Sandgren et al., 1998; 
Eigenbrodt et al., 2006). It is possible that the ageing effect on carotid and popliteal 
artery diameter plateaus with increasing age after ~67 yrs of age, as the previous 
findings from Eigenbrodt et al. (2006) and Sandgren et al. (1998) were from younger 
populations (45 – 64, 25 – 67 yrs, respectively) compared to the current study (60 – 
89 yrs). In line with this, analysis of data from Benetos et al. (1993) suggests that 
carotid artery diameter of normotensive participants begins to plateau at age 60 
(r2=0.19), following a 2nd order polynomial trend line. 
 
The Impact of Medication on Further Ageing 
 
A limitation of the current study is that it did not account for blood pressure 
lowering (60% of participants) or lipid lowering (30% of participants) medication, 
which would undoubtedly impact the natural ageing effect on artery diameter and 
thus the results of this study. However, with more than 313 million prescriptions for 
CVD dispensed within England in 2014 (Townsend et al., 2015), it is reasonable to 
say that our sample population is representative of the entire population and 
therefore, normalisation for medication would reduce the external validity of the 
study. A subsequent comparison of the effect of further ageing on cardiovascular 
markers between non-medicated (n=19) and medicated participants (n=74, data is 
based on participant self-reporting of medication) suggested that medication use 
influenced brachial artery diameter and IMT, as age became a significant predictor 
of these markers in the medicated group (b: 0.01 [95%CI 0.01, 0.06], b: 0.01 [95%CI 
0.001, 0.01], respectively). In addition, the use of medication masked the effect of 
further ageing, as significant associations between popliteal IMT and age were 
attenuated in the medicated group (Appendix Chapter 04 figure A4.1 - 10). The 
interpretation of these pilot data needs to be done with caution as the grouping of 
the participants was skewed (not medicated: n=19, medicated: n=74). However, this 
pilot data suggests further research may be necessary to illustrate the differences 
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in the effect of further ageing on cardiovascular parameters between not medicated 




The results from the current study suggest that further ageing after 60 yrs old 
does not affect blood pressure, resting heart rate, carotid and popliteal artery 
diameter, and brachial and carotid IMT. However, there is an apparent effect of 
further ageing on brachial artery diameter, which increased an average 0.23±0.10 
mm per lustrum of age (up to age 84). Notably also, popliteal IMT increased 
0.08±0.05 mm per lustrum increase in age however, this was attenuated when LIPA 
and LIPA% engagement was accounted for. This suggested that older adults may 
be able to combat the effect of further ageing by increasing their daily engagement 





Segregating the distinct effects 
of sedentary behaviour and 
physical activity on older adults’ 
cardio-metabolic status. 
 
Part 1: ‘Compositional data analysis approach.’ 
 
Part 2: ‘Isotemporal substitution approach.’ 
 









Between 2011 and 2014, medication prescription for the prevention and 
treatment of circulatory diseases within an adult population increased 2.2 fold in 
England (Townsend et al., 2015). These prescriptions include medications such as: 
lipid-lowering, anticoagulant and anti-fibrinolytic drugs, with 62 – 95% of adults 
above the age of 55 years taking at least one prescribed drug per day for treatment 
or prevention of any condition (Chaplin, 2015). Critically, many of the metabolites 
that these drugs target are adjustable through physical activity (PA) interventions 
(Gennuso et al., 2013; Rosique-Esteban et al., 2017; Henson et al., 2013b). In older 
adult cohorts (65 – 94 years [yrs]), 3 х 60 min aerobic sessions per week, for 8 
months, at 60 – 80% of heart rate reserve was sufficient to reduce total cholesterol 
and triglyceride concentration (Verissimo et al., 2002). Emerging-evidence also 
suggests that changes in sedentary behaviour (SB) could also modulate 
‘problematic metabolites’, through mechanistic pathways, which are different from 
those of PA (specifically moderate to vigorous intensity PA [MVPA]) (Bey and 
Hamilton, 2003). In rodent modelling of SB, six hours of hind limb unloading in rats 
decreased oxidative skeletal muscle lipoprotein-lipase (LPL) by 50% relative to 
ambulatory controls, whereas, treadmill running (56 m∙min-1, 3.5 hr·day-1) did not 
increase oxidative muscle LPL above that of ambulatory controls but did in glycolytic 
muscle (Bey and Hamilton, 2003). It is suggested that SB targets post-
transcriptional modification of LPL, as its mRNA expression remained unchanged 
during hind limb unloading (Bey and Hamilton, 2003). Given that SB and PA 
(collectively known as physical behaviour [PB] (Bussmann and van den Berg-
Emons, 2013)) may act through independent mechanisms in the prevention of 
cardio-metabolic disease , it is hypothesised that future studies should  consider SB 
and PA together, not in isolation.  
Common analysis of daily PB, uses PA as a covariate when determining the 
effect of SB on health parameters (Gennuso et al., 2013; Henson et al., 2013b; 
Horta et al., 2015; Kulinski et al., 2016; Pereira et al., 2012; Rosique-Esteban et al., 
2017; Saunders et al., 2013). However, this does not take into account the finite 
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simplex of a day or the contributions to health status that other intensities of PB may 
provide. For example, SB may affect health status independent of MVPA; however, 
the impact of SB may be attenuated by sleep, light intensity PA (LIPA) or a 
combination of both. In addition, this common form of analysis does not account for 
the time limiting effect that engagement in one PB can have on engagement in other 
PB(s).  
Compositional Data Analysis (CoDA) overcomes these issues by presenting 
the geometric mean engagement in a PB as a standardised score, relative to the 
geometric mean of all engaged PB(s), as a denominator of 24 hours. This allows 
the standardised score of a particular PB engagement of a sub-group to be 
presented as a log ratio, relative to the standardised score for the same PB for the 
sample population (log ratio = ln[centred geometric mean of group ÷ centred 
geometric mean of population]) (Chastin et al., 2015b; Carson et al., 2016). CoDA 
is normally used to compare the composition of two or more groups, relative to the 
entire sample population and although a new form of analysis in PB research, CoDA 
has provided interesting descriptive data. CoDA of the participants from the 
NHANES 2005-06 cycle suggested those with a relatively low high-density lipid 
(HDL-C) concentration engaged in 9% less MVPA relative to the overall geometric 
mean composition. Whereas, those with a healthy HDL-C concentration engage in 
4% more MVPA relative to the overall geometric mean composition (Chastin et al., 
2015b). 
 Another new and pertinent form of data analysis is Isotemporal Substitution 
Modelling (ISM), which has previously been described in Chapter 03 Part 2. In brief, 
rather than analysing PB(s) as a composition, ISM illustrates how health markers 
may change should engagement in one PB be replaced with another PB of the same 
duration (Mekary et al., 2013). This is performed by removing a PB from a regression 
model to change the beta coefficient between the other PB(s) and the health marker, 
which represents the change in health status that may occur with a change in 
habitual PB engagement (Mekary et al., 2013; Fanning et al., 2016; Buman et al., 
2013). ISM has illustrated that replacing 10 min·day-1 of SB with LIPA could reduce 
the prevalence of metabolic syndrome (odds ratio: 0.96 [95% confidence interval 
(CI) 0.93, 0.98]) in healthy middle – older adults (50 - 64 yrs) (Ekblom-Bak et al., 
2016). With the emergence of these new analyses, little research has yet to be 
conducted applying these analyses to cardio-metabolic health data of older adults 
(Ekblom-Bak et al., 2016; Hamer et al., 2014; Healy et al., 2015).  
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 In addition, it has also been suggested that the patterns of PB accumulation 
could be just as important for the prediction of cardio-metabolic markers as total PB 
engagement time. The addition of 10 extra breaks in SB per day was associated 
with a 3.72% (95%CI 1.34, 6.13) reduction in triglyceride concentration in adults (20 
– 79 yrs) (Carson et al., 2014). Therefore, it is essential to assess the effect of both 
total, and patterns of, PB engagement in order to capture the complete influence of 
PB on health status. 
The aim of this study was therefore to illustrate which PB intensity(s) and/or 
pattern(s) influence cardio-metabolic parameters in older adults. The objectives of 
this study were; Part 1) illustrate the difference in the PB profile between older adults 
with ‘low’ and ‘high’ cardio-metabolic profiles using CoDA, Part 2) theoretically 
illustrate how older adults can change their cardio-metabolic profile through a 
change(s) in PB engagement using ISM. Part 3) Illustrate how the patterns of PB 
engagement differ between ‘low’ and ‘high’ cardio-metabolic marker groups. The 
hypotheses were: Part 1) that PB composition in the ‘high’ cardio-metabolic profile 
sub-groups will illustrate a greater engagement in SB and a lower engagement in 
PA relative to the entire sample population geometric mean. Whereas the ‘low’ 
cardio-metabolic profile sub-group will engage in more PA and less SB relative to 
the entire sample population geometric mean which, has been shown in previous 
studies (Chastin et al., 2015b; Carson et al., 2016). Part 2) Substitution of SB or PA 
with PA of higher intensity may improve cardio-metabolic profile whilst the 
substitution of a higher intensity PA with a lower intensity PA or SB may worsen 
cardio-metabolic profile, as has been illustrated previously in younger persons 
(Ekblom-Bak et al., 2016; Hamer et al., 2014; Healy et al., 2015). Part 3) The ‘low’ 
cardio-metabolic marker group will present more ‘cardio-metabolic endocrine health’ 
enhancing patterns of PB engagement than the ‘high’ group (Carson et al., 2014; 
Lord et al., 2011; Healy et al., 2011). 
 The statistical analyses, results and discussion of this chapter will be 
provided in three parts; 1) CoDA, 2) ISM, and 3) Group comparison of patterns of 








First Laboratory Visit 
 
The details of the first laboratory visit follows that of the Chapter 03 Part 1. 
Please refer to it for details regarding recruitment and accelerometer use. Absolute 
measures of Sleep, SB, Standing, LIPA, sporadic MVPA (sMVPA, MVPA 
accumulated in bouts <10 mins), and 10 mins MVPA (10MVPA, MVPA accumulated 
in bouts ≥10 mins) were used for CoDA and ISM. 
 
Second Laboratory Visit  
 
 Whole Blood Endocrine Analysis 
 
Participants (n=93) arrived to the laboratory in an overnight (>10 hours) 
fasted, hydrated state. Where appropriate, participants were asked to refrain from 
taking medication until testing had been completed. All participants refrained from 
taking medication prior to the completion of the laboratory tests and all provided a 
10 mL venous blood sample. Whole blood analyses of fasting plasma glucose, total 
cholesterol, and triglycerides were performed immediately using an Accturend Plus 
(Roche Diagnostics Limited, Welwyn Garden City, UK) monitoring device and 
Accutrend test strips (Roche Diagnostics Limited, Welwyn Garden City, UK) 
(Coqueiro et al., 2014). Whole blood analysis of glycated haemoglobin (HbA1c) was 
performed on a sub-group of participants (n=33) using boronate fluorescence 
quenching (HbA1c 501 device and test cartridges, HemoCue, Ängelholm, Sweden). 
HemoCue 501 has shown good reliability (Coefficient of Variation [CV] <5.0%) and 
validity (Bland-Altman: 4.4 [95%CI -7.3, 16.2] mmol∙mol-1 compared to high 
performance liquid chromatography ion exchange (Phillips et al., 2014)).  
Remaining blood samples were stored on ice for <2 hours before 
centrifugation at 1687 G for five minutes (Z380, Hermle, Gosheim, Germany). 
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Serum was harvested and stored at -20 ºC in 1.00 mL aliquots (Eppendorf Ltd, 
Hamburg, Germany) until further analyses.  
 
 Serum Endocrine Analyses 
 
Commercially available enzyme-linked immunosorbent assay kits were used 
to determine the concentration of serum lipoprotein lipase (LPL) (Cell Biolabs Inc., 
California, USA), procollagen III N-terminal propeptide (PIIINP) (Biomatik, 
Delaware, USA), and interleukin-6 (IL-6) (high-sensitivity, Bio-Techne, Minnesota, 
USA) using a two-fold sample dilution. Manufacturer reported LPL intra-assay CV 
was 4% whereas it reached 13% in house. For PIIINP, manufacturer sample intra-
assay CV was <10%, which coincided with in house data (6.5 - 9.6%). IL-6 
manufacture intra-assay CV was 7.8% whereas in house it ranged from 7.4 – 9.2%. 
ELISA data were derived using a 96-well spectrophotometer (EL808, BioTek, 











SPSS version 22 (IBM, New York, USA) was used for statistical analysis. 1×5 
independent analysis of variance (ANOVA) and bonferroni correction (Kruskall-
Wallis and Mann-Whitney U for non-parametric data) was used to determine 
whether participant demographics changed per lustrum change in age and whether 
CoDA needed to be performed for age grouped or pooled populations. Data are 
presented as mean (standard deviation [SD]) or median (interquartile range [IR]) if 
rules of parametricity are violated. Statistical significance was set at p≤0.05. 
 
Compositional Data Analysis 
 
Participants were grouped into ‘low’ or ‘high’ endocrine concentration groups 
for each cardio-metabolic parameter based on whether they were less than or equal 
to, or above the recognised threshold concentration for the respective cardio-
metabolic marker (table 5.5.1). Where threshold concentrations from previous 
research could not be applied, median (PIIINP) and mean (HbA1c) were used as 
the threshold. The HbA1c threshold of 6.5% (World Health Organization, 2015a) 
could not be applied to the study population as the participants did not display 
diabetic symptoms and therefore every participant’s HbA1c percentage fell below 
6.5%. Similarly, the 4780 pg·mL-1 threshold (Agarwal et al., 2014) could not be 







Table 5.1.1. Cardio-metabolic threshold values used to determine participant groupings into ‘low’ 
and ‘high’ endocrine concentration. 
Cardio-metabolic Parameter Threshold 
Glucose 6.0 mmol∙l-1 (World Health Organization, 
2015a) 
Total Cholesterol 5.0 mmol∙l-1 (World Health Organization, 
2015a) 
Triglyceride 1.7 mmol∙l-1 (World Health Organization, 
2015a) 
HbA1c 5.29% 
LPL 63.5 pg∙mL-1 (Rip et al., 2006) 
IL-6 2.29 pg∙mL-1 (Cesari et al., 2003) 
PIIINP 229.215 pg∙mL-1 
Mean % HbA1c used as the threshold. Median PIIINP concentration used as the threshold. 
 
Using Excel 2013 (Microsoft, Washington, USA), the geometric mean 
(hrs∙day-1) was calculated for each PB for the entire sample population. The grand 
geometric mean was further calculated for the entire PB (Sleep + SB + Standing + 
LIPA + sMVPA + 10MVPA) data for the entire sample population. The sample 
population data were centred (ceno) by dividing the geometric mean for each PB by 
the grand geometric mean and then by the available time in a day (24 hours). These 
steps were then performed on the cardio-metabolic parameter sub-groups (ceni) 
(‘low’ and ‘high’). The centred data for each PB for each sub-group, was compared 
to the centred data for the respective PB of the entire sample population as a log 
ratio (ln[ceni ÷ ceno]) (figure 5.1.1). The log ratio represents the sub-group’s 
engagement in a PB relative to the entire sample population’s standardised 








Figure 5.1.1. Flow chart of the CoDA calculations. Calculation steps staring outwards and moving 
towards centre. 
 
 Handling Covariates 
 
Analysis of covariance (ANCOVA) was performed using SPSS version 22 
(IBM, New York, USA) to determine whether covariates (blood pressure (BP) 
medication [mg∙day-1], lipid-lowering medication [mg∙day-1], primary CVD targeting 
medication [n∙day-1], CVD (in)directly targeting medication [n∙day-1], and 
inflammatory + CVD (in)directly targeting medication [mg∙day-1]) influenced the 
concentration of the cardio-metabolic parameters within the current study (table 
5.1.2) as they have previously been shown to be associated with cardio-metabolic 
parameters (Furberg et al., 1994; Bakris et al., 2004; McIntyre et al., 2006; Tsuboi 
et al., 1995). LPL was found to be influenced by inflammatory + CVD (in)directly 
targeting medication (p≤0.05). LPL data were adjusted for the aforementioned 
covariate and the participants were regrouped before CoDA was performed. No 







Table 5.1.2. Covariate influence of different medication variables on cardio-metabolic parameters 
when comparing the difference between ‘low’ and ‘high’ group’s mean concentration. Data 
presented as significant value (p). 
Medication Cardio-metabolic Parameter 
 Glucose Triglyceride 
Total 
Cholesterol 
HbA1c LPL IL-6 PIIINP 
BP 0.71 0.93 0.57 0.53 0.14 0.95 0.70 
Lipid-lowering 0.36 0.47 0.84 0.63 0.46 0.81 0.53 
Primary CVD 
targeting 
0.94 0.06 0.69 0.27 0.89 0.24 0.59 
CVD (in)directly 
targeting 




0.47 0.92 0.09 0.19 0.00* 0.71 0.88 
* Covariate has a significant effect on a cardio-metabolic parameter concentration (p≤0.05). 
 
 Handling ‘Essential’ Zeros  
 
Within CoDA, there are rounded zeros, which represent data that could not 
be measured due to the sensitivity of the equipment used, and there are essential 
zeros, which represent real values for a parameter. In the current study, essential 
zeros were common in PB data, as many participants did not engage in 10MVPA. It 
is not possible to log transform zeros or calculate geometric means, therefore they 
need to be accounted for so they still carry weight in the analyses. One method is 
to remove all the participants who have essential zero data, which has been 
performed in previous studies (Chastin et al., 2015b; Carson et al., 2016). However, 
given the sample size (n=93), removal of participants would severely reduce the 
power of the study and thus, is not deemed an appropriate approach. An alternative 
method is to add 1 to every data point, then minus 1 from the geometric mean 
calculations (Costa and Judge, 2013).  
 To determine the best method for handling zeros, the geometric mean of 
each PB was calculated to act as the ‘gold standard’. The geometric means were 
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subsequently recalculated using four conditions; removing essential zeroes 
(Chastin et al., 2015b; Carson et al., 2016), addition and subtraction of 1 (Costa and 
Judge, 2013), addition and subtraction of 0.5, and addition and subtraction of 0.01. 
The difference between the ‘gold standard’ geometric mean and the adjusted means 
suggested that the addition and subtraction of 0.01 was the best method for our 
current data set as it displayed the smallest change in geometric mean (table 5.1.3). 
Therefore, this method was used during CoDA. 
Table 5.1.3. Comparison between the gold standard and essential zeros adjusted methods 
geometric means. 
Method PB (hrs∙day-1) 
 Sleep SB Standing LIPA sMVPA 10MVPA 
Gold-standard 8.40 9.56 1.02 1.86 2.49 NA 
Method Difference from gold standard 
Remove essential 
zeroes 
0 0 0 0 0 0.124* 
Add 1, remove 1 for 
geometric mean 
-0.004 -0.009 -0.042 -0.040 -0.029 0.129* 
Add 0.5, remove 0.5 
for geometric mean 
-0.002 -0.005 -0.029 -0.025 -0.017 0.123* 
Add 0.01, remove 
0.01 for geometric 
mean 
-4.2E-05 -9.7E-05 -0.001 -0.001 0.000 0.062* 
* Geometric mean for 10MVPA. The difference from gold standard cannot be displayed as the 
geometric mean cannot be calculated with the presence of zeros.  
 
 Physical Behaviour Co-dependence 
 
To determine the co-dependence between PB intensities a variation matrix 
was used. A variation matrix displays the variance in the sample population’s log-
ratios for each PB comparison (equation 5.1.1). A variance close to zero would imply 
the time spent in the corresponding behaviours are proportional and therefore, 
143 
 
suggest a change in engagement of one of those PB would likely result in a change 
in engagement of the corresponding PB. 
  Equation 5.1.1. Physical behaviour co-dependence calculation. 
Variation Matrix = ln(PB1÷PB2) 
Where: ln is natural LOG transformation 
PB1 is a PB 




The demographics of the 93 older adults who participated in the study (73.6 
[7.17] yrs, 55% female) are displayed in table 5.1.4. Notably, there was no difference 
between lustrum age groups on any of the cardio-metabolic, PB, or covariate 




Table 5.1.4. Participant demographics displayed per lustrum of age. Data presented as Mean(SD), 
Median(IR), or geometric mean. 







60 – 65 
10  
90 
66 – 71 
19  
47 
72 – 77 
31  
54 




















































































































































































Table 5.1.4 continued.       

























































































































† Participants are currently prescribed an amount of medication that reduces the risk or treats CVD (i.e. 
statins, warfarin). ‡ Participants are currently prescribed a medication that may affect the cardiovascular 
system either directly or as a side effect. ¥ Participants are currently prescribed a medication that may affect 
the cardiovascular system either directly or as a side effect, including inflammatory medication. m Median 
(IR). g Geometric mean. 
 
Whole Blood Endocrine Parameters 
 
The composition of PB for ‘low’ and ‘high’ cardio-metabolic parameter sub-
groups is displayed in figure 5.1.2A-D. Triglyceride concentration appears to be 
highly dependent on 10MVPA engagement as the ‘low’ triglyceride concentration 
group engaged in 48% more 10MVPA relative to the geometric mean of the entire 
sample population (figure 5.1.2A). It also suggests that reducing 10MVPA 
engagement may result in a change to a ‘high’ triglyceride profile more readily than 
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the opposite. Indeed those with a ‘high’ triglyceride concentration only engaged in 
32% less 10MVPA than the geometric mean of the entire sample population, 
whereas those with a ‘low’ triglyceride concentration required a 48% greater 
engagement in 10MVPA compared to the entire sample population (figure 5.1.2A). It 
appears that differences in total cholesterol profile may be influenced by most PB 
intensities as those with a ‘low’ total cholesterol profile engaged in less sleep (3.0%), 
SB (2.9%), LIPA (7.1%), sMVPA (6.0%), and more standing (7.9%) and 10MVPA 
(4.4%) than the entire sample population. The opposite PB profile was true for the 
‘high’ total cholesterol concentration group (figure 5.1.2B). The composition of the 
‘high’ glucose and HbA1c groups appeared to be similar as both engaged in more 
sleep and SB, and less PA (excluding sMVPA) compared to the entire sample 
population (figure 5.1.2C-D). 
 
Figure 5.1.2. Compositional geometric mean bar plots displaying the difference in PB composition 
between ‘low’ and ‘high’ cardio-metabolic parameter sub-groups. A) triglyceride (n ‘low’: 39, ‘high’: 
50) B) total cholesterol (n ‘low’: 30, ‘high’: 59), C) glucose (n ‘low’: 57, ‘high’: 32), and D) HbA1c (n 
‘low’: 13, ‘high’: 20). 
 
Serum Endocrine Parameters 
 
Before correcting for covariate effects, LPL was heavily influenced by 
10MVPA, with a large difference in engagement compared to the entire sample 
population (‘low’ LPL: 27% less 10MVPA, ‘high’ LPL: 11% more 10MVPA) (figure 
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5.1.3A). Whereas the difference from the entire population for the other PB 
intensities did not exceed 2.2% (figure 5.1.3A). Following normalisation for 
inflammatory + CVD (in)directly targeting medication, the ‘low’ LPL group’s 
engagement in 10MVPA was 26% less while the ‘high’ LPL group was 7.9% more 
than the entire population (figure 5.1.3B). Sleep appeared to be a main determinant 
of IL-6 concentration as those in the ‘low’ and ‘high’ IL-6 group engaged in 4.8% 
more and 3.1% less sleep compared to the entire sample population, respectively. 
Whereas the other PB intensities had a lower difference in engagement compared 
to the entire sample population (figure 5.1.3C). The results suggest that bouts of 
MVPA above 10 mins are sufficient to stimulate an inflammatory response as the 
‘high’ IL-6 group engaged in 2.7% more 10MVPA and 2.2% less sMVPA compared 
to the entire sample population (figure 5.1.3C). PIIINP followed a similar composition 
to IL-6, with sleep displaying the greatest difference from the entire sample 
population in both ‘low’ (6.2%) and ‘high’ (5.9%) groups compared to the other PB 
intensities.  
 
Figure 5.1.3. Compositional geometric mean bar plots displaying the difference in PB composition 
between ‘low’ and ‘high’ cardio-metabolic parameter sub-groups. A) LPL (n ‘low’: 26, ‘high’: 57), B) 
LPL normalised for inflammatory + CVD (in)directly targeting medication (n ‘low’: 21, ‘high’: 55), C) 






Physical Behaviour Co-dependence 
 
The greatest co-dependence existed between sleep against SB, standing 
against LIPA, and LIPA against sMVPA, thus indicating that changes in one of these 
PB will likely result in a change in engagement for the corresponding PB. The lowest 
co-dependence existed between 10MVPA and all other PB (table 5.1.5), indicating 
that changes in 10MVPA engagement will likely not result in changes in other PB 
engagement. 
Table 5.1.5. Variation matrix between PB(s). 
  Sleep SB Standing LIPA sMVPA 10MVPA 
Sleep 
 
0.03 0.20 0.15 0.10 1.88 
SB 
  
0.24 0.19 0.15 1.93 
Standing   
 
0.09 0.16 1.95 
LIPA    
 
0.09 1.85 




The aim of this study was to illustrate which PB intensity(s) influence cardio-
metabolic parameters in older adults. The objective of this chapter part (1) was to 
illustrate the difference in the PB profile between older adults with ‘low’ and ‘high’ 
cardio-metabolic profiles using CoDA. It was hypothesised that ‘high’ sub-group’s 
PB composition would illustrate a greater engagement in SB and a lower 
engagement in PA relative to the entire sample population geometric mean. 
Whereas the ‘low’ sub-group would engage in more PA and less SB relative to the 
entire sample population geometric mean which, has been shown in previous 
studies (Chastin et al., 2015b; Carson et al., 2016). This hypothesised was 
confirmed throughout the cardio-metabolic markers except for IL-6 and PIIINP, 





Lipoprotein – LPL Axis 
 
Lipoprotein lipase was one of the first identified cardio-metabolic markers to 
illustrate independent effects of SB and MVPA (Bey and Hamilton, 2003). It was 
suggested that prolonged SB targets oxidative skeletal muscle LPL activity whereas; 
MVPA appears to primarily target glycolytic muscle LPL activity (Bey and Hamilton, 
2003). LPL is responsible for the hydrolysis of triglyceride into glycerol and fatty 
acid. Pre-heparin serum LPL (measured in the current study) primarily represents 
inactive LPL as a dimer bound to isolated remnant lipoproteins (Sato et al., 2016), 
which, in the presence of active LPL, augments triglyceride hydrolysis and the 
uptake of very low-density lipoproteins and cholesterol esters (Merkel et al., 2002). 
Therefore, reduced serum LPL concentration, similar to muscle LPL activity, may 
lead to increased circulating triglyceride concentration (Petibois et al., 2004). The 
comparison of PB composition between triglyceride and LPL groups supports the 
LPL-triglyceride-PA complex as those in the ‘high’ LPL concentration and ‘low’ 
triglyceride concentration groups both displayed a greater engagement in 10MVPA 
(7.8% and 48.4%, respectively) compared to the entire sample population. In 
addition, 10MVPA had the greatest difference from the entire sample population, 
compared to the other PB intensities, for both LPL and triglyceride, suggesting that 
these cardio-metabolic markers are influenced more by 10MVPA compared to any 
other PB. This finding supports that of a previous SB break study, which found 30 
mins of MVPA (which would be classified as 10MVPA in the current study) 
maintained plasma triglyceride concentration (relative to baseline) following 
ingestion of a high fat meal (35%) (Engeroff et al., 2017). In addition, Engeroff et al. 
(2017) reported that short bouts of MVPA (representing sMVPA in the current study) 
were not sufficient to prevent an increase in triglyceride concentration following meal 
ingestion. This was also notable in the present study, as engagement in sMVPA in 
the ‘low’ and ‘high’ triglyceride groups only deviated 2.3% and 1.9% from the entire 
sample population, respectively, suggesting that sMVPA has little influence on 
circulating triglyceride levels.  
The pattern of PB compositions for total cholesterol is not as clear within the 
current study. This is likely due to total cholesterol containing lipoproteins that have 
opposite responses to inactivity. Both triglyceride and low-density lipids (LDL-C) 
increase in concentration, whereas high-density lipids (HDL-C) decrease in 
150 
 
concentration, during detraining (Petibois et al., 2004). Therefore, it is difficult to 
ascertain whether/which PB(s) are affecting LDL-C and HDL-C profile. Future 
research, should conduct CoDA with total cholesterol segregated into HDL-C and 
LDL-C to provide a more precise understand of the effects of PB. 
Overall, our results suggest that engagement in 10MVPA influences 
triglyceride concentration by targeting LPL pathways. This finding advocates the 
need for older adults to be ‘physically active’ in terms of attaining sufficient 10MVPA, 
as defined in the UK government PA guidelines, especially as LPL is already 




The prevalence of physical inactivity and SB, even in acute episodes, has a 
marked influence on insulin insensitivity and subsequently on reduced glucose 
uptake (Stephens et al., 2011; Dunstan et al., 2012; Bailey and Locke, 2014), 
predominantly in skeletal muscle tissue (Stuart et al., 1988). Our results support this 
concept as those with a ‘high’ glucose concentration engaged in more sleep and 
SB, and less PA (excluding sMVPA), compared to the entire sample population. 
This increased circulating glucose concentration is thought to be due to the reduced 
translocation of glucose transporter type 4 (GLUT4) to the skeletal muscle cell 
membrane (Xu et al., 2015) and reduced expression of carbohydrate metabolism 
genes during bouts of reduced muscle contractile activity (Sleep and SB) such as, 
cytoplasmic dynein light chain 1 (DYNLL1) (Latouche et al., 2013) which, plays a 
role in GLUT4 translocation (Fletcher et al., 2000). Our results may also suggest 
that habitual higher SB and lower PA engagement can have a chronic effect on 
glucose homeostasis, as participants with a ‘high’ HbA1c percentage also engaged 
in more sleep and SB, and less 10MVPA, compared to the entire sample population 
(with other PA apparently having little effect on HbA1c). HbA1c represents a 1-3 
month average of blood glucose concentration (Gabbay et al., 1977) and can be 
used in the diagnosis of diabetes mellitus if blood tests exceed 6.5%. The results of 
the current study are consistent with previous findings in older English adult 
populations (≥ 60 yrs), which found HbA1c percentage increased as objective SB 
time increased from 8.45 – 9.52 hrs∙day-1 to >9.52 hrs∙day-1 (5.8 [0.8], 6.0 [0.8]%, 
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p=0.01, respectively) and reduced 0.13% (95%CI -0.24, -0.03) per 0.5 hrs∙day-1 
increase in MVPA engagement (Stamatakis et al., 2012). Interestingly, in line with 
our results, Stamatakis et al. (2012) also reported that LIPA was not associated with 
HbA1c. Our results therefore support that PA has to be of at least moderate intensity 
in order to maintain increased insulin sensitivity and subsequently glucose uptake, 
post-exercise (Fujii et al., 2000). 
 Overall, the current study suggests that reduced SB and increased PA could 
lead to acutely reduced blood glucose concentration in older adults. However, to 
maintain a ‘healthier’ chronic glucose homeostasis, PA may have to be of a 
moderate-vigorous intensity. Therefore, we urge older adults to minimise SB 
engagement and attain a ‘physically active’ lifestyle to increase the likelihood of a 
‘healthy’ glucose profile.  
 
Inflammation and Vascular Stiffness 
 
In older adults, IL-6 serum concentration is greater compared to young adults 
(Wei et al., 1992) and is associated with an increased risk of CVD (Jenny et al., 
2002). The current study suggested that a greater engagement in sleep and SB 
could be beneficial towards the reduction in inflammation as those with a ‘low’ IL-6 
concentration engaged in 4.8% and 3.8% more sleep and SB, respectively, 
compared to the entire sample population. This is in agreement with previous older 
adult findings, which suggested that IL-6 concentration reduced by 2.0 pg∙mL-1 with 
a >1.5 hour reduction in total awake time (Vgontzas et al., 2003). However, it was 
previously illustrated that an hour increase in SB would increase IL-6 by 0.24 
(95%CI 0.13, 0.35) pg∙mL-1 in older adults (Henson et al., 2013a). The discrepancies 
between Henson et al. (2013a) and the current study may lie in the type of analysis. 
Henson et al. (2013a) used a multiple linear regression model, which does not 
account for the influence of other PB(s) on IL-6 in the same way CoDA does, and 
has been shown to under-estimate the magnitude and direction of associations, 
when all other PB(s) are not accounted for (Dumuid et al., 2017). It is thought that 
increases in serum IL-6 is a result of increased IL-6 concentration within the muscle, 
which occurs during repeated muscular contraction (Steensberg et al., 2000). 
Therefore, it is possible to postulate that an elevated amount of sleep engagement 
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may be necessary for older adults to manage the inflammatory response, as 
reduced engagement in sleep is associated with an increase in IL-6 concentration 
and subsequently increased pain ratings within healthy middle-aged adults (Haack 
et al., 2007). This relationship between pain and IL-6 may also explain why the ‘low’ 
IL-6 group engage in more SB as qualitative evidence stated that older adults’ main 
determinant for engaging in SB is to reduce sensations of pain (Chastin et al., 2014). 
However, given the negative effects SB appears to have on other cardio-metabolic 
parameters within the current study (total cholesterol, triglyceride, glucose, HbA1c, 
and LPL); it would be advised that older adults engage in more sleep than SB to 
improve IL-6 profile. 
Increased PIIINP concentration is a marker of vascular stiffness in older 
adults (Agarwal et al., 2014). Within PB research, there is an apparent lack of 
investigations into changes in PIIINP with PB (excluding resistance training). To the 
author’s knowledge, only one study exists, which suggested 10-weeks of LIPA and 
MVPA were not sufficient to cause a change in middle-older adults’ (51 – 71 yrs) 
PIIINP concentration (Cornelissen et al., 2010). Our results suggest that those with 
a ‘low’ PIIINP concentration engage in a longer duration of all PB(s) (excluding 
10MVPA), most noticeably sleep, compared to the sample population and vice versa 
for the ‘high’ PIIINP population. The current study, therefore suggests that future 
research should examine the associations between PB and PIIINP in older adults 
to confirm or refute whether PB behaviour change can help reduce vascular stiffness 




The current study is the first (to the author’s knowledge) to utilise CoDA to 
analyse the effect of PB on the cardio-metabolic profile of an older adult population. 
CoDA revealed that all PB intensities play a role in the maintenance of cardio-
metabolic profile. For a healthy lipid profile our results suggested that older adults 
should attain a ‘physically active’ status, as 10MVPA engagement was greater in the 
‘high’ LPL concentration group and subsequently greater in the ‘low’ triglyceride 
concentration group. For glucose homeostasis, the current study recommended that 
older adults should reduce their engagement in SB by engaging in PA. In addition, 
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it was suggested that being ‘physically active’ may contribute to chronic glucose 
homeostasis, as shown by the HbA1c results. Finally, a 4.8% (approximately 25 
minsday-1, based on the geometric mean of sleep for our sample population) 
increase in the amount of sleep engagement may be essential for older adults to 
reduce inflammation, especially in episodes of pain, which has been associated with 
increasing IL-6 concentration.  
Overall, the current study recommends that older adults should aim to be 
‘physically active’ by engaging in prolonged bouts of MVPA whilst in the remaining 
hours of the day, they should aim to reduce SB (in spite of the apparent benefit for 
IL-6), where possible (to minimise pain), by engaging in low intensity PA (standing 








SPSS version 22 (IBM, New York, USA) was used for statistical modelling. 
Only total PB variables, measured in mean hrs∙day-1 (SB, Standing, LIPA, sMVPA, 
and 10MVPA) and the summation of these parameters (Total PB) were used for ISM. 
Pearson correlation was used to assess multicollinearity between PB parameters 
and total PB; no adjustment to the data was made if multicollinearity was present. 
The multicollinearity results are the same as those found in Chapter 03 Part 2. The 
largest case of collinearity was between SB and LIPA (r2=-0.69), which was below 
the suggested limits of collinearity (r2>0.9) (Mekary et al., 2013). To illustrate the 
effect on cardio-metabolic parameters with the replacement of one hour of a PB with 
another, the replaced PB parameter was removed  from the linear regression model 
(forced entry) (i.e. replace SB model: Intercept + (ẞ1 х Standing) + (ẞ2 х LIPA) + (ẞ3 
х sMVPA) + (ẞ4 х 10MVPA) + (ẞ5 х Total PB) + Covariates + Error) (Mekary et al., 
2013). Significant predictors in the model illustrate that the replacement of a PB with 
the significant PB would have an effect on the cardio-metabolic parameter. To 
standardise the reporting the outcome of the ISM the removed PB is mentioned first. 
For example, ‘the replacement of one hour of SB with standing reduced total 
cholesterol’ means that SB engagement has been reduced by one hour and 
replaced with one hour of standing.  
ISM was performed without (Model 1) and with (Model 2) covariate 
adjustment (BP medication [mg∙day-1], lipid-lowering medication [mg∙day-1], primary 
CVD targeting medication [n∙day-1], CVD (in)directly targeting medication [n∙day-1], 
and inflammatory + CVD (in)directly targeting medication [mg∙day-1]). A covariate 
was included in the ISM if a forced entry linear regression model had highlighted an 
association between the covariate and the respective cardio-metabolic parameter. 
These covariates were chosen as they have been shown to influence the cardio-
metabolic parameters assessed in the current study (Furberg et al., 1994; Bakris et 
al., 2004; McIntyre et al., 2006; Tsuboi et al., 1995). Cardio-metabolic data were 
naturally LOG transformed if they violated normal distribution (total cholesterol, 
triglyceride, LPL, IL-6, and PIIINP). Post-hoc power analysis was performed using 
155 
 
G* Power version 3.1.9.2 (Heinrich Heine University, Dusseldorf, Germany) to 
determine the probability of finding a ‘true’ effect. Data are presented as beta 





The demographics of the participants are the same as previously mentioned 
in Chapter 03 Part 1 and Part 2. It is pertinent to note that for simplicity, only 
significant models are presented in the results section. The complete set of the 
results is displayed in Appendix Chapter 05 table A5.2.1-7. Significant ISM was 
present for total cholesterol and triglyceride (figure 5.2.1-2) i.e. two out of a possible 




Without covariate adjustment the replacement of one hour of SB with 
standing reduced total cholesterol by (anti-logged data) 1.14 (95%CI 1.28, 1.01) 
mmol∙l-1 (figure 5.2.1). This is clinically relevant as a 0.5 mmol∙l-1 decrease in total 
cholesterol concentration is associated with a 17% decreased risk in coronary heart 
disease mortality (Verschuren et al., 1995). The replacement of LIPA with SB also 
reduced total cholesterol (anti-logged data, 1.08 [95%CI 1.19, 1.0001] mmol∙l-1). 
Interestingly, the replacement of LIPA with standing caused a larger reduction in 
total cholesterol (anti-logged data, 1.25 [95%CI 1.49, 1.04] mmol∙l-1) (figure 5.2.1). 
Finally, the replacement of sMVPA with standing reduced total cholesterol by (anti-
logged data) 1.15 (95%CI 1.32, 1.01) mmol∙l-1 (figure 5.2.1). With adjustment for 
primary CVD targeting medication (n∙day-1) and CVD (in)directly targeting 
medication (n∙day-1), the replacement of LIPA with SB was no longer significant 
whilst all other models remained significant (figure 5.2.1). The power of the ISM for 





Figure 5.2.1. Significant changes in total cholesterol concentration with the replacement of one hour 
of PB with another. Model 1: no covariate adjustment. Model 2: adjusted for primary CVD targeting 
medication (n∙day-1) and CVD (in)directly targeting medication (n∙day-1). Data points represent LOG 
data (from left to right): -95%CI, beta coefficient, +95%CI. p≤0.05. Blue circles indicate a positive 





There were no covariates for triglyceride. Most notably, the replacement of 
any PB with 10MVPA decreased triglyceride concentration by similar amounts, as 
the change in concentration fell between (anti-logged data) 1.89 – 2.03 (95%CI 
range: 3.16, 1.17) mmol∙l-1 (figure 5.2.2). On the other hand, the replacement of 
10MVPA with any other PB (excluding sMVPA) increased triglyceride concentration 
by similar amounts (anti-logged data, beta coefficient range: 1.79 – 1.86 [95%CI 
range: 1.17, 2.94]) mmol∙l-1 (figure 5.2.2). These results are clinically relevant as a 
1.0 mmol∙l-1 increase in triglyceride concentration is associated with a 14% (95%CI 
5, 28%, male) - 37% (95%CI 13, 66%, female) relative risk increase in CVD 
prevalence (Hokanson and Austin, 1996). The power of the ISM for triglyceride 





Figure 5.2.2. Significant changes in triglyceride concentration with the replacement of one hour of 
PB with another. Model 1: no covariate adjustment. Data points represent LOG data (from left to 
right): -95%CI, beta coefficient, +95%CI. p≤0.05. Blue circles indicate a positive effect on cardio-




The objective of this analysis study was to theoretically illustrate how a strictly 
older adult population (60 – 89 yrs) can change their cardio-metabolic profile through 
a change(s) in PB engagement using ISM. It was hypothesised that substitution of 
SB or PA with PA of higher intensity may improve cardio-metabolic profile whilst the 
substitution of a higher intensity PA with a lower intensity PA or SB may worsen 
cardio-metabolic profile, as has been illustrated previously in young-middle and 
middle-older adult populations (Ekblom-Bak et al., 2016; Hamer et al., 2014; Healy 
et al., 2015). Indeed the hypotheses were confirmed as the replacement of SB with 
standing decreased total cholesterol concentration and the replacement of any PB 
with 10MVPA decreased triglyceride concentration. Furthermore, the replacement of 
sMVPA and LIPA with standing decreased total cholesterol concentration and the 




Isotemporal Substitution Modelling is a relatively new form of statistical 
analysis within PB research, first used to predict weight change in middle-aged 
women (25 – 42 yrs) (Mekary et al., 2009). Since the seminal research, 38 
publications have utilised ISM (PubMed, retrieved 17/07/2017). Of those, only one 
study investigated the effects on cardio-metabolic health in a strictly older adult 
population (65 – 70 yrs) (Nilsson et al., 2017). However, ISM was only used to 
predict the effect of PB change on clustered metabolic risk scores and waist 
circumference. Therefore, the current study is the first, in older adult populations, to 
provide a case-by-case ISM analysis for seven cardio-metabolic parameters that 
are associated with CVD. 
 
The Two Sides to Standing 
 
Total cholesterol is comprised of high-density lipid cholesterol (HDL-C), low-
density lipid cholesterol (LDL-C), and triglyceride. The reduction in total cholesterol 
concentration, after sMVPA and LIPA were replaced with standing in the current 
model, may be a product of lowered HDL-C, thereby suggesting that standing 
negatively affects cardio-metabolic status. Indeed, one month of detraining following 
a LIPA intervention in older adults (mean age 75.5±5.60 yrs) has been reported to 
decrease HDL-C concentration whilst LDL-C and triglyceride remained constant 
(Motoyama et al., 1995). These results are apparently trustworthy as post-hoc 
analysis suggests that the power of the study is 98% and therefore there was only 
a 2% chance of a type I error.  
Not only did the replacement of sMVPA and LIPA with standing reduce total 
cholesterol within the current study but total cholesterol concentration also 
decreased when SB was replaced with standing, in the current study. It could be 
postulated that standing is positively affecting lipoprotein profile in this case, 
possibly by reducing non HDL-C lipoproteins. This postulation is in agreement with 
a four-day intervention study in young adults (21±2 yrs), which found non-HDL-C 
concentration decreased from 2.94±0.47 to 2.65±0.48 mmol·l-1 following the 
replacement of six hours of SB with two hours of standing and four hours of walking, 
compared to a 14 hrs·day-1 of SB day (Duvivier et al., 2013). Meanwhile, there was 
also a non-significant trend for total cholesterol to decrease from 4.20±0.67 to 
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3.96±0.50 mmol·l-1 (p=0.17) (Duvivier et al., 2013). Although ISM can suggest an 
intervention, it cannot state how long an intervention can take to have a significant 
effect on health status. However, along with the results of Duvivier et al. (2013), it 
can be suggested that the replacement of one hour of SB with standing could reduce 
total cholesterol if the intervention lasts longer than four days.  
Overall, these findings suggest that standing can affect circulating 
cholesterol, differentially, depending on which PB parameter it is displacing and thus 
facilitates the prediction of individualised outcomes from PB change interventions.  
 
Benefits of Prolonged Moderate Activity  
 
Performing longer bouts of MVPA may induce a chronic physiological effect 
that protects against physical inactivity, as total cholesterol concentration decreased 
when sMVPA but not 10MVPA, was replaced with standing within the current study. 
In terms of the time frame for adaption in cholesterol profile with the introduction of 
physical inactivity, previous studies have varied considerably depending on what 
duration of MVPA bouts was being undertaken prior to physical inactivity. For 
example, the lipoprotein profile of trained endurance rowers took 29 weeks, 
following the cessation of exercise (performed in bouts of MVPA ≥10 mins), to 
become significantly different. Specifically, HDL-C decreased from 0.92±0.09 pre 
detraining to 0.81±0.11 mmol·l-1 post detraining (p<0.05, a 0.004 mmol·l-1 reduction 
per week) (Petibois et al., 2004). Whereas, it took only four weeks until HDL-C 
concentration was significantly reduced (from 1.42±0.05 to 1.34±0.05 mmol·l-1, 
p<0.05, a 0.02 mmol·l-1 reduction per week) following the cessation of a four-month 
interval training intervention (performed in bouts of MVPA <10 mins, 4 × 4 mins 
MVPA, 3 mins rest) (Mora-Rodriguez et al., 2014). Despite these previous finding 
being reported in middle-aged adults, there are similarities in cardio-metabolic 
change with a reduction in MVPA when compared with the current study. It is likely 
that engagement in prolonged bouts of MVPA (10MVPA) would be beneficial in the 
preservation of long-term cholesterol profile should an older adult be temporarily 
reduced to a physically inactive lifestyle (i.e. due to illness or injury). 
Furthermore, the decrease in fasted triglyceride concentration when any PB, 
including sMVPA, is replaced with 10MVPA in the current study, also strengthens 
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the theorem that prolonged MVPA bouts would improve/maintain lipoprotein profile. 
In addition, the lack of effect on fasted triglyceride concentration when SB was 
replaced for PA suggests that a focus on reducing physical inactivity is more 
important than SB reduction when attempting to improve triglyceride profile. 
Whereas the lack of effect on fasted total cholesterol when 10MVPA is substituted 
out of the model (and improvements when SB is substituted) could suggest that SB 
reduction as opposed to physical inactivity reduction could be more important for 
total cholesterol profile improvements, possibly due to the effects on LDL-C and 
HDL-C pathway alluded to above. However, intervention studies would be required 
to confirm or deny this hypothesis.  
 
No Effect of Physical Behaviour on Lipoprotein Lipase  
 
Pre-heparin serum LPL concentration was measured within the current study 
and it is thought to represent whole-body LPL production and the systemic potential 
to hydrolyse triglycerides (Shirai et al., 1999; Watanabe et al., 1999). Additionally, 
pre-heparin serum LPL has been shown to be inversely related to the progression 
of coronary artery disease in young/middle – older aged populations (Hitsumoto et 
al. (2000): 22 – 79 yrs, Rip et al. (2006): 45 – 79 yrs), highlighting that pre-heparin 
serum LPL is anti-atherogenic. Furthermore, exercise has been shown to increase 
LPL within humans and rats in all age groups (Kantor et al., 1987; Hamilton et al., 
1998; Nikkilä et al., 1978), thus suggesting that PA can protect against 
atherosclerosis through the mediation of the LPL pathway. Conversely, the results 
of the current study suggested that the modelling of replacement of any PB did not 
affect serum LPL concentration. A possible explanation for these results is that pre-
heparin serum LPL is representative of whole-body LPL (Shirai et al., 1999; 
Watanabe et al., 1999), in which, the expression of LPL within certain sites can 
portray a pro-atherogenic effect (e.g. artery wall) (see Goldberg (1996) for a review). 
Therefore, the representation of both pro and anti-atherogenic LPL within pre-
heparin serum LPL may cause ‘noise’ within the ISM, thus nullifying any effects on 
pro or anti-atherogenic LPL that may exist with PB change. Furthermore, this ‘noise’ 
effect is likely to be more pronounced in the older adult population, who already 
have an increased serum LPL concentration compared to middle aged adults (Saito 
et al., 1998) and are more likely to show progression of atherosclerosis, which has 
161 
 
been positively associated with LPL concentration within the aorta (Zilversmit, 
1979). 
 
Are These Results Generalisable to the Population? 
 
There is a strong confidence that the results for total cholesterol are 
displaying a ‘true’ effect as post-hoc power analysis suggested that there was a 97 
– 99% probability of detecting an effect of replacing a PB, if one genuinely existed, 
when ISM was adjusted for primary CVD targeting medication and CVD (in)directly 
targeting medication (Model 2). This was also the case for triglyceride, where there 
was a 93 – 98% probability of detecting an effect of replacing a PB, if one genuinely 
existed. Therefore, these predicted changes in total cholesterol and triglyceride 
concentration with a change in PB are generalizable to the population as a whole 
and likely to be observed in replicated studies. 
 Regarding the cardio-metabolic parameters that showed no predicted 
change in the ISM (glucose, HbA1c, LPL, IL-6, and PIIINP), the post-hoc power 
analysis suggested that the probability of detecting an effect of replacing PB ranged 
between 13.5% (IL-6) – 61% (LPL). This would suggest that these results would 
need to be replicated in larger samples in future studies in order to confirm or refute 
the results of the current study. Post-hoc analysis of the results of the current study 
would suggest a sample size between 846 (IL-6) – 139 (LPL) would be required in 




Isotemporal substitution modelling highlighted that only the lipid markers 
within the seven assessed cardio-metabolic markers (total cholesterol, triglyceride, 
LPL, plasma glucose, HbA1c, IL-6, and PIIINP) were affected by PB. Therefore, the 
results of the current study suggest that using PB interventions could be a useful 
method for the prevention and treatment of lipid disorders, such as atherosclerosis, 
which when it manifests in the coronary arteries, is responsible for 44.5% of CVD 
deaths in UK older adults (Townsend et al., 2015). The results of the current study 
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suggested that replacing SB with standing could decrease total cholesterol 
concentration, possibly through a reduction in LDL-C, although this was not 
measured in this study. However, the replacement of LIPA and sMVPA with 
standing also reduced total cholesterol concentration within the current study. It was 
postulated that in this instance, the decrease in total cholesterol was presenting a 
detraining effect, targeting HDL-C concentration, which has been shown previously 
in older adults (Motoyama et al., 1995).  
At the other end of the PB spectrum, prolonged engagement in MVPA (bouts 
≥10 mins) appeared to be essential to the mediation of triglyceride concentration as 
the replacement of any PB with 10MVPA decreased triglyceride concentration. 
Overall, the current study adds further evidence to support the 10-minute bout 
recommendation within the MVPA guidelines of PA for older adults, as well as 
highlighting that quantitative guidelines are required for reducing SB engagement in 
older adults. Finally, the recent study has potentially shown that a PB can have both 
a positive and negative effect on cardio-metabolic status (though requiring further 
investigation), dependent on what PB it is replacing. Thus, advocating the need for 
individualised interventions, where possible, that account for the participant’s 










Excel 2013 (Microsoft, Washington, USA) was used to create radar graphs 
displaying the difference in patterns of PB parameters between participants with a 
‘low’ and ‘high’ cardio-metabolic concentration for the parameters outlined in table 
5.3.1. The thresholds provided and the handling of covariates are the same as those 
in Part 1 of this chapter. 
Table 5.3.1. Cardio-metabolic threshold values used to determine participant groupings into ‘low’ 
and ‘high’ endocrine concentration. 
Cardio-metabolic Parameter Threshold 
Glucose 6.0 mmol∙l-1 (World Health Organization, 
2015a) 
Total Cholesterol 5.0 mmol∙l-1 (World Health Organization, 
2015a) 
Triglyceride 1.7 mmol∙l-1 (World Health Organization, 
2015a) 
HbA1c 5.29% 
LPL 63.5 pg∙mL-1 (Rip et al., 2006) 
IL-6 2.29 pg∙mL-1 (Cesari et al., 2003) 
PIIINP 229.215 pg∙mL-1 





SPSS version 22 (IBM, New York, USA) was used to conduct Pearson’s 
correlations (or Spearman rho, if one variable violated normal distribution) were 
used to determine whether patterns of PB parameters could explain the variance in 





To improve ease of graphical representation, the mean PB pattern parameter 
for the ‘low’ and ‘high’ cardio-metabolic parameter concentration groups was 
transformed into a z-score, relative to the entire sample population (equation 5.3.1). 
Therefore, data within these radar graphs are dimensionless quantities with each 
number in effect being the number of standard deviations (SD) from the mean of the 
entire sample population. 
Equation 5.3.1. Z-score calculation. 





To calculate the difference between group z-scores for a respective pattern 
of PB, the area (presented as a percentage within a normal distribution) left of the 
z-score of the ‘low’ and ‘high’ cardio-metabolic parameter groups was determined 
using a standard normal distribution z-score table and/or excel function 
=NORMSDIST(z-score). The distance (presented as a percentage of area within a 
normal distribution) between the calculated areas was then determined by 
subtracting the lowest area from the largest area. 
 
Overall Cardio-metabolic Impact 
 
To determine the effect patterns of PB have on overall cardio-metabolic 
profile (n=7 parameters), three methods were used as there is no single standard 
method to combining effects on different systems/scales. In the first, each pattern 
of SB and PA was ranked (highest to lowest) based on how large the distance in z-
scores was between the respective ‘low’ and ‘high’ cardio-metabolic parameter 
groups. These rankings were then summed and ranked, from lowest to highest. This 
was performed separately for patterns of SB and PA. 
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For method 2, participants were also grouped based on how frequently they 
had a ‘high’ cardio-metabolic parameter concentration, or ‘low’ LPL concentration. 
These groups were: 0 – 3 ‘high’ metabolites score, and 4 – 6 ‘high’ metabolites 
score. This categorisation was performed using the concentrations of glucose, total 
cholesterol, triglyceride, LPL normalised for inflammatory + CVD (in)directly 
targeting medication (mg∙day-1]), IL-6, and PIIINP. HbA1c was excluded from this 
categorisation as data was only present for 33 out of 93 participants. Missing data 
for the other cardio-metabolic variables was considered as a ‘low’ cardio-metabolic 
concentration. 
Finally, for method 3 of overall cardio-metabolic effect, participants had a z-
score calculated for each cardio-metabolic parameter (e.g. z-score = [participant IL-
6 concentration – study population mean IL-6 concentration] ÷ SD of study 
population IL-6 concentration), excluding HbA1c due to a low sample size for this 
variable. As a ‘high’ LPL concentration is associated with an improved health status, 
the direction of the z-scores for LPL were reversed. Therefore, a positive z-score 
would represent an ‘unhealthy’ profile for all cardio-metabolic parameters. The z-
scores for the respective cardio-metabolic parameters were summed for each 
participant, known as a unit weighted method, to calculate a composite z-score. 
Participants were then grouped into a composite z-score ≤0 or >0. Participants with 






The average engagement in patterns of PB are presented in table 5.3.2 and 
are segregated based on which cardio-metabolic marker was being assessed and 
whether the participant was classified into the ‘low’ or ‘high’ concentration group. A 
z-score of 1 in these results represented the SD of the pooled data for the respective 




Table 5.3.2. Patterns of PB engagement segregated into pooled, ‘low’, and ‘high cardio-metabolic 
marker groups. Data presented as Mean±SD. 
Patterns of PB 
Total Cholesterol Triglyceride LPL 
Pooled Low High Pooled Low High Pooled Low High 






















































































































































































































































































































Table 5.3.2 continued. 
Patterns of PB 
Glucose HbA1c IL-6 PIIINP 


































































































































































































































































































































































































Which Patterns of PB Explain the Variance in Cardio -metabolic Profile? 
 
Triglyceride concentration was associated with 11 out of 16 patterns of PB 
parameters. W50% and 10MVPA% had the largest associations with triglyceride 
concentration, as they explained 12% (positive and negative association, 
respectively) of the variance in concentration (table 5.3.3). Glucose was associated 
with 4 out of 16 patterns of PB parameters. The strongest associated pattern of PB 
with glucose was W50%, which explained 5% (positive association) of the variation 
in concentration (table 5.3.3). Finally, total cholesterol was only associated with true 
mean PA bout, which explained 5% (negative association) of the variation in 
concentration (table 5.3.3). Patterns of PB did not explain any of the variance in the 
other cardio-metabolic endocrine profile markers. 
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Table 5.3.3. The percentage of the variance in cardio-metabolic parameters that is explained by 





Triglyceride LPL Glucose HbA1c IL-6 PIIINP 
SB% 0.00 11.0** 1.00 3.00* 1.00 0.00 0.06 
SB Breaks 1.00 -2.00 2.00 -1.00 -3.00 1.00 -0.08 
<5min SB Bout 0.00 -4.00* 3.00 -2.00 0.00 3.00 -0.06 
≥5min SB Bout 3.00 -1.00 1.00 -0.00 -5.00 0.00 -0.70 
True Mean SB 
Bout 
0.00 6.00* -0.00 2.00 4.00 -0.00 0.60 
Alpha -2.00 -3.00* -0.00 -3.00* -0.00 -1.00 -2.00 
W50% -0.00 12.0** 0.00 5.00* 1.00 0.00 2.00 
Standing% -1.0 -1.00 -0.00 -4.00* -0.00 -0.00 0.20 
LIPA% 0.00 -2.00 -1.00 -2.00 -6.00 0.00 0.60 
sMVPA% -0.00 -11.0** -1.00 -2.00 1.00 -1.00 -0.20 
10MVPA% -1.00 -12.0** -0.00 0.00 0.00 0.00 -0.20 
PA Bouts 1.00 -2.00 2.00 -1.00 -3.00 1.00 -0.08 
PA Bout Time -0.00 -10.0** -1.00 -3.00 -2.00 -0.00 0.00 
True Mean PA 
Bout 
-5.00* -6.00* -4.00 -0.00 -0.00 -1.00 1.00 
10MVPA Bouts -0.00 -8.00** -1.00 0.00 0.00 0.00 -0.10 
Total 10MVPA -1.00 -7.00** -3.00 1.00 -0.00 0.00 -0.10 
Spearman rho correlations (one-tailed) used to examine the association between total cholesterol, 
triglyceride, LPL, glucose, IL-6, PIIINP, and patterns of PB parameters. Pearson correlations (one-
tailed) used to examine the association between HbA1c and patterns of PB parameters, excluding 




The group who had a ‘high’ triglyceride concentration had patterns of SB 
(figure 5.3.1A), which are thought to be unfavourable to cardio-metabolic profile 
(SB%, W50%, true mean SB bout), compared to the ‘low’ triglyceride concentration 
group (distance between z-scores: W50%: 22.8%, SB%: 18.0%, and true mean SB 
bout: 14.7%). While the ‘low’ triglyceride concentration group had more SB breaks 
(distance between z-scores: 14.5%), <5min SB bouts (14.3%), and a greater alpha 
value (9.26%) compared to the ‘high’ triglyceride group, all of which are suggested 
to favourable towards cardio-metabolic profile (figure 5.3.1A). The ‘low’ triglyceride 
concentration group had a greater z-score for all of the patterns of PA parameters 
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compared to the ‘high’ triglyceride concentration group (distance between z-scores 
range: 2.07 [LIPA%] – 21.2% [10MVPA%]) (figure 5.3.1B). 
 
Figure 5.3.1 A) SB z-scores between ‘low’ (blue) and ‘high’ (orange) triglyceride concentration 
groups. B) PA z-scores between ‘low’ (blue) and ‘high’ (orange) triglyceride concentration groups. 




The ‘low’ total cholesterol group had a greater W50%, and true mean SB bout 
and alpha value compared to the ‘high’ total cholesterol group (figure 5.3.2 A, 
distance between z-scores: 8.59, 3.63, and 11.1%, respectively). While the ‘high’ 
total cholesterol group had a greater amount of SB breaks, <5min SB bouts, and 
>5min SB bouts compared to the ‘low’ total cholesterol group (figure 5.3.2 A, 
distance between z-scores: 11.6, 3.13, and 20.0%, respectively). For patterns of PA 
(figure 5.3.2 B), the ‘low’ total cholesterol group had a greater Standing%, 
10MVPA%, PA bout time, true mean PA bout, 10MVPA bouts, and Total 10MVPA, 
compared to the ‘high’ total cholesterol group (distance between z-scores range: 








Figure 5.3.2 A) SB z-scores in ‘low’ (blue) and ‘high’ (orange) total cholesterol concentration groups. 
B) PA z-scores between ‘low’ (blue) and ‘high’ (orange) total cholesterol concentration groups. Black 




Participants’ serum LPL was normalised for inflammatory + CVD (in)directly 
targeting medication (mg∙day-1) before being grouped. The ‘low’ LPL group had a 
greater W50%, alpha value, and true mean SB bout compared to the ‘high’ LPL 
concentration group (figure 5.3.3 A, distance between z-scores: 2.20, 1.07, and 
7.56%, respectively). The ‘high’ LPL group a more SB%, SB breaks, <5min SB 
bouts, and >5min SB bouts compared to the ‘low’ LPL concentration group (figure 
5.3.3 A, distance between z-scores: 7.77, 10.9, 12.4, and 9.25%, respectively). 
There was less than one percent distance in 10MVPA bouts z-scores between the 
‘low’ and ‘high’ LPL concentration groups (figure 5.3.3 B). the ‘low’ LPL group had 
a greater total 10MVPA, true mean PA bout, PA bout time, and LIPA% z-score 
compared to the ‘high’ LPL group (figure x B, distance between z-scores: 22.8, 9.29, 
4.79, and 3.48%, respectively). Meanwhile, the ‘high’ LPL group had a greater PA 
bouts, Standing%, 10MVPA%, and sMVPA z-score compared to the ‘low’ LPL group 








Figure 5.3.3 A) SB z-scores between ‘low’ (blue) and ‘high’ (orange) LPL concentration groups. B) 
PA z-scores between ‘low’ (blue) and ‘high’ (orange) LPL concentration groups. Black line indicates 




The ‘high’ glucose concentration group had a greater W50% (distance 
between z-scores: 12.0%) and SB% (distance between z-scores: 8.66%) z-score 
compared to the ‘low’ glucose group (figure 5.3.4 A). The ‘low’ glucose group had a 
greater z-score for all other patterns of SB compared to the ‘high’ glucose group, 
with the greater difference being present for >5min SB bouts (8.91%) (figure 5.3.4 
A). The ‘low’ glucose group had greater z-scores for all patterns of PA compared to 
the ‘high’ glucose group (distance between z-scores range: 1.29 [total 10MVPA] – 
13.8% [standing%]), excluding true mean PA bout, which displayed no group 






Figure 5.3.4 A) SB z-scores between ‘low’ (blue) and ‘high’ (orange) glucose concentration groups. 
B) PA z-scores between ‘low’ (blue) and ‘high’ (orange) glucose concentration groups. Black line 




The ‘high’ HbA1c group had a larger true mean SB bout, W50%, SB%, and 
<5min SB bout z-score compared to the ‘low’ HbA1c group (figure 5.3.5 A, distance 
between z-scores: 17.2, 10.4, 10.2, and 1.89%, respectively). Whilst the ‘low’ HbA1c 
group had a greater z-score for ≥5min SB bouts, alpha value, and SB breaks 
compared to the ‘high’ HbA1c group (figure 5.3.5 A, distance between z-scores: 
12.6, 6.57, and 3.37%, respectively). The ‘low’ HbA1c group had a greater z-score 
for all patterns of PA parameters, excluding Standing % (distance between groups: 
0.19%), compared to the ‘high’ HbA1c group (figure 5.3.5 B, distance between z-






Figure 5.3.5 A) SB z-scores in ‘low’ (blue) and ‘high’ (orange) HbA1c percentage groups. B) 
Comparison of patterns of PA z-scores between ‘low’ (blue) and ‘high’ (orange) HbA1c percentage 




The ‘low’ IL-6 group had a greater z-score for alpha value, W50%, and true 
mean SB bout compared to the ‘high’ IL-6 group (figure 5.3.6 A, distance between 
z-scores: 10.9, 3.45, and 2.15%, respectively). The ‘high’ IL-6 group had a larger z-
score for <5min SB bouts, SB breaks, and >5min SB bouts compared to the ‘low’ 
IL-6 group (figure 5.3.6 A, distance between z-scores: 20.9, 13.4, and 7.07%, 
respectively). Notably, there was no difference in z-score between groups for SB% 
(0.11%) (figure 5.3.6 A). There was no IL-6 group difference for 10MVPA bouts or 
PA bout time z-scores (<1.00%) (figure 5.3.6 B). The ‘high’ IL-6 group had a greater 
z-score for PA bouts, 10MVPA%, total 10MVPA, Standing%, and LIPA% (figure 5.3.6 
B, distance between z-scores: 13.4, 7.90, 4.77, 4.45, and 3.53%, respectively). 
Meanwhile the ‘low’ IL-6 group had a larger z-score for sMVPA% (distance between 
z-scores: 3.15%) and true mean PA bout (distance between z-scores: 2.75%) 




Figure 5.3.6 A) SB z-scores between ‘low’ (blue) and ‘high’ (orange) IL-6 concentration groups. B) 
PA z-scores between ‘low’ (blue) and ‘high’ (orange) IL-6 concentration groups. Black line indicates 
z-score mean (zero). ‘Low’ group n=35, ‘high’ group n=53. 
 
Procollagen 3 N-Terminal Peptide 
 
The ‘low’ PIIINP concentration group had a larger z-score for alpha value 
(distance between z-scores: 10.6%) (figure 5.3.7 A). There was no difference in z-
score between groups for SB% (distance between z-scores: <1.00%). The ‘high’ 
PIIINP group had a greater z-score for W50%, SB breaks, true mean SB bout, <5min 
SB bouts, and >5min SB bouts compared to the ‘low’ PIIINP group (figure 5.3.7 A, 
distance between z-scores: 7.29, 4.14, 3.92, 1.53, and 1.38%, respectively). The 
‘high’ PIIINP group had a greater z-score for all patterns of PA parameters, 
excluding sMVPA% (‘low’ group was greater than ‘high’ group), compared to the 
‘low’ PIIINP group (figure 5.3.7 B, distance between z-scores range: 1.95 [10MVPA 





Figure 5.3.7 A) SB z-scores between ‘low’ (blue) and ‘high’ (orange) PIIINP concentration groups. B) 
PA z-scores between ‘low’ (blue) and ‘high’ (orange) PIIINP concentration groups. Black line 
indicates z-score mean (zero). ‘Low’ group n=38, ‘high’ group n=38. 
 
Overall Cardio-metabolic Impact 
 
Using the rank method, for patterns of SB, W50% was the best overall 
distinguisher between ‘low’ and ‘high’ cardio-metabolic parameter groups, as it had 
the lowest sum of cardio-metabolic parameter rankings (table 5.3.4). Overall, PA 
bouts was the best distinguisher between ‘low’ and ‘high’ cardio-metabolic 






Table 5.3.4. Difference between ‘low’ and ‘high’ group z-score’s patterns of SB, ranked in 
descending order for each cardio-metabolic parameter and overall rank in ascending order based 











SB% 7 2 4 3 4 7 7 34 7 
SB Breaks 2 4 2 4 6 2 3 23 2 
<5min SB 
Bout 
6 5 1 5 7 1 5 30 4 
≥5min SB 
Bout 
1 6 3 2 2 4 6 24 3 
True Mean 
SB Bout 
5 3 5 6 1 6 4 30 4 
Alpha 3 7 7 7 5 3 1 33 6 
W50% 4 1 6 1 3 5 2 22 1 
  
 
Table 5.3.5. Difference between ‘low’ and ‘high’ group z-score’s patterns of PA, ranked in 
descending order for each cardio-metabolic parameter and overall rank in ascending order based 











Standing% 3 8 4 1 9 4 6 35 5 
LIPA% 5 9 7 5 1 5 7 39 7 
sMVPA% 8 2 8 7 8 6 5 44 8 
10MVPA% 4 1 5 4 6 2 4 26 2 
PA Bouts 2 5 2 3 7 1 3 23 1 
PA Bout 
Time 
7 4 6 2 3 8 8 38 6 
True Mean 
PA Bout 
1 6 3 9 5 7 1 32 4 
10MVPA 
Bouts 
9 3 9 6 4 9 9 49 9 
Total 
10MVPA 
6 7 1 8 2 3 2 29 3 
 
Using method 2, for patterns of SB, the ‘low’ metabolite score group had a 
greater alpha z-score compared to the ‘high’ metabolite score group (distance of 
14% between group z-scores) (figure 5.3.8A). The ‘low’ and ‘high’ metabolite score 
groups had a similar z-score for <5 min SB bout, >5 min SB bout, and true mean 
SB bout (figure 5.3.8A). The ‘high’ metabolite score group had a larger z-score for 
SB%, W50%, and SB breaks compared to the ‘low’ metabolite score group (distance 
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between z-scores: 14%, 10%, and 5%, respectively) (figure 5.3.8A). For patterns of 
PA, the ‘low’ metabolite score group has a greater z-score for all parameters 
(distance between z-score range: 23% [10MVPA bouts] – 3% [LIPA%]) compared to 
the ‘high’ metabolite score group, excluding PA bouts, which was larger in the ‘high’ 
metabolite group (distance between z-scores: 5%) (figure 5.3.8B). 
 
Figure 5.3.8 A) SB z-scores between ‘low’ (blue) and ‘high’ (orange) metabolite score groups. B) PA 
z-scores between ‘low’ (blue) and ‘high’ (orange) metabolite score groups. Black line indicates z-
score mean (zero). ‘Low’ group n=65, ‘high’ group n=28. 
 
Using method 3, for patterns of SB, alpha value displayed the greater 
distance (15%) between group z-scores as the ‘low’ composite z-score group had a 
greater z-score than the ‘high’ composite z-score group (figure 5.3.9). The ‘low’ 
composite z-score group also had a higher z-score for <5 min SB bout, >5 min SB 
bout, and SB breaks compared to the ‘high’ composite z-score group (distance 
between z-scores: 6%, 5%, and 3%, respectively) (figure 5.3.9). The ‘high’ 
composite z-score group had a larger true mean SB bout, W50%, and SB% 
(distance between z-scores: 11%, 10%, and 7%, respectively) compared to the ‘low’ 
composite z-score group (figure 5.3.9). For patterns of PA, the ‘low’ composite z-
score group had a larger z-score for all parameters (distance between z-score 
range: 18% [sMVPA%] – 5% [LIPA% and PA bouts], excluding total 10MVPA (figure 




Figure 5.3.9 A) Comparison of patterns of SB z-scores between ‘low’ (blue) and ‘high’ (orange) 
composite z-score groups. B) Comparison of patterns of PA z-scores between ‘low’ (blue) and ‘high’ 
(orange) composite z-score groups. Black line indicates z-score mean (zero). ‘Low’ group n=48, 




The objective of this study was to illustrate which PB intensity(s) influence 
cardio-metabolic parameters in older adults. For Part 3, the aim was to determine 
which pattern of SB and PA was most important to monitor when using future 
lifestyle interventions to improve the cardio-metabolic profile of older adults. The 
objective was to illustrate how the patterns of PB engagement differ between ‘low’ 
and ‘high’ cardio-metabolic marker groups. It was hypothesised that the ‘low’ cardio-
metabolic marker group would present more favourable patterns of PB engagement 
than the ‘high’ group (Carson et al., 2014; Lord et al., 2011; Healy et al., 2011).  
Z-scores are unit-less values that normalise participant data by presenting 
them as the number of standard deviations away from the mean, when the mean of 
the population is zero, assuming a normally distributed data set. Z-scores are 
particularly useful for comparing variables that have different units (such as SB%: 
%∙waking hrs∙day-1, and W50%: mins∙day-1) as it allows the researcher to simplify 
the multiplicities through determining if the magnitude of difference/change in a 
variable is equivalent to the difference/change in another variable, which has 
different units. For example, is a 20%∙waking hrs∙day-1 difference in SB% the same 
as a 20 mins∙day-1 difference in W50%. Therefore, z-scores are useful for the current 
study, as it can illustrate which pattern of PB displays the largest difference in the 
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comparison between ‘low’ and ‘high’ cardio-metabolic parameter concentration 
groups and subsequently, provide a simplified indication of the overall influence of 
PB on all cardio-metabolic parameters of interest. 
 
The Most Important Pattern of SB for Assessing Cardio -metabolic Profile 
 
Using method 1, W50% displayed the largest cumulative distance between 
‘low’ and ‘high’ cardio-metabolic concentration groups (table 5.3.4), however alpha 
had the largest distance between the ‘low’ and ‘high’ metabolite score (method 2) 
(figure 5.3.8A) and composite z-score (method 3) (figure 5.3.9A) groups suggesting 
that alpha and W50% may be the most important pattern of SB to measure within 
PB research. Alpha and W50% were first proposed by Chastin and Granat (2010) 
as a more sensitive to change measure in SB, compared to SB breaks and absolute 
SB engagement. Alpha is a unit-less power law scaling variable where an increase 
in its size would indicate that a participant would accumulate their SB time with more 
SB bouts of a shorter duration (Chastin and Granat, 2010). Meanwhile, W50% 
represents the length of an SB bout where the summation of all the SB bouts greater 
or equal to that length would account for 50% of absolute total SB engagement 
(Chastin and Granat, 2010). The recent study suggested that older adults with 
‘unhealthy’ triglyceride and glucose concentrations would accumulate 50% of their 
daily SB time using longer SB bouts and that they have fewer SB bouts but of a 
longer duration. This was illustrated in the comparison of ‘low’ and ‘high’ groups for 
both triglyceride and glucose concentration, which showed that the ‘high’ groups 
had a greater W50% z-score (distance between z-scores: triglyceride, 22.8%, 
glucose, 12.0%) and lower alpha z-score (distance between z-scores: triglyceride, 
9.3%, glucose, 3.9%) compared to the ‘low’ groups. Furthermore, it was suggested 
that W50% and alpha explained 12% and 3% of the variance in triglyceride 
concentration, respectively, as well as 5.0% and 3.9% of the variance in fasting 
glucose concentration, respectively. To the author’s knowledge, no previous 
research has examined the relationship between alpha, W50% and cardio-
metabolic health in an older adult population (60 – 89 yrs). However, the results of 
the current study are consistent with adult populations (58±10 yrs), where an 
increase in alpha value was also associated with a decrease in triglyceride and 
fasting plasma glucose concentration (Bellettiere et al., 2017). Conversely, 
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Bellettiere et al. (2017) reported a decrease in W50% (referred to as usual bout 
length) without observing a change in triglyceride or fasting glucose concentration. 
The discrepancies in W50% findings may be explained by the fact that the sample 
population of the current study had a mean W50% that was 27.9 min·day-1 greater 
than the aforementioned study (Bellettiere et al., 2017), which suggests that there 
may be a maximum W50% threshold that must not be exceeded to prevent W50% 
from influencing triglyceride and glucose concentration. As triglyceride and glucose 
play an important role in the pathogenesis of diabetes mellitus (Boden, 1997), the 
results of the current study may suggest that it is pertinent to manipulate alpha and 
W50% in at risk/diabetic populations. This is particularly relevant for older adults 
(60+ yrs), where at risk/diabetics constitute an estimated 14.8% (95% confidence 
interval [95%CI] 14.4, 15.2) of the population (Melzer et al., 2015). 
 Furthermore, participants displaying a greater PIIINP concentration, a marker 
of vascular stiffness (Bonapace et al., 2006), and greater IL-6 concentration, 
involved in the pathogenesis of atherosclerosis (Ciccone et al., 2014), had a larger 
and lower z-score for W50% (PIIINP only) and alpha, respectively, suggesting that 
extended engagement in SB bouts could increase vascular stiffness and 
inflammation. Vascular stiffness was not measured in the current thesis, however 
intima-media thickness (IMT) was, which is associated with vascular stiffness 
(r2=0.18, p<0.001, n=423) (Shoji et al., 2010) and inflammation (r2=0.18, p<0.001) 
(Ciccone et al., 2014). In Chapter 03, a 0.003 mm (95%CI -0.001, -0.00, p=0.001) 
increase in popliteal IMT was predicted with a one minute per day increase in 
W50%. The increase in IMT with increasing W50% may be a result of the increasing 
PIIINP concentration with increasing W50% as PIIINP is associated with IMT 
(Agarwal et al., 2014). In addition, this observed increase in PIIINP (in the current 
study) and IMT (Chapter 03) with increasing W50% would likely increase total 
peripheral resistance and thus require an increased resting heart rate (Siddiqui, 
2011) to maintain the required resting cardiac output, which would explain why an 
increase in W50% was associated with an increase in resting heart rate (Chapter 
03). Overall, the current study suggested that patterns of SB, specifically alpha and 






The Most Important Pattern of PA for Assessing Cardio -metabolic Profile 
 
 The number of PA bouts in a day was ranked as the best determinant of 
cardio-metabolic markers (method 1), as the cumulative distance between ‘low’ and 
‘high’ concentration groups was greatest for PA bouts compared to the other 
patterns of PA. The greatest distance in PA bouts occurred in the comparison 
between ‘low’ and ‘high’ concentration groups of lipid markers (3 out of the top 4 
cardio-metabolic markers, triglyceride: ‘low’ 14% greater, total cholesterol: ‘low’ 12% 
greater, and LPL: ‘high’ 11% greater). Serum LPL is generally thought to be anti-
atherogenic (Rip et al., 2006) . The presence of more PA bouts in the ‘high’ LPL 
group would support this paradigm as physical activity is known to increase LPL 
within skeletal muscle (Bey and Hamilton, 2003), which is also anti-atherogenic 
(Tsutsumi, 2003). Furthermore, LPL is responsible for the hydrolysis of triglyceride 
(Sato et al., 2016) and therefore, the presence of more PA bouts in the ‘high’ LPL 
group and ‘low’ triglyceride group, compared to their respective ‘low’ and ‘high’ 
groups, may suggest a potential mechanistic link between increased PA 
engagement, increased LPL concentration, and decreased triglyceride 
concentration.  
PA bouts was also ranked higher than patterns of PA that were specific to a 
PA intensity (e.g. 10MVPA bouts); it suggests that a PA bout of any intensity may be 
beneficial to the cardio-metabolic status of older adults. This has certainly been an 
ongoing theme throughout the current thesis (Chapter 03, 04, 05 Part 1 and 2) and 
has been illustrated in acute and chronic SB break studies that have used PA, from 
standing to MVPA, as a method of SB interruption (see Benatti and Ried-Larsen 
(2015) for a review). Benatti and Ried-Larsen (2015) suggested that as the baseline 
physical fitness of the participants increased, a higher intensity of PA interruption 
was needed to elicit health benefits; however, none of the reviewed studies included 
older adults so it is unknown whether this hypothesis holds true in older adult 
populations. Given that the majority of older adults in the UK are physically inactive 
(100 - 95% from Craig et al. (2009), 90.5% from the current thesis), it is likely that 
the physical fitness of older adults is low and therefore, it is probable that they may 
experience a maintenance/improvement in cardio-metabolic status in response to 
low intensity PA bouts. The demographic data of the ‘low’ cholesterol and 
triglyceride, and ‘high’ LPL groups of the current study suggests that bouts of SB 
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may need to be interrupted every 30.2±1.21 mins with PA bouts of 16.5±0.76 mins 
on an average 22.1±0.77 times a day (which would require 17 waking hours) for 
older adults to have a ‘healthy’ lipid profile.   
Interestingly, 10MVPA bouts and sMVPA% were suggested to be the best 
determinants of overall cardio-metabolic profile when the metabolite score (method 
2, figure 5.3.8B) and composite z-score (method 3, figure 5.3.9B) were used, 
respectively. This was unexpected as both of these patterns of PA were listed as 
the bottom two (least distance between ‘low’ and ‘high’ z-scores) when using 
method 1 (table 5.3.5). These three methods of collating impact are hard to compare 
and it is not possible to suggest which is the best method to use when assessing 
overall cardio-metabolic impact. Rather, when reviewing in isolation, each method 
tells its own story. Using the metabolic score method (method 2) would suggest that 
if two people engage in a similar amount of 10MVPA over seven days, the person 
that accumulates this 10MVPA time with more bouts per day and spreads their 
10MVPA engagement out across the week will have a ‘healthier’ cardio-metabolic 
profile. This was evident as there was only a 4% distance between total 10MVPA but 
a 23% and 22% distance between 10MVPA bouts (average n·day-1) and 10MVPA% 
(average %·waking hrs·day-1) z-scores, respectively (figure 5.3.8B). This concept 
supports earlier self-reported MVPA of men from the Harvard Alumni Study (age: 
66.3 years, SD not reported), which suggested that those who were ‘regularly active’ 
throughout the week have a greater reduction in mortality risk compared to those 
who achieve sufficient weekly MVPA targets within one-to-two days, dubbed the 
‘weekend warriors’ (Lee et al., 2004).  
The composite z-score method (method 3) suggests that those whose 
waking hours are made up of more sMVPA will have a healthier overall cardio-
metabolic profile (figure 5.3.9B). This is a strong message for older adults who 
physically or mentally are unable to sustain the prolonged bouts of MVPA that 
government guidelines recommend, as it suggests that they would still be able to 
improve their cardio-metabolic profile. As mentioned earlier in the discussion, using 
MVPA bouts of a shorter duration than ten minutes have been shown to improve 
several cardio-metabolic markers (Benatti and Ried-Larsen, 2015) during phases of 
prolonged SB engagement. Overall, it is apparent that engaging in more bouts of 
PA, whether that be any PA or specifically 10MVPA, is an important determinant of 





As PB monitoring becomes more commercially available, it is important that 
the patterns in which PB(s) are engaged be considered, as the current study has 
highlighted that these patterns, more so than total PB engagement, may influence 
the cardio-metabolic profile of older adults. Of note, alpha and W50% for patterns 
of SB and PA bouts, 10MVPA bouts, and sMVPA% for patterns of PA had the 
greatest distinction in the comparison of ‘low’ and ‘high’ overall cardio-metabolic 
profile groups, suggesting that these patterns of PB, at least, should be monitored 
in older adults. Furthermore, the presence of differences in patterns of SB and PA 
between the ‘low’ and ‘high’ cardio-metabolic concentration groups adds further 
evidence to show that objective recommendations for the patterns of SB and PA (off 
all intensities) engagement, not just total engagement time, are required for older 
adults, to provide education to maintain/improve health status.  
 The findings of the current study illustrate that future research needs to 
develop laboratory based interventions to determine the magnitude to which these 
patterns of PB acutely influence cardio-metabolic health, specifically in older adult 
populations, where CVD is one of the most prevalent causes of death (Townsend 
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Until recently, it was thought that being sedentary and physically inactive 
were interchangeable terms. However, seminal research has found that the positive 
effects of PA, specifically of moderate intensity, cannot always offset the negative 
effects of concurrent prolonged SB engagement on health status. Thus, the 
spectrum of PB became biaxial, segregating SB and 10MVPA on to separate axes. 
Furthermore, in 2012, a letter signed by 48 researchers from around the world was 
written to the editor of Applied Physiology, Nutrition, and Metabolism (Barnes et al., 
2012) urging that the definition of sedentary behaviour and physical inactivity be 
standardised to (respectively); 
“Any waking behaviour characterised by an energy expenditure ≤1.50 METs 
while in a sitting or reclined posture.” 
“Those who are performing insufficient amounts on moderate to vigorous 
physical activity (i.e., not meeting specified physical activity guidelines).” 
Barnes et al. (2012) 
  The review of the current literature in Chapter 01 highlighted that there were 
methodological limitations in the monitoring of PB, especially in population specific 
studies, as PB intensity thresholds from middle-aged populations, along with the 
inability to recognise posture, were applied to children and older adult populations. 
This would have likely miss-estimated engagement in PB and thus any associations 
with health status. Furthermore, there was an apparent lack of PB epidemiological 
studies specific to older adults. As the demographics of the UK shifts to an increased 
older adult population (~ 25% of the UK population by 2035), there is a potential 
socio-economic burden due to the exponential annual healthcare costs within the 
NHS that occur with the increasing age of the patient (50 year-old male: £605, 70 
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year-old male: £1,834, 89 year-old male: £5,198). Although non-communicable, 
CVD is the leading cause of death, after cancer, in UK older adults. Becoming 
physically active in older age has been shown to reduce the risk of mortality by 35% 
(95% confidence interval [CI] 30.0, 40.0) whilst engaging in more sedentary 
behaviour carries a 90% (95%CI 36.0, 166) increased risk of mortality. Additionally, 
maintaining quality of life during their later years is also of particular importance. 
However, whilst life expectancy in the UK at age 65 years (yrs) increased by 1.43 
years, between 2001 and 2008, healthy life expectancy only increased by 0.65 yrs, 
suggesting that older adults are living longer but not necessarily healthier lives.  
Therefore, the aims of this thesis were 1) to illustrate how and what PB(s) 
older adults should engage in (increase or minimise) to improve their 
cardiovascular/metabolic profile and thus hopefully improve their health-related 
quality of later life. 2) Determine whether cardiovascular/metabolic markers are 
affected by increasing age after the age of 60 yrs and whether PB(s) can mediate 
any apparent ageing effects. To achieve these overarching aims, it was pertinent to 
establish the most suitable PB measurement tool. Therefore, Chapter 02 served as 
a development chapter to firstly determine the ability of an in-house developed 
accelerometer algorithm to classify PB intensity by comparing it to a criterion 
measure (oxygen utilisation) and secondly, compare the ability of the International 
Physical Activity Questionnaire (IPAQ) against the in-house developed 
accelerometer in the classification of PB intensity. Chapter 02 indicated that 
accelerometry would be the most suitable measurement tool for PB within the 
subsequent chapters (03 – 05). The subsequent chapters (03 – 05) answered at 
least one of the overarching aims however, each chapter used different statistical 
models that asked different questions and therefore, required more refined aims for 
the chapter. Table 6.1 provides an overview of the refined aims for the thesis 























































































































































































































































































































































































































































































Total Physical Behaviour Engagement  
 
Within the UK public media, reports often suggest that only 25% of adults 
(18+ yrs) are physically inactive (British Broadcasting Company, 2017; Gifford, 
2017; Bates, 2017), which ranks the UK as the 35th most inactive country in the 
world (146 countries monitored out of a possible 195) (World Health Organization, 
2015b). Self-report questionnaires often adapted to each country, such as the IPAQ 
are used to make these comparisons. However, as shown in Chapter 02 Part 2, self-
report measures of PA are grossly overestimated leading to reports that 
underestimate the degree to which there is a physical inactivity crisis to contend 
with. Indeed from our data, over 90% of the older adult population (in Cheshire - a 
generally wealthy and educated population by UK standards (Fenton, 2017; Office 
for National Statistics, 2014)) are physically inactive (Chapter 02 Part 2). The same 
can be said for SB, with older adults (Chapter 02 Part 2) self-reporting 5 hrs·day-1 
of sitting, with the occasional participant reporting zero hours of SB, whereas 
accelerometer monitoring, averages these older adults at 10 hrs·day-1 of SB 
(Chapter 02 Part 2). From Chapter 02 Part 2, it is clear that older adults know how 
MVPA should feel, as their accelerometer-measured sMVPA (MVPA bouts <10 
mins) was similar to their self-reported 10MVPA (MVPA bouts ≥10 mins). Therefore, 
education is not required for older adults to understand PA intensity but rather for a 
greater awareness of the optimal length of time they engage in PB(s) across the 
spectrum. 
 With technological advancements, epidemiological research is moving away 
from subjective PB monitoring towards objective monitoring, such as 
accelerometers. The most notable epidemiological ‘big data’ set is the National 
Health and Nutrition Examination Survey (NHANES) (Centers for Disease Control 
Prevention, 2009). It aimed to obtain accelerometer measured PB from 5000 US 
adults and has been analysed in 296 research articles (PubMed, keywords: 
NHANES accelerometer, search date: 14.08.2017). However, as knowledge of the 
level of sophistication in data analysis has improved, accelerometer data can now 
provide upwards of 20 PB parameters from the standard total engagement to the 
patterns in which they are accumulated. With this abundance of data, it is important 
to focus in on the essential PB parameters, which are able to predict the 
cardiovascular/metabolic profile of older adults.  
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In isolation, an hour of LIPA had a notable effect on popliteal IMT, decreasing 
it by 0.09 (95%CI 0.15, 0.03) mm (Chapter 03 Part 1) as well as attenuating the age 
related increase in popliteal IMT (Chapter 04). Meanwhile, an hour of SB would 
increase resting heart rate by 1.58 (95%CI 0.17, 2.99) bpm (Chapter 03 Part 1). 
However, in reality, the impact of a PB on health does not happen in isolation. Until 
recently, statistical modelling was limited to this isolative approach (Henson et al., 
2013b; Bankoski et al., 2011; van der Berg et al., 2016). Seminal research, which 
has brought new PB modelling, namely isotemporal substitution modelling (ISM) 
(Mekary et al., 2009) and compositional data analysis (CoDA) (Chastin et al., 
2015b). ISM predicts how health parameters may change if a PB is replaced with 
another of the same duration; as such, it is proposed as a useful model for 
practitioners who advocate behaviour change to improve health. Once again, SB 
and LIPA played a role in mediating cardiovascular profile of older adults, within the 
current thesis (Chapter 03). Modelling the replacement of one hour of SB with 
standing or sMVPA predicted a reduced resting heart rate by 6.20 – 3.72 bpm 
(Chapter 03 Part 2), which would negate the positive association observed between 
SB and resting heart rate in Chapter 03 Part 1. Furthermore, the replacement of one 
hour of SB with LIPA decreased carotid artery diameter, which is proposed to be a 
health benefit as increased carotid artery diameter is associated with an increased 
risk of stroke in older adults (Van Dijk et al., 2001). Meanwhile, 10MVPA, 
engagement appeared to be essential for the mediation of triglyceride concentration, 
as the replacement of any PB, including sMVPA, with 10MVPA decreased 
triglyceride concentration (Chapter 05). 
 From a CoDA approach, which acknowledges that the engagement in one 
PB limits the time available to engage in other PB(s), 10MVPA was again suggested 
to be the main mediator of triglyceride concentration. For instance, those with a low 
triglyceride concentration (≤1.7 mmol·l-1) engaged in 48% more, and those with a 
high triglyceride concentration (>1.7 mmol·l-1) engaged in 32% less, 10MVPA than 
the sample population. This interaction is probably mediated through LPL pathways, 
which are responsible for the hydrolysis of triglyceride (Merkel et al., 2002). Indeed 
participants with a high LPL (>63.5 pg·mL-1) concentration engaged in 11% more, 
and those with a low LPL (≤63.5 pg·mL-1) concentration engaged in 27% less, 




Patterns of Physical Behaviour Engagement 
 
It has been recommended that SB is monitored using the ‘SITT’ principle, (S) 
sedentary bouts of a certain duration, (I) interruptions in SB, (T) time duration of SB, 
and (T) type of SB (Tremblay et al., 2010). Early research that used the SITT 
principle, found SB breaks was a consistent predictor of health status (Saunders et 
al., 2013; Healy et al., 2008b; Chastin et al., 2015a). More recently, the development 
of W50% (Chastin and Granat, 2010), to provide a more sensitive (to change) 
measure of SB patterns than SB breaks, has yielded further associations with health 
outcomes (Bellettiere et al., 2017; Van Roekel et al., 2016). Indeed, in the current 
thesis, W50% was a consistent mediator of older adults’ cardiovascular/metabolic 
profile (Chapter 03 and 05), more so than SB breaks. The most notable finding was 
the mediating effects W50% had on PIIINP (Chapter 05), popliteal IMT (Chapter 03), 
and resting heart rate (Chapter 03). It was suggested that participants with a high 
W50% are likely to have a high PIIINP concentration (Chapter 05), which is 
associated with vascular stiffness (Bonapace et al., 2006) and IMT (Agarwal et al., 
2014). An increase in vascular stiffness and IMT would increase total peripheral 
resistance and thus, a higher resting heart rate (Siddiqui, 2011) would be required 
to maintain resting cardiac output. Therefore, the positive association between 
W50% and resting heart rate (Chapter 03) may be a result of increased IMT 
(Chapter 03) due to the higher concentration of PIIINP (Chapter 05) in these 
participants who have a longer W50%. 
 The current thesis proposes that engaging in PA, across the spectrum from 
standing to 10MVPA, may be best for mediating older adults’ 
cardiovascular/metabolic profile. This was due to patterns of PA parameters, such 
as true mean PA bout length (Chapter 03), daily sum of PA bout time (Chapter 03), 
and the number of PA bouts (Chapter 05) being the most frequent predictors of 
cardiovascular/metabolic parameters. However, when overall cardio-metabolic 
profile was considered (Chapter 05), it was suggested that older adults should attain 
a physically active lifestyle by spreading out their 10MVPA across multiple bouts 







 Throughout the thesis, it has been clear that SB and the patterns in which it 
is engaged is a mediator of cardiovascular/metabolic profile in older adults (figure 
6.2). Therefore, there is a strong need to educate the public about the risks of 
prolonged SB and the methods that can be used to reduce engagement. The thesis 
has suggested that LIPA may be a useful substitute for SB as these two PB(s) are 
highly co-dependent (Chapter 05) on one another. This thesis also provided 
evidence to show that LIPA can mediate cardiovascular/metabolic profile (figure 
6.2). This is a useful message for older adults as it shows that they could still attain 
health benefits, even if they are physically or mentally unable to achieve a more 
demanding physically active lifestyle. 
 However, the current thesis has also advocated that attaining a demanding 
physically active lifestyle (if possible) is essential for some cardiovascular/metabolic 
markers, in particular, reduced triglyceride concentration (figure 6.2). Therefore, the 
overarching conclusion of this thesis highlights that older adults need to consider 
both axes of the PB spectrum (figure 6.1). In other words, older persons need to 
ensure they attain an ‘active ambulator’ lifestyle (low SB, physically active) in order 
to attain the best chance of having a healthy cardiovascular/metabolic profile. 
 
Figure 6.1. Proposed PB spectrum, which follows the recommended definition of physical inactivity 
(Barnes et al., 2012). Green presents the points on the spectrum that older adults should aim to place 





Although this thesis provides a comprehensive break down of the effects PB 
has on cardiovascular/metabolic markers within central, upper limb, and lower limb 
arteries of older adults, it has some limitations. Firstly, the automated analysis of 
participants’ flow mediated dilation data led to its omittance from the thesis as it 
suggested a number of counter-intuitive results. A case in point is the finding that 
the majority of older adults had a negative response (vasoconstriction) to vascular 
occlusion. Therefore, it suggested that increasing PA would decrease vasodilatory 
response, which is not an expected association (Pierce et al., 2011; Rakobowchuk 
et al., 2008). In the future, reanalysis of the data will need to be conducted to confirm 
or refute the observed vasoconstrictive response to vascular occlusion. Secondly, 
energy balance was not monitored, which may have influenced some of the 
cardiovascular/metabolic parameters (Hjerkinn et al., 2006; Kris-Etherton et al., 
1988). However, given the amount of possible dietary modulators of physical 
function, the sample size of the thesis would have needed to be increased 
substantially to retain a suitable statistic power. Finally, the older adults that were 
recruited for the thesis were community dwelling and living independently, mainly 
representing the ‘healthy’ proportion of the older adult population. Although, 
recruitment also targeted older adults living in sheltered accommodation, response 
rates were poor (4 older adults from 10 sheltered accommodations). Therefore, how 
the results of the thesis translate to a frailer, dependently living older adult is 




Although parameters of PB have shown associations with older adults’ 
cardiovascular/metabolic profile in these cross-sectional analyses, it does not prove 
causation. To strengthen the evidence base of this thesis, a follow-up study of the 
participants’ change in PB and cardiovascular/metabolic profile in the years since 
original data collection would provide a longitudinal data set. This would allow the 
determination of whether the original habitual PB engagement of the older adults 
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(PB data in the current thesis) could predict their cardiovascular/metabolic status 
three-four years later. 
 Furthermore, the design of both acute and chronic intervention studies would 
confirm or refute the changes in cardiovascular/metabolic profile that ISM predicted 
with hypothetical changes in PB engagement. Thus, confirming the validity of the 
predictability of ISM and the time course for these predicted changes in 
cardiovascular/metabolic profile to occur. 
 The ultimate goal is to further the evidence base of this thesis so that 
objective recommendations for total SB engagement, the patterns in which SB in 
engaged, and PA engagement (other than 10MVPA) can be developed for older 





Figure 6.2. Statistically significant associations (Chapter 03 Part 1 and 2, 04, 05 Part 2) and greatest 
differences (Chapter 05 Part 1 and 3) between PB parameters and cardiovascular/metabolic 
parameters and whether the PB improved or worsened the cardiovascular/metabolic parameter. 
Colours indicate intensity of PB. Red – SB, Yellow – PA, Orange – Standing, Light Green – LIPA, 
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Utilising triaxial accelerometers and resting metabolic rate to identify an older person’s 
physical activity vs. sedentary behaviour thresholds. 
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Background: The assessment of physical activity and sedentary behaviour levels has progressed 
from subjective self-reports to more objective measures using triaxial accelerometry. However, 
published regression equations that identify physical activity intensity from accelerometer outputs 
have used young populations (35 ± 11.4 yrs) and the 3.5 mlkgmin-1 = 1 Metabolic Equivalent Task 
(MET) estimate [1]. This could cause physical activity intensities to be underestimated in older 
persons as 1 MET should represent resting metabolic rate (RMR), which is likely to be lower than 
3.5 mlkgmin-1 in the elderly [2].  
Objective: To determine whether using the 3.5 mlkgmin-1 = 1 MET equivalent underestimates 
objectively measured free-living physical activity intensity and sedentary behaviour in older 
persons. 
Methods: Five older persons (aged > 65 yrs) underwent a laboratory-based incremental physical 
activity protocol, which ranged from sedentary (e.g. lying, < 1.5 METs) to vigorous ( 6.0 METs) 
intensity behaviours. Participants wore a triaxial accelerometer on each thigh (50% upper limb 
length) while oxygen utilization was assessed using indirect calorimetry. With the accelerometer in 
situ, participants resumed their daily activities for 7 continuous days. Accelerometer data was 
subsequently analysed using physical activity intensity cut-points utilising both the 3.5 mlkgmin-1 = 
1 MET, and RMR = 1 MET equivalents.  
Results: RMR was lower than the standard 3.5 mlkgmin-1 = 1 MET equivalent (p < 0.01). The 
standard 3.5 mlkgmin-1 = 1 MET equivalent tended to underestimate time spent performing 
moderate to vigorous intensity physical activities and overestimate time spent performing light 
intensity physical activity. However, it accurately estimated time spent performing sedentary 
behaviour, compared to RMR = 1 MET derived cut-points. 
Conclusion: Using the standard 3.5 mlkgmin-1 = 1 MET equivalent does not allow for an accurate 
tracking of an older person’s levels of physical activity in free-living conditions. Accelerometry 
studies should apply RMR to 1 MET equivalents to truly reflect time spent performing physical 
activities of varying intensity in this segment of the population. 
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Age-related differences in objectively measuring population-specific physical activity 
intensity and sedentary behaviour 
 
Declan Ryan1, Jorgen Wullems1, Georgina Stebbings1 and Gladys Onambele-Pearson1 
 
1Manchester Metropolitan University, Crewe, Cheshire, United Kingdom 
 
Introduction: Objectively measuring physical activity levels through accelerometry utilises 
regression equations to determine the metabolic equivalent task (METs) for a given accelerometer 
output. These regression equations are developed through protocols that analyse accelerometer 
outputs and oxygen utilisation for a given physical activity. To convert oxygen utilisation to METs, 
the ‘3.5 mlkgmin-1 = 1 MET’ equivalent is used. However, 1 MET should represent resting 
metabolic rate (RMR). RMR declines throughout the ageing process. Therefore applying the ‘3.5 
mlkgmin-1 = 1 MET’ equivalent could indicate that a given physical activity is of the same intensity 
for young and ageing populations due to accelerometer outputs being similar when, in reality, the 
given physical activity is of a higher intensity for the older population because of a reduction in 
RMR. Aim: Therefore, the aim of this study was to examine the difference in accelerometer cut-
points when applying 3.5 mlkgmin-1, and the RMR of young vs. older persons in the calculation of 
METs. Methods: Six normal weight (BMI: 18.5 – 24.9 kg·m2) participants (3 young; 20-25 yrs, 3 
older; 65-70 yrs) wore a triaxial accelerometer on each thigh (50% upper limb length) while 
undergoing an incremental, nine stage, physical activity protocol, which ranged from sedentary 
behaviours (< 1.5 METs) (e.g. lying, sitting) to vigorous intensity functions ( 6.0 METs). Each 
stage was three minutes in duration, with oxygen utilisation collected during the last minute of each 
stage using indirect calorimetry. Oxygen utilisation was converted to METs using the ‘3.5 mlkgmin-
1 = 1 MET’ equivalent, the mean observed RMR of the young and that of the older persons. A t-test 
was used for between group RMR comparison and 2-way mixed ANOVA’s were used for 
accelerometer output and METs for within and between group comparison. Results: The 
computation method affected the resultant MET values. The older persons exhibited markedly 
different RMR values compared to their younger counterparts (p < 0.05). There was a trend for the 
older persons to experience all physical activities tested to be at a higher intensity compared to the 
young persons (p < 0.05). Thus, the physical activity for a number of activities was ultimately 
categorised as a different physical activity intensity for the older group compared to the young 
group. There was a trend for accelerometer outputs to be similar across both age groups (p > 
0.05). Conclusion: The development of accelerometer cut-points used to identify physical activity 
intensity should be based on RMR = 1 MET and should be population-specific, in order to correctly 
identify time spent performing free-living physical activity and sedentary behaviour, thereby 
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Is the International Physical Activity Questionnaire Long Form (IPAQ) a reliable measure of 
free-living sedentary behaviour and physical activity in older persons? Comparisons with 
accelerometer measures. 
 
D Ryan1, JA Wullems1, G Stebbings1, CI Morse1, CE Stewart2, G Onambele-Pearson1, 
 
declan.ryan@stu.mmu.ac.uk, 1Manchester Metropolitan University, United Kingdom; 2Liverpool 
John Moores University, United Kingdom 
 
Relevance of the research. In recent years, accurate quantification of free-living sedentary 
behaviour (SB) and physical activity (PA) has moved towards objective measurement methods [5]. 
Although, deemed a more accurate determination of lifestyle patterns, objective measures can be 
costly in large epidemiological studies.  Self-report data collection methods are useful as they can 
be widely distributed, generate large data sets and are relatively more cost effective. The 
International Physical Activity Questionnaire (IPAQ) is used worldwide [1], however, its application 
in persons older than 69 years of age, is limited [4].  
The object of the research was to compare the results of the IPAQ to accelerometer measures 
of free-living lifestyle patterns. The hypothesis was that both measures would agree in determining 
SB and moderate to vigorous physical activity (MVPA) in older people. The aim was to provide a 
reliable record of the degree of sedentarism and PA in older persons. 
Research methods and organization. 44 older participants (74.1 ± 6.1 yrs, 57% female) wore 
a thigh-mounted (anterior aspect, at 50% of greater trochanter to femoral condyle distance) triaxial 
accelerometer (GENEActiv Original, Activinsights Ltd, Kimbolton, UK), for seven consecutive free-
living days. Residual G (G), adapted from Onambele et al. [3] was the chosen accelerometer output 
for the study. SB was identified from the accelerometer output using 10 s epoch axis orientation and 
a 1.50 Metabolic Equivalent Task (MET; where 1 MET = resting metabolic rate) cut-off point (0.057 
G). MVPA was identified using a 3.00 MET cut-off point (0.216 G). Sleeping time was identified using 
a sleep diary. After seven days, 39 participants (48% female), successfully, completed the IPAQ 
Long Form (English) [2]. Association between IPAQ and accelerometer measures of SB and MVPA 
were performed using a Spearman rho. Any sex differences were compared with independent 
samples t-tests. Significance was set at a p value of 0.05. Data presented as Mean ± SD. 
Results and discussion. For MVPA (total hours over seven days), no association (r = 0.07; p = 
0.84,) between IPAQ (45.5 ± 34.5 hrs) and accelerometer (19.3 ± 7.0 hrs) measures was present. 
For SB (mean hours per 24 h day), a moderate association (r = 0.34, p = 0.03) between IPAQ (5.5 ± 
2.2 hrs) and accelerometer (9.2 ± 2.2 hrs) measures was found. It is notable, no sex differences were 
found in IPAQ or accelerometer assessed lifestyle patterns (p > 0.05). 
Conclusions. The use of IPAQ with older participants does not appear to reflect objective 
measures of free-living lifestyle patterns as the IPAQ underestimates SB and overestimates MVPA. 
Thus, where possible, we would recommend the use of accelerometry to capture SB and/or PA.  
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Comparing patterns of sedentary behaviour and physical activity accumulation between 
Sedentary, Ambulator, and Active Couch Potato older adults. 
Ryan, D.J.1, Morse, C.I.1, Stebbings, G.K.1, Stewart, C.E2, Pearson, G.L.1,  
1Health, Exercise and Active Living Research Centre, Manchester Metropolitan University, United 
Kingdom 
2Liverpool John Moores University, United Kingdom 
 Sedentary behaviour (SB) independently affects health status (Healy et al., 2008) and is 
prevalent in older adults (10.27±0.80 hours·24 hours-1, vs. young adults: 9.48±0.70 hours·24 hours-
1) (Craig et al., 2009). However, the patterns of SB and Physical activity (PA) accumulations have 
not been described. The present study aimed to examine the patterns of SB and PA accumulation 
in a population of free-living older adults, classifying groups by mobility patterns.  
A triaxial GENEActiv accelerometer (ActivInsights, Kimbolton, UK) was mounted anteriorly at 50% 
of femur length using 2 Tegaderm patches (3M Health Care, St. Paul, USA). Participants (n=90, age: 
73.72±6.28 years, 48 females) completed 7 days of habitual mobility before returning the 
accelerometer. The Cheshire Algorithm of Sedentarism (Wullems et al., 2015) was used to analyse 
the raw data. Participants were then grouped into Sedentary (n=65, 37 female) (SB: ≥8 hours·24 
hours-1, ≥150 min of Continuous MVPA (cMVPA): <150 mins·7 days-1), Ambulator (n=11, 6 female) 
(SB: <8 hours·24 hours-1, cMVPA: <150 mins·7 days-1), Active Couch Potato (ACP) (n=13, 5 female) 
(SB: ≥8 hours·24 hours-1, cMVPA: ≥150 mins·7 days-1), or Active Ambulator, 0 female) (SB: <8 
hours·24 hours-1, cMVPA: ≥150 mins·7 days-1). The single Active Ambulator participant was removed 
from between group comparison due to small group size. 
Results are presented as Mean ± Standard Deviation, p = 0.05, with groups compared by Kruskall-
Wallis and Mann Whitney-U (post hoc).  
Ambulators accumulated the least amount of SB (Figure 1). Number of SB breaks per 24 hours 
(2mins of PA following ≥1min SB) was similar between groups (Sedentary: 22.0±5.62, Ambulator: 
22.44±4.73, ACP: 22.36±6.32). However, Ambulators accumulated 50% of their SB time (W50%) 
through shorter bouts (39.16±13.33 mins·24 hours-1, Sedentary: 58.53±22.86 mins·24 hours-1, ACP: 
49.32±20.54 mins·24 hours-1). This was due to Ambulators accumulating more Standing, Light 
Intensity Physical Activity (LIPA), and <10 min Continuous MVPA (sMVPA) than ACP and Sedentary 
populations (Figure 1). The ACP population accumulated more cMVPA than Ambulator and 
Sedentary populations (Figure 1) by performing more frequent cMVPA bouts per 24 hours 




Figure 1. The distribution of an average 24-hour day across different SB and PA for Sedentary, 
Ambulator and ACP in a free-living older adult populations. † Significantly different from Ambulator. 
* Significantly different from ACP. p ≤ 0.05. 
The results suggest that older adults use different patterns of SB/PA. Thus, 1%, 12%, 14% and 72% 
of the study population could be categorised as Active Ambulator, Ambulator, ACP and Sedentary 
respectively. Those who have shorter SB bouts and accumulate the least amount of SB appear to 
substitute this time with Standing, LIPA and sMVPA as opposed to cMVPA. Using only SB breaks 
as a measure of SB patterns maybe insufficient to highlight differences between older adults. Future 
research should aim to examine how these multiple SB/PA patterns affect health status. 
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Healy, G. N., Dunstan, D. W., Salmon, J., Shaw, J. E., Zimmet, P. Z. and Owen, N. (2008) 'Television 
time and continuous metabolic risk in physically active adults.' Medicine and Science in Sports and 
Exercise, 40(4) pp. 639-645. 
 
Wullems, J. A., Morse, C. I., Degans, H., Verschueren, S. V. P. and Onambele-Pearson, G. L. (2015) 
'A novel triaxial accelerometer data algorithm for quantifying physical activity and sedentary 
behaviour in both young and older adults.' In Healthy Ageing: From Molecules to Organisms. Hinxton, 








The 9th MMU Postgraduate Research Conference 2017 – Manchester, UK 
 
Modelling any impact on cardiovascular health of sedentary behaviour and physical activity 
lifestyle substitution in older adults. 
 
DJ Ryan1, JA Wullems1, GK Stebbings1, CI Morse1, CE Stewart2, GL Onambele-Pearson1, 
Cardiovascular disease (CVD) incidence is modifiable through lifestyle, including sedentary 
behaviour (SB) and physical activity (PA). Only 5-12% of older adults attain the recommended 2.5 
hrs·wk-1 of moderate intensity PA (MVPA), accumulated in ≥10 minute bouts (10MVPA)12 needed to 
minimise CVD related mortality3. Additionally, OA engage in over 9 hrs·day-1 SB1, which is an 
independent risk factor for CVD4. The aim of this study was to model the degree to which 44 key 
cardiometabolic parameters alter with a change in mobility using isotemporal substitution modelling. 
Ninety-three OA (60 – 89 years) were fitted with a thigh-mounted accelerometer for seven continuous 
days to measure levels of SB, standing, light-intensity PA (LIPA), sporadic MVPA (sMVPA, 
accumulated in <10 minute bouts), and 10MVPA. Replacing an hour of SB, LIPA, and sMVPA with 
Standing reduced LOG total cholesterol whereas LIPA would increase LOG total cholesterol when it 
replaced SB. Replacement of any mobility for 10MVPA decreased LOG plasma triglyceride 
concentration and vice versa. Replacing SB with Standing and sMVPA reduced resting heart rate. 
Replacing SB with LIPA decreased LOG blood velocity post cuff deflation. Replacing SB with LIPA 
decreased carotid artery diameter (AD) and vice versa. Replacing Standing with sMVPA increased 
popliteal AD and vice versa. Out of 44 cardiometabolic parameters, 8 were effected by replacing SB 
with PA and 2 were effected by replacing 10MVPA with a lower intensity mobility. Our findings 
suggest that PA, other than 10MVPA, may be an effective method to reduce SB and improve certain 
health parameters.  
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3. Townsend N, Bhatnagar P, Wilkins E, Wickramasinghe K and Rayner M. Cardiovascular 
disease statistics 2015. 2015. 
4. Young DR, Hivert M-F, Alhassan S, Camhi SM, Ferguson JF, Katzmarzyk PT, Lewis CE, 
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Chapter 03: ‘Part 1: Flow mediated dilation data.’ 
‘Part 1: Full patterns of PB results.’ 
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diameter relationship.’  
Chapter 04: ‘Effect of medication on further ageing.’ 




Chapter 03: Part 1: Flow mediated dilation data. 
 
Table A3.1.1. Flow mediated dilation demographics for pooled, male, and female populations. 
Variable Pooled Male Female 
FMD    










































































m Median (IR).FMD:SR Unscaled FMD to shear rate 15 s post deflation ratio. * p≤0.05, 





Table A3.1.2. Bivariate and multivariate stepwise linear regressions between PB, covariates and 
FMD parameters. 
Variable Model b -95% CI +95% CI p r2 adj. P. Corr. 
FMD        
Unscaled SBa -0.198 -1.113 0.716 0.667 -0.010  
Standingb -0.456 -3.461 2.550 0.764 -0.011  
LIPAc -0.487 -2.612 1.638 0.650 -0.009  
sMVPAd 0.331 -1.373 2.035 0.700 -0.010  
10MVPAe -5.709 -10.403 -1.015 0.018 0.053  
(in)direct 
CVD Medsg 
0.796 0.063 1.528 0.034 0.039  
MRe -5.709 -10.403 -1.015 0.018 0.053  
Scaled SBa -0.066 -0.371 0.239 0.667 -0.010  
Standingb -0.153 -1.156 0.850 0.763 -0.011  
LIPAc -0.181 -0.890 -0.528 0.614 -0.009  
sMVPAd 0.054 -0.515 0.623 0.851 -0.011  
10MVPAe -1.859 -3.428 -0.290 0.021 0.050  
LOG Scaled SBa 0.061 0.011 0.112 0.019 0.054  
Standingb -0.129 -0.299 0.041 0.135 0.015  
LIPAc -0.134 -0.252 -0.016 0.026 0.047  
sMVPAd -0.072 -0.168 0.025 0.143 0.014  
10MVPAe 0.051 0.226 0.328 0.716 -0.011  
Primary CVD 
Medsf 
0.047 0.001 0.092 0.045 0.035  





SBa -0.034 -0.148 0.080 0.551 -0.008  
Standingb 0.109 -0.258 0.476 0.557 -0.008  
LIPAc 0.052 -0213 0.316 0.699 -0.010  
sMVPAd 0.103 -0.113 0.318 0.346 -0.001  
10MVPAe -0.198 -0.797 0.400 0.512 -0.007  
Primary CVD 
Medsf 
0.119 0.021 0.217 0.018 0.054  













Velocity 15 s 
Post 
Deflation 
SBa 13.204 -8.508 34.916 0.230 0.006  
Standingb -13.885 -84.446 56.677 0.696 -0.010  
LIPAc -48.257 -97.971 1.458 0.057 0.032  
sMVPAd -14.555 -55.983 26.872 0.487 -0.006  
10MVPAe -71.269 -186.497 43.958 0.222 0.006  
LOG Blood 
Velocity 15 s 
Post 
Deflation 
SBa 0.025 -0.018 0.068 0.248 0.004  
Standingb -0.024 -0.164 0.115 0.731 -0.011  
LIPAc -0.089 -0.188 0.009 0.076 0.027  
sMVPAd -0.032 -0.114 0.050 0.439 -0.005  
10MVPAe 0.114 -0.378 0.077 0.191 0.009  
239 
 
Table A3.1.2 continued. 
Shear Rate 
15 s Post 
Deflation 
SBa 36.190 -18.108 90.488 0.189 0.009  
Standingb -71.355 -247.599 104.889 0.423 -0.004  
LIPAc -124.652 -249.023 -0.280 0.049 0.035  
sMVPAd -58.270 -161.572 45.033 0.265 0.003  
10MVPAe -102.979 -393.459 187.502 0.483 -0.006  
LOG Shear 
Rate 15 s 
Post 
Deflation 
SBa 0.033 -0.018 0.083 0.200 0.008  
Standingb -0.053 -0.217 0.112 0.527 -0.007  
LIPAc -0.192 -0.220 0.013 0.081 0.025  
sMVPAd -0.055 -0.151 0.041 0.257 0.004  
10MVPAe -0.107 -0.377 0.164 0.434 -0.005  
FMD:SR SBa 0.000 -0.001 0.000 0.269 0.003  
Standingb 8.1E-05 -0.001 0.002 0.917 -0.012  
LIPAc 0.000 -0.001 0.002 0.481 -0.006  
sMVPAd 0.000 0.000 0.001 0.325 0.000  




SBa 2.225 -1.787 6.237 0.273 0.003  
Standingb -8.183 -21.342 4.976 0.220 0.006  
LIPAc -8.222 -17.447 1.004 0.080 0.024  
sMVPAd -5.447 -12.886 1.992 0.149 0.013  
10MVPAe 2.235 -19.184 23.653 0.836 -0.011  
LOG Time to 
Peak 
Diameter 
SBa 0.036 -0.030 0.102 0.281 0.002  
Standingb -0.138 -0.355 0.079 0.209 0.007  
LIPAc -0.139 -0.291 0.013 0.073 -0.026  
sMVPAd -0.091 -0.214 0.031 0.142 0.014  
10MVPAe 0.083 -0.270 0.436 0.642 -0.009  
FMD:SR Unscaled FMD to shear rate 15 s post deflation ratio. Bold font highlights significant 
(p≤0.05) bivariate and multivariate stepwise linear regression models. Hydration Change per 
percent increase in total body water. Primary CVD Meds Change per one unit increase in the 
number of medications directly targeting CVD risk. (in)direct CVD Meds Change per one unit 
increase in the number of medications (in)directly targeting CVD risk. MR Multivariate stepwise 
linear regression model. Superscript letters represent which, and what order PB variables are 
included in the multivariate model. b Change in cardiovascular variable per unit increase in GENEA 
variable. -95%CI Negative 95% confidence interval. +95%CI Positive 95% confidence interval. p 





Table A3.1.3. Change in bivariate and multivariate stepwise linear FMD regressions models 
following the removal of PB outliers. 
Variable Model b -95% CI +95% CI p r2 adj. P. Corr. 
FMD        
Unscaled SBa -0.198 -1.113 0.716 0.667 -0.010  
 Standingb -0.456 -3.461 2.550 0.764 -0.011  
 LIPAc -0.487 -2.612 1.638 0.650 -0.009  
 sMVPAd 0.331 -1.373 2.035 0.700 -0.010  
 10MVPAe -5.709 -10.40 -1.015 0.018 0.053  
 (in)direct CVD Medsg 0.796 0.063 1.528 0.034 0.039  
 MRe -5.709 -10.40 -1.015 0.018 0.053  
Unscaled SBa -0.118 -0.907 1.143 0.819 -0.011  
 Standingb -0.435 -3.783 2.912 0.797 -0.011  
 LIPAc -0.487 -2.612 1.655 0.650 -0.010  
 sMVPAd 0.491 -2.638 2.035 0.700 -0.010  
 10MVPAe -5.615 -14.41 3.185 0.208 0.008  
 (in)direct CVD Medsg 0.796 0.063 1.528 0.034 0.039  
Scaled SBa -0.066 -0.371 0.239 0.667 -0.010  
 Standingb -0.153 -1.156 0.850 0.763 -0.011  
 LIPAc -0.181 -0.890 -0.528 0.614 -0.009  
 sMVPAd 0.054 -0.515 0.623 0.851 -0.011  
 10MVPAe -1.859 -3.428 -0.290 0.021 0.050  
Scaled SBa 0.040 -0.302 0.381 0.818 -0.011  
 Standingb -0.084 -1.201 1.032 0.881 -0.012  
 LIPAc -0.181 -0.890 -0.528 0.614 -0.009  
 sMVPAd -0.247 -0.962 0.469 0.494 -0.006  
 10MVPAe -2.027 -4.972 0.918 0.175 0.011  
LOG Scaled SBa 0.061 0.011 0.112 0.019 0.054  
 Standingb -0.129 -0.299 0.041 0.135 0.015  
 LIPAc -0.134 -0.252 -0.016 0.026 0.047  
 sMVPAd -0.072 -0.168 0.025 0.143 0.014  
 10MVPAe 0.051 0.226 0.328 0.716 -0.011  
 Primary CVD Medsf 0.047 0.001 0.092 0.045 0.035  
 MRa 0.061 0.011 0.112 0.019 0.054  
LOG Scaled SBa 0.055 -0.002 0.112 0.059 0.032  
 Standingb -0.130 -0.320 0.060 0.176 0.010  
 LIPAc -0.134 -0.252 -0.016 0.026 0.047  
 sMVPAd -0.071 -0.189 0.048 0.241 0.005  
 10MVPAe -0.006 -0.554 0.543 0.984 -0.013  
 Primary CVD Medsf 0.053 0.005 0.100 0.032 0.042  
 MRf 0.065 0.016 0.114 0.009 0.077 0.300 
 Excludeda 0.213   0.064  0.218 
FMD:SR Unscaled FMD to shear rate 15 s post deflation ratio. Bold font highlights significant 
(p≤0.05) bivariate and multivariate stepwise linear regression models. Orange shading 
highlights regression models following outlier removal. Hydration Change per percent increase 
in total body water. Primary CVD Meds Change per one unit increase in the number of 
medications directly targeting CVD risk. (in)direct CVD Meds Change per one unit increase in 
the number of medications (in)directly targeting CVD risk. MR Multivariate stepwise linear 
regression. Superscript letters represent which, and what order PB variables are included in 
the multivariate model. b Change in cardiovascular variable per unit increase in GENEA 
variable. -95%CI Negative 95% confidence interval. +95%CI Positive 95% confidence interval. 





Table A3.1.4. Bivariate linear regressions models between patterns of PB and FMD parameters. 
Variable Model b -95% CI +95% CI p r2  r2 adj. 
FMD        
Unscaled SB Breaks -0.249 -0.612 0.114 0.176 0.021 0.010 
<5min SB 
Bout 
-0.143 -0.827 0.540 0.678 0.002 -0.010 
≥5min SB 
Bout 
-0.457 -1.017 0.103 0.108 0.030 0.019 
True Mean 
SB Bout 
0.022 -0.101 0.146 0.718 0.002 -0.010 
Alpha 0.318 -36.544 37.180 0.986 0.000 -0.012 
W50% 0.061 -0.028 0.150 0.176 0.021 0.010 
PA Bouts -0.249 -0.612 0.114 0.176 0.021 0.010 
Daily Sum of 
PA Bout Time 
-0.004 -0.018 0.010 0.595 0.003 -0.008 
True Mean 
PA Bout 
0.051 -0.223 0.324 0.714 0.002 -0.010 
10MVPA 
Bouts 
-2.051 -3.773 -0.328 0.020 0.062 0.051 
Total Week 
10MVPA 
-0.827 -1.497 -0.156 0.016 0.066 0.055 
SB% 0.015 -0.125 0.156 0.827 0.001 -0.011 
Standing% -0.030 -0.505 0.444 0.899 0.000 -0.012 
LIPA% -0.041 -0.386 0.304 0.813 0.001 -0.011 
sMVPA% 0.084 -0.182 0.349 0.533 0.005 -0.007 
10MVPA% -0.937 -1.702 -0.171 0.017 0.065 0.054 
Scaled SB Breaks -0.084 -0.205 0.037 0.173 0.022 0.010 
<5min SB 
Bout 
-0.064 -0.292 0.164 0.581 0.004 -0.008 
≥5min SB 
Bout 
-0.144 -0.331 0.044 0.131 0.027 0.015 
True Mean 
SB Bout 
0.007 -0.034 0.048 0.743 0.001 -0.010 
Alpha 0.533 -11.769 12.835 0.932 0.000 -0.012 
W50% 0.021 -0.009 0.051 0.160 0.023 0.012 
PA Bouts -0.084 -0.205 0.037 0.173 0.022 0.010 
Daily Sum of 
PA Bout Time 
-0.002 -0.006 0.003 0.519 0.005 -0.007 
True Mean 
PA Bout 
0.013 -0.079 0.104 0.781 0.001 -0.011 
10MVPA 
Bouts 
-0.692 -1.266 -0.177 0.019 0.063 0.052 
Total Week 
10MVPA 
-0.268 -0.492 -0.044 0.020 0.062 0.051 
SB% 0.007 -0.040 0.054 0.756 0.001 -0.011 
Standing% -0.009 -0.168 0.149 0.909 0.000 -0.012 




Table A3.1.4 continued. 
Scaled sMVPA% 0.020 -0.069 0.109 0.657 0.002 -0.009 
10MVPA% -0.306 -0.562 -0.050 0.020 0.062 0.051 
LOG Scaled SB Breaks -0.016 -0.037 0.005 0.139 0.026 0.015 
<5min SB 
Bout 
-0.033 -0.072 0.006 0.098 0.033 0.021 
≥5min SB 
Bout 
-0.014 -0.046 0.019 0.405 0.008 -0.004 
True Mean 
SB Bout 
0.010 0.003 0.017 0.008 0.083 0.072 
Alpha -1.788 -3.773 0.196 0.077 0.038 0.026 
W50% 0.006 0.001 0.011 0.027 0.058 0.047 
PA Bouts -0.016 -0.037 0.005 0.139 0.026 0.015 
Daily Sum of 
PA Bout Time 
-0.001 -0.002 0.000 0.047 0.047 0.036 
True Mean 
PA Bout 
-0.009 -0.024 0.007 0.264 0.015 0.003 
10MVPA 
Bouts 
0.005 -0.099 0.108 0.930 0.000 -0.012 
Total Week 
10MVPA 
0.008 -0.032 0.047 0.707 0.002 -0.010 
SB% 0.009 0.001 0.016 0.029 0.057 0.045 
Standing% -0.022 -0.049 0.005 0.107 0.031 0.019 
LIPA% -0.023 -0.042 -0.004 0.018 0.066 0.054 
sMVPA% -0.012 -0.027 0.003 0.128 0.028 0.016 
10MVPA% 0.008 -0.038 0.053 0.742 0.001 -0.011 
Artery 
Diameter 15 s 
Post Deflation 
SB Breaks 0.011 -0.034 0.057 0.630 0.003 -0.009 
<5min SB 
Bout 
0.042 -0.041 0.126 0.319 0.012 0.000 
≥5min SB 
Bout 
-0.004 -0.076 0.068 0.916 0.000 -0.012 
True Mean 
SB Bout 
-0.002 -0.017 0.014 0.825 0.001 -0.012 
Alpha -0.209 -4.821 4.403 0.928 0.000 -0.012 
W50% -0.007 -0.018 0.004 0.206 0.019 0.007 
PA Bouts 0.011 -0.034 0.057 0.630 0.003 -0.009 
Daily Sum of 
PA Bout Time 
0.001 -0.001 0.002 0.441 0.007 -0.005 
True Mean 
PA Bout 
0.002 -0.032 0.036 0.908 0.000 -0.012 
10MVPA 
Bouts 
-0.061 -0.286 0.163 0.587 0.004 -0.009 
Total Week 
10MVPA 
-0.031 -0.117 0.054 0.472 0.006 -0.006 




Table A3.1.4 continued. 
Artery 
Diameter 15 s 
Post Deflation 
Standing% 0.017 -0.041 0.075 0.561 0.004 -0.008 
LIPA% 0.008 -0.035 0.050 0.723 0.002 -0.011 
sMVPA% 0.015 -0.019 0.049 0.374 0.010 -0.002 
10MVPA% -0.030 -0.128 0.068 0.541 0.005 -0.008 
Blood Velocity 
15 s Post 
Deflation 
SB Breaks 0.841 -7.947 9.628 0.849 0.000 -0.012 
<5min SB 
Bout 
1.912 -14.504 18.329 0.817 0.001 -0.012 
≥5min SB 
Bout 
1.049 -12.736 14.834 0.880 0.000 -0.012 
True Mean 
SB Bout 
0.260 -2.672 3.191 0.861 0.000 -0.012 
Alpha -310.353 -1192.640 571.935 0.486 0.006 -0.006 
W50% 0.942 -1.185 3.068 0.381 0.009 -0.003 
PA Bouts 0.841 -7.947 9.628 0.849 0.000 -0.012 
Daily Sum of 
PA Bout Time 
-0.255 -0.587 0.077 0.131 0.028 0.016 
True Mean 
PA Bout 
-5.205 -11.659 1.249 0.112 0.031 0.019 
10MVPA 
Bouts 
-22.487 -66.426 21.452 0.312 0.013 0.000 
Total Week 
10MVPA 
-11.150 -27.603 5.302 0.181 0.022 0.010 
SB% 2.367 -0.947 5.681 0.159 0.024 0.012 
Standing% -1.887 -13.027 9.254 0.737 0.001 -0.011 
LIPA% -7.670 -15.722 0.382 0.062 0.042 0.031 
sMVPA% -2.028 -8.503 4.447 0.535 0.005 -0.008 
10MVPA% -11.887 -30.722 6.949 0.213 0.019 0.007 
LOG Blood 
Velocity 15 s 
Post Deflation 
SB Breaks 0.002 -0.016 0.019 0.849 0.000 -0.012 
<5min SB 
Bout 
0.006 -0.027 0.038 0.737 0.001 -0.011 
≥5min SB 
Bout 
0.001 -0.027 0.028 0.964 0.000 -0.012 
True Mean 
SB Bout 
0.001 -0.005 0.007 0.763 0.001 -0.011 
Alpha -0.612 -2.357 1.133 0.487 0.006 -0.006 
W50% 0.002 -0.002 0.006 0.418 0.008 -0.004 
PA Bouts 0.002 -0.016 0.019 0.849 0.000 -0.012 
Daily Sum of 
PA Bout Time 
0.000 -0.001 0.000 0.136 0.027 0.015 
True Mean 
PA Bout 
-0.010 -0.023 0.003 0.130 0.028 0.016 
10MVPA 
Bouts 




Table A3.1.4 continued. 
LOG Blood 




-0.023 -0.056 0.009 0.161 0.024 0.012 
SB% 0.005 -0.002 0.011 0.163 0.024 0.012 
Standing% -0.003 -0.025 0.019 0.772 0.001 -0.011 
LIPA% -0.014 -0.030 0.002 0.083 0.037 0.025 
sMVPA% -0.004 -0.017 0.008 0.490 0.006 -0.006 
10MVPA% -0.025 -0.063 0.012 0.177 0.022 0.010 
Shear Rate 
15 s Post 
Deflation 
SB Breaks 1.005 -21.015 23.025 0.928 0.000 -0.012 
<5min SB 
Bout 
-3.548 -44.684 37.587 0.864 0.000 -0.012 
≥5min SB 
Bout 
5.834 -28.683 40.351 0.738 0.001 -0.011 
True Mean 
SB Bout 
0.409 -6.937 7.755 0.912 0.000 -0.012 
Alpha -587.413 -2800.721 1625.896 0.599 0.003 -0.009 
W50% 3.618 -1.676 8.912 0.178 0.022 0.010 
PA Bouts 1.005 -21.015 23.025 0.928 0.000 -0.012 
Daily Sum of 
PA Bout Time 
-0.769 -1.596 0.058 0.068 0.041 0.029 
True Mean 
PA Bout 
13.971 -30.101 2.160 0.089 0.035 0.023 
10MVPA 
Bouts 
-30.265 -140.848 80.318 0.588 0.004 -0.009 
Total Week 
10MVPA 
-15.518 -57.055 26.019 0.459 0.007 -0.005 
SB% 6.874 -1.394 15.142 0.102 0.003 0.021 
Standing% -10.351 -38.187 17.486 0.462 0.007 -0.006 
LIPA% -19.438 -39.601 0.725 0.059 0.043 0.032 
sMVPA% -7.980 -24.146 8.186 0.329 0.012 0.000 
10MVPA% -17.278 -64.772 30.215 0.471 0.006 -0.006 
LOG Shear 
Rate 15 s 
Post Deflation 
SB Breaks -0.001 -0.021 0.020 0.938 0.000 -0.012 
<5min SB 
Bout 
-0.004 -0.042 0.034 0.834 0.001 -0.012 
≥5min SB 
Bout 
0.002 -0.031 0.034 0.926 0.000 -0.012 
True Mean 
SB Bout 
0.001 -0.006 0.008 0.735 0.001 -0.011 
Alpha -0.547 -2.608 1.514 0.599 0.003 -0.009 
W50% 0.003 -0.002 0.008 0.174 0.023 0.011 
PA Bouts -0.001 -0.021 0.020 0.938 0.000 -0.012 
Daily Sum of 
PA Bout Time 
-0.001 -0.001 0.000 0.090 0.035 0.023 
True Mean 
PA Bout 
-0.011 -0.026 0.005 0.166 0.024 0.011 
10MVPA 
Bouts 




Table A3.1.4 continued. 
LOG Shear 




-0.016 -0.055 0.022 0.407 0.009 -0.004 
SB% 0.006 -0.002 0.014 0.121 0.029 0.017 
Standing% -0.008 -0.034 0.018 0.561 0.004 -0.008 
LIPA% -0.016 -0.035 0.003 0.092 0.035 0.023 
sMVPA% -0.008 -0.023 0.007 0.305 0.013 0.001 
10MVPA% -0.019 -0.063 0.026 0.403 0.009 -0.004 
FMD:SR SB Breaks -3.9E-05 0.000 0.000 0.685 0.002 -0.010 
<5min SB 
Bout 
2.5E-06 0.000 0.000 0.989 0.000 -0.012 
≥5min SB 
Bout 
-8.0E-05 0.000 0.000 0.599 0.003 -0.009 
True Mean 
SB Bout 
-1.1E-05 0.000 0.000 0.734 0.001 -0.011 
Alpha 0.005 -0.014 0.024 0.612 0.003 -0.009 
W50% -2.7E-06 0.000 0.000 0.909 0.000 -0.012 
PA Bouts -3.9E-05 0.000 0.000 0.685 0.002 -0.010 
Daily Sum of 
PA Bout Time 
2.3E-06 0.000 0.000 0.534 0.005 -0.008 
True Mean 
PA Bout 
5.0E-05 0.000 0.000 0.487 0.006 -0.006 
10MVPA 
Bouts 
-0.001 -0.001 0.000 0.282 0.014 0.002 
Total Week 
10MVPA 
0.000 -0.001 0.000 0.244 0.017 0.005 
SB% -2.8E-05 0.000 0.000 0.446 0.007 -0.005 
Standing% 2.4E-05 0.000 0.000 0.845 0.000 -0.012 
LIPA% 7.4E-05 0.000 0.000 0.415 0.008 -0.004 
sMVPA% 7.8E-05 0.000 0.000 0.272 0.015 0.003 
10MVPA% 0.000 -0.001 0.000 0.242 0.017 0.005 
Time to Peak 
Diameter 
SB Breaks -0.299 -1.918 1.319 0.714 0.002 -0.010 
<5min SB 
Bout 
-0.914 -3.929 2.101 0.548 0.004 -0.007 
≥5min SB 
Bout 
-0.067 -2.578 2.443 0.958 0.000 -0.012 
True Mean 
SB Bout 
0.318 -0.223 0.860 0.246 0.016 0.004 
Alpha 17.485 -145.217 180.186 0.831 0.001 -0.011 
W50% 0.216 -0.177 0.609 0.277 0.014 0.002 
PA Bouts -0.299 -1.918 1.319 0.714 0.002 -0.010 
Daily Sum of 
PA Bout Time 
-0.058 -0.119 0.003 0.064 0.040 0.029 
True Mean 
PA Bout 




Table A3.1.4 continued. 




0.661 -7.191 8.512 0.868 0.000 -0.011 
Total Week 
10MVPA 
0.296 -2.767 3.359 0.848 0.000 -0.011 
SB% 0.526 -0.084 1.136 0.090 0.033 0.022 
Standing% -1.268 -3.346 0.811 0.229 0.017 0.005 
LIPA% -1.273 -2.772 0.227 0.095 0.032 0.021 
sMVPA% -0.786 -1.949 0.376 0.182 0.021 0.009 
10MVPA% 0.349 -3.146 3.844 0.843 0.000 -0.011 
LOG Time to 
Peak 
Diameter 
SB Breaks -0.004 -0.031 0.023 0.778 0.001 -0.011 
<5min SB 
Bout 
-0.017 -0.067 0.033 0.503 0.005 -0.006 
≥5min SB 
Bout 
0.003 -0.039 0.044 0.891 0.000 -0.012 
True Mean 
SB Bout 
0.005 -0.004 0.014 0.259 0.015 0.003 
Alpha 0.467 -2.216 3.150 0.730 0.001 -0.010 
W50% 0.003 -0.003 0.010 0.354 0.010 -0.002 
PA Bouts -0.004 -0.031 0.023 0.778 0.001 -0.011 
Daily Sum of 
PA Bout Time 
-0.001 -0.002 0.000 0.065 0.040 0.028 
True Mean 
PA Bout 
-0.016 -0.035 0.004 0.112 0.029 0.018 
10MVPA 
Bouts 
0.034 -0.095 0.164 0.598 0.003 -0.008 
Total Week 
10MVPA 
0.011 -0.039 0.062 0.657 0.002 -0.009 
SB% 0.009 -0.001 0.019 0.093 0.033 0.021 
Standing% -0.021 -0.056 0.013 0.221 0.018 0.006 
LIPA% -0.021 -0.046 0.003 0.087 0.034 0.023 
sMVPA% -0.013 -0.032 0.006 0.175 0.022 0.010 
10MVPA% 0.014 -0.044 0.071 0.634 0.003 -0.009 
FMD:SR Unscaled FMD to shear rate 15 s post deflation ratio. Bold Significant bivariate linear 
regressions (p≤0.05). b Change in cardiovascular variable per unit increase in GENEA variable. -
95%CI Negative 95% confidence interval. +95%CI Positive 95% confidence interval. p 





Table A3.1.5. Change in bivariate linear regression models between patterns of PB and FMD 
parameters after patterns of PB outliers were removed.  
Variable Model b -95% CI +95% CI p r2  r2 adj. 
FMD        
Unscaled 10MVPA 
Bouts 
-2.051 -3.773 -0.328 0.020 0.062 0.051 
-1.042 -4.190 2.107 0.512 0.006 -0.007 
 Total Week 
10MVPA 
-0.827 -1.497 -0.156 0.016 0.066 0.055 
 -0.853 -1.728 0.023 0.056 0.045 0.033 
 
10MVPA% 
-0.937 -1.702 -0.171 0.017 0.065 0.054 
 -0.870 -2.224 0.484 0.205 0.020 0.008 
Scaled 10MVPA 
Bouts 
-0.692 -1.266 -0.177 0.019 0.063 0.052 
 -0.425 -1.481 0.631 0.425 0.008 -0.005 
 Total Week 
10MVPA 
-0.268 -0.492 -0.044 0.020 0.062 0.051 
 -0.279 -0.572 0.014 0.062 0.043 0.031 
 
10MVPA% 
-0.306 -0.562 -0.050 0.020 0.062 0.051 
 -0.314 -0.767 0.140 0.172 0.023 0.011 
Bold font highlights significant (p≤0.05) bivariate linear regressions. Orange shading highlights 
regression models following outlier removal. b Change in cardiovascular variable per unit increase 
in GENEA variable. -95%CI Negative 95% confidence interval. +95%CI Positive 95% confidence 





Chapter 03: Part 1: Full patterns of PB results. 
 
Table A3.1.6. Complete Bivariate linear regressions models between patterns of PB and cardiovascular parameters. 
Variable Model b -95% CI +95% CI p r2 r2 adj. 
Systolic BP SB Breaks 0.08 -0.90 1.08 0.86 0.00 -0.01 
<5min SB Bout -0.14 -2.00 1.71 0.87 0.00 -0.01 
≥5min SB Bout 0.32 -1.20 1.84 0.67 0.002 -0.01 
True Mean SB 
Bout 
-0.08 -0.42 0.25 0.62 0.003 -0.01 
Alpha 78.2 -15.8 172 0.10 0.03 0.01 
W50% -0.09 -0.33 0.15 0.46 0.01 -0.01 
PA Bouts 0.08 -0.90 1.08 0.86 0.00 -0.01 
Daily Sum of 
PA Bout Time 
0.002 -0.03 0.04 0.91 0.00 -0.01 
True Mean PA 
Bout 
0.10 -0.62 0.83 0.77 0.001 -0.01 
10MVPA Bouts




0.21 -1.66 2.10 0.81 0.001 -0.01 
SB% -0.04 -0.42 0.33 0.81 0.001 -0.01 
Standing% -0.13 -1.42 1.14 0.83 0.001 -0.01 
LIPA% -0.07 -0.99 0.85 0.87 0.00 -0.01 
sMVPA% 0.22 -0.49 0.94 0.54 0.004 -0.01 
10MVPA%
 0.24 -1.90 2.39 0.82 0.001 -0.01 
LOG Diastolic 
BP 
SB Breaks 0.003 -0.004 0.01 0.35 0.01 -0.001 
<5min SB Bout -0.002 -0.01 0.01 0.79 0.001 -0.01 
≥5min SB Bout 0.01 -0.002 0.01 0.10 0.02 0.01 
True Mean SB 
Bout 
-0.001 -0.004 0.001 0.24 0.01 0.004 
Alpha 0.73 0.10 1.37 0.02 0.05 0.04 
W50% -0.001 -0.002 0.001 0.36 0.01 -0.002 
PA Bouts 0.003 -0.004 0.01 0.35 0.01 -0.001 
Daily Sum of 
PA Bout Time 
-4.1E-05 0.00 0.00 0.74 0.001 -0.01 
True Mean PA 
Bout 
-0.001 -0.01 0.004 0.73 0.001 -0.01 
10MVPA Bouts




-0.002 -0.01 0.01 0.80 0.001 -0.01 
SB% 0.00 -0.002 0.003 0.89 0.00 -0.01 
Standing% -0.01 -0.01 0.003 0.18 0.02 0.01 
LIPA% -0.002 -0.01 0.004 0.44 0.01 -0.01 
 sMVPA% 0.003 -0.002 0.01 0.25 0.02 0.004 
10MVPA%
 -0.001 -0.01 0.01 0.87 0.00 -0.01 
Pulse Pressure SB Breaks -0.15 -0.90 0.59 0.68 0.002 -0.01 
<5min SB Bout -0.03 -1.44 1.36 0.95 0.00 -0.01 
≥5min SB Bout -0.31 -1.46 0.83 0.58 0.003 -0.01 
True Mean SB 
Bout 
0.01 -0.23 0.27 0.89 0.00 -0.01 
Alpha 23.9 -47.8 95.8 0.50 0.01 -0.01 
W50% -0.03 -0.21 0.14 0.71 0.002 -0.01 




Table A3.1.6 continued. 
Pulse Pressure Daily Sum of 
PA Bout Time 
0.01 -0.02 0.03 0.65 0.002 -0.01 
True Mean PA 
Bout 
0.18 -0.36 0.74 0.50 0.01 -0.01 
10MVPA Bouts




0.37 -1.04 1.79 0.60 0.003 -0.01 
SB% -0.06 -0.35 0.21 0.64 0.002 -0.01 
Standing% 0.26 -0.69 1.23 0.58 0.003 -0.01 
LIPA% 0.12 -0.57 0.82 0.72 0.001 -0.01 
sMVPA% 0.04 -0.50 0.58 0.88 0.00 -0.01 
10MVPA%
 0.37 -1.25 1.99 0.65 0.002 -0.01 
Heart Rate SB Breaks -0.63 -1.13 -0.13 0.01 0.06 0.05 
<5min SB Bout -1.34 -2.27 -0.40 0.01 0.08 0.07 
≥5min SB Bout -0.57 -1.36 0.21 0.15 0.02 0.01 
True Mean SB 
Bout 
0.17 0.01 0.35 0.04 0.04 0.03 
Alpha -35.2 -84.6 14.2 0.16 0.02 0.01 
W50% 0.19 0.17 0.31 0.001 0.11 0.10 
PA Bouts -0.63 -1.13 -0.13 0.01 0.06 0.05 
Daily Sum of 
PA Bout Time 
-0.03 -0.05 -0.01 0.001 0.11 0.10 
True Mean PA 
Bout 
-0.30 -0.68 0.07 0.11 0.02 0.01 
10MVPA Bouts




-0.93 -1.90 0.03 0.05 0.04 0.02 
SB% 0.27 0.08 0.46 0.01 0.08 0.07 
 Standing% -0.80 -1.45 -0.15 0.01 0.06 0.05 
LIPA% -0.34 -0.82 0.14 0.16 0.02 0.01 
sMVPA% -0.41 -0.78 -0.04 0.02 0.05 0.04 
10MVPA%
 -1.02 -2.12 0.08 0.06 0.03 0.02 
Brachial        
Artery Diameter SB Breaks 0.01 -0.03 0.05 0.60 0.003 -0.01 
<5min SB Bout 0.02 -0.05 0.10 0.53 0.004 -0.01 
≥5min SB Bout 0.01 -0.06 0.07 0.83 0.00 -0.01 
True Mean SB 
Bout 
7.5E-05 -0.01 0.01 0.99 0.00 -0.01 
Alpha -1.08 -5.33 3.16 0.61 0.003 -0.01 
W50% -0.01 -0.01 0.01 0.26 0.01 0.003 
PA Bouts 0.01 -0.03 0.05 0.60 0.003 -0.01 
Daily Sum of 
PA Bout Time 
0.00 -0.001 0.002 0.56 0.004 -0.01 
True Mean PA 
Bout 
-0.001 -0.03 0.03 0.95 0.00 -0.01 
10MVPA Bouts




0.001 -0.08 0.08 0.99 0.00 -0.01 
SB% -0.003 -0.01 0.01 0.74 0.001 -0.01 




Table A3.1.6 continued. 
Artery Diameter LIPA% 0.00 -0.04 0.04 0.99 0.00 -0.01 
sMVPA% 0.01 -0.02 0.03 0.70 0.002 -0.01 
 10MVPA%
 0.01 -0.08 0.09 0.90 0.00 -0.01 
LOG Blood 
Velocity 
SB Breaks 0.01 -0.01 0.02 0.36 0.01 -0.002 
<5min SB Bout 0.02 -0.004 0.05 0.09 0.03 0.02 
≥5min SB Bout 0.001 -0.02 0.02 0.93 0.00 -0.01 
True Mean SB 
Bout 
-0.003 -0.01 0.003 0.34 0.01 -0.001 
Alpha -0.34 -1.92 1.24 0.67 0.002 -0.01 
W50% 0.00 -0.004 0.004 0.89 0.00 -0.01 
PA Bouts 0.01 -0.01 0.02 0.36 0.01 -0.002 
Daily Sum of 
PA Bout Time 
8.2E-05 -0.001 0.001 0.79 0.001 -0.01 
True Mean PA 
Bout 
-0.002 -0.01 0.01 0.71 0.002 -0.01 
10MVPA Bouts
 0.02 -0.05 0.10 0.51 0.01 -0.01 
 Total Week 
10MVPA
 
0.004 -0.02 0.03 0.78 0.001 -0.01 
SB% -0.001 -0.01 0.01 0.82 0.001 -0.01 
Standing% -0.001 -0.02 0.02 0.91 0.00 -0.01 
LIPA% -0.01 -0.02 0.01 0.45 0.01 -0.01 
sMVPA% 0.01 -0.01 0.01 0.32 0.01 0.00 
10MVPA%
 0.01 -0.03 0.04 0.78 0.001 -0.01 
LOG Shear 
Rate 
SB Breaks 0.01 -0.01 0.02 0.52 0.01 -0.01 
<5min SB Bout 0.02 -0.01 0.05 0.26 0.01 0.003 
≥5min SB Bout 0.003 -0.02 0.03 0.85 0.00 -0.01 
True Mean SB 
Bout 
-0.003 -0.01 0.004 0.39 0.00 -0.01 
Alpha 0.23 -1.68 2.15 0.80 0.001 -0.01 
W50% 0.002 -0.003 0.01 0.48 0.01 -0.01 
PA Bouts 0.01 -0.01 0.02 0.52 0.01 -0.01 
Daily Sum of 
PA Bout Time 
-9.7E-05 -0.001 0.001 0.79 0.001 -0.01 
True Mean PA 
Bout 
-0.004 -0.01 0.01 0.62 0.003 -0.01 
10MVPA Bouts




0.002 -0.03 0.03 0.91 0.00 -0.01 
SB% 0.001 -0.01 0.01 0.86 0.00 -0.01 
Standing% -0.01 -0.03 0.01 0.62 0.003 -0.01 
LIPA% -0.01 -0.02 0.01 0.42 0.01 -0.004 
sMVPA% 0.004 -0.01 0.01 0.56 0.004 -0.01 
10MVPA%
 0.001 -0.04 0.04 0.96 0.00 -0.01 
LOG IMT SB Breaks -0.002 -0.01 0.01 0.75 0.001 -0.01 
<5min SB Bout -0.01 -0.03 0.02 0.67 0.002 -0.01 
≥5min SB Bout -0.002 -0.02 0.01 0.86 0.00 -0.01 
True Mean SB 
Bout 
0.001 -0.003 0.01 0.55 0.004 -0.01 
Alpha -0.20 -1.51 1.11 0.75 0.001 -0.01 




Table A3.1.6 continued. 
LOG IMT PA Bouts -0.002 -0.01 0.01 0.75 0.001 -0.01 
 Daily Sum of 
PA Bout Time 
0.00 0.00 0.001 0.70 0.002 -0.01 
True Mean PA 
Bout 
0.002 -0.01 0.01 0.62 0.003 -0.01 
 10MVPA Bouts




-0.01 -0.03 0.01 0.45 0.01 -0.01 
SB% 0.00 -0.01 0.01 0.86 0.00 -0.01 
Standing% 0.01 -0.01 0.02 0.44 0.01 -0.01 
LIPA% 0.002 -0.01 0.01 0.78 0.001 -0.01 
sMVPA% 0.00 -0.01 0.01 0.94 0.00 -0.01 
10MVPA%
 -0.01 -0.04 0.02 0.50 0.01 -0.01 
Carotid        
AL Artery 
Diameter 
SB Breaks -0.01 -0.06 0.03 0.63 0.003 -0.01 
<5min SB Bout -0.02 -0.11 0.07 0.65 0.002 -0.01 
≥5min SB Bout -0.01 -0.09 0.05 0.63 0.003 -0.01 
True Mean SB 
Bout 
0.01 -0.003 0.03 0.09 0.03 0.02 
Alpha 1.05 -3.77 5.88 0.66 0.002 -0.01 
W50% 0.001 -0.01 0.01 0.88 0.00 -0.01 
PA Bouts -0.01 -0.06 0.03 0.63 0.003 -0.01 
Daily Sum of 
PA Bout Time 
-0.001 -0.002 0.001 0.58 0.003 -0.01 
True Mean PA 
Bout 
-0.002 -0.03 0.03 0.90 0.00 -0.01 
10MVPA Bouts




0.04 -0.05 0.14 0.35 0.01 -0.002 
SB% 0.01 -0.01 0.02 0.44 0.01 -0.01 
Standing% -0.02 -0.09 0.04 0.44 0.01 -0.01 
LIPA% -0.04 -0.08 0.01 0.09 0.03 0.02 
sMVPA% -0.002 -0.03 0.03 0.92 0.00 -0.01 
10MVPA%
 0.05 -0.05 0.16 0.29 0.01 0.001 
LOG AL IMT SB Breaks -0.001 -0.01 0.01 0.90 0.00 -0.01 
<5min SB Bout 0.01 -0.01 0.02 0.59 0.003 -0.01 
≥5min SB Bout -0.004 -0.01 0.01 0.54 0.004 -0.01 
True Mean SB 
Bout 
0.00 -0.003 0.003 0.84 0.00 -0.01 
Alpha 0.69 -0.17 1.56 0.11 0.02 0.01 
W50% 0.00 -0.002 0.002 0.85 0.00 -0.01 
PA Bouts -0.001 -0.01 0.01 0.90 0.00 -0.01 
 Daily Sum of 
PA Bout Time 
0.00 0.00 0.001 0.36 0.01 -0.002 
True Mean PA 
Bout 
0.004 -0.003 0.01 0.23 0.01 0.01 
10MVPA Bouts








Table A3.1.6 continued. 
LOG AL IMT SB% -0.001 -0.01 0.002 0.54 0.004 -0.01 
Standing% 0.01 -0.01 0.01 0.25 0.01 0.004 
LIPA% 0.002 -0.01 0.01 0.66 0.002 -0.01 
sMVPA% -0.001 -0.01 0.01 0.86 0.00 -0.01 
 10MVPA%
 0.010 -0.010 0.03 0.31 0.01 0.00 
LOG AL Blood 
Velocity 
SB Breaks 0.01 -0.01 0.02 0.43 0.01 -0.004 
<5min SB Bout 0.01 -0.01 0.04 0.42 0.01 -0.004 
≥5min SB Bout 0.01 -0.01 0.03 0.60 0.003 -0.01 
True Mean SB 
Bout 
-0.004 -0.01 0.002 0.17 0.02 0.01 
Alpha 0.73 -0.80 2.27 0.34 0.01 -0.001 
W50% -0.001 -0.01 0.003 0.52 0.01 -0.01 
PA Bouts 0.01 -0.01 0.02 0.43 0.01 -0.004 
Daily Sum of 
PA Bout Time 
0.00 0.00 0.001 0.33 0.01 -0.001 
True Mean PA 
Bout 
-6.5E-05 -0.01 0.01 0.99 0.00 -0.01 
10MVPA Bouts




0.01 -0.01 0.04 0.27 0.01 0.002 
SB% -0.003 -0.01 0.003 0.34 0.01 -0.001 
Standing% -0.001 -0.02 0.02 0.92 0.00 -0.01 
LIPA% 0.01 -0.01 0.02 0.53 0.004 -0.01 
sMVPA% 0.01 -0.01 0.01 0.31 0.01 0.00 
10MVPA%
 0.01 -0.01 0.05 0.27 0.01 0.002 
AL Shear Rate SB Breaks 2.66 -4.58 9.91 0.46 0.01 -0.01 
<5min SB Bout 4.04 -9.81 17.8 0.56 0.004 -0.01 
≥5min SB Bout 3.80 -7.34 14.9 0.49 0.01 -0.01 
True Mean SB 
Bout 
-1.78 -4.21 0.64 0.14 0.02 0.01 
Alpha 197 -497 893 0.57 0.004 -0.01 
W50% -0.47 -2.23 1.28 0.59 0.003 -0.01 
PA Bouts 2.66 -4.58 9.91 0.46 0.01 -0.01 
 Daily Sum of 
PA Bout Time 
0.12 -0.15 0.39 0.38 0.01 -0.003 
True Mean PA 
Bout 
-0.01 -5.37 5.33 0.99 0.00 -0.01 
10MVPA Bouts




3.51 -10.3 17.3 0.61 0.003 -0.01 
SB% -1.29 -4.03 1.45 0.35 0.01 -0.001 
Standing% 0.47 -8.89 9.84 0.91 0.00 -0.01 
LIPA% 3.44 -3.30 10.1 0.31 0.01 0.00 
sMVPA% 2.08 -3.16 7.32 0.43 0.01 -0.004 
10MVPA%
 3.77 -12.0 19.6 0.63 0.003 -0.01 
LOG AL RI SB Breaks -0.001 -0.01 0.01 0.85 0.00 -0.01 
<5min SB Bout 0.01 -0.01 0.01 0.45 0.01 -0.01 
≥5min SB Bout -0.004 -0.01 0.01 0.44 0.01 -0.01 
True Mean SB 
Bout 




Table A3.1.6 continued. 
LOG AL RI Alpha -0.24 -0.90 0.42 0.47 0.01 -0.01 
W50% 0.00 -0.002 0.001 0.79 0.001 -0.01 
PA Bouts -0.001 -0.01 0.001 0.85 0.00 -0.01 
 Daily Sum of 
PA Bout Time 
-2.6E-05 0.00 0.00 0.84 0.00 -0.01 
True Mean PA 
Bout 
-0.001 -0.01 0.004 0.61 0.003 -0.01 
10MVPA Bouts




-0.01 -0.02 0.01 0.23 0.01 0.01 
SB% 0.00 -0.002 0.003 0.86 0.00 -0.01 
Standing% 0.004 -0.01 0.01 0.38 0.01 -0.003 
LIPA% 0.001 -0.01 0.01 0.69 0.002 -0.01 
sMVPA% -0.002 -0.01 0.003 0.45 0.01 -0.01 
10MVPA%
 -0.01 -0.02 0.01 0.26 0.01 0.003 
PL Artery 
Diameter 
SB Breaks -0.05 -0.12 0.01 0.10 0.08 0.05 
<5min SB Bout -0.09 -0.20 0.02 0.12 0.08 0.04 
≥5min SB Bout -0.05 -0.15 0.04 0.24 0.04 0.01 
True Mean SB 
Bout 
0.01 -0.001 0.03 0.06 0.11 0.07 
Alpha -1.91 -7.82 3.99 0.51 0.01 -0.01 
 W50% 0.01 -0.01 0.02 0.38 0.02 -0.01 
PA Bouts -0.05 -0.12 0.01 0.10 0.08 0.05 
Daily Sum of 
PA Bout Time 
-0.001 -0.003 0.001 0.28 0.04 0.01 
True Mean PA 
Bout 
-0.01 -0.05 0.02 0.55 0.01 -0.02 
10MVPA Bouts




0.03 -0.11 0.18 0.61 0.01 -0.02 
SB% 0.01 -0.01 0.03 0.27 0.04 0.01 
Standing% -0.01 -0.06 0.04 0.67 0.01 -0.02 
LIPA% -0.02 -0.07 0.02 0.23 0.04 0.01 
sMVPA% -0.03 -0.07 0.01 0.17 0.06 0.03 
10MVPA%
 0.04 -0.11 0.21 0.57 0.01 -0.02 
PL IMT SB Breaks 0.01 -0.01 0.02 0.38 0.02 -0.01 
<5min SB Bout 0.01 -0.01 0.04 0.17 0.06 0.03 
≥5min SB Bout 0.002 -0.02 0.02 0.89 0.001 -0.03 
True Mean SB 
Bout 
-0.003 -0.007 0.002 0.24 0.04 0.01 
Alpha 1.60 0.29 2.90 0.01 0.17 0.14 
W50% -0.001 -0.004 0.002 0.59 0.01 -0.02 
PA Bouts 0.01 -0.01 0.02 0.38 0.02 -0.01 
Daily Sum of 
PA Bout Time 
0.00 0.00 0.001 0.62 0.01 -0.02 
True Mean PA 
Bout 
0.001 -0.01 0.01 0.75 0.004 -0.03 
10MVPA Bouts








Table A3.1.6 continued. 
PL IMT SB% -0.002 -0.01 0.003 0.50 0.01 -0.01 
Standing% -0.001 -0.01 0.01 0.89 0.001 -0.03 
LIPA% 0.01 -0.01 0.01 0.42 0.02 -0.01 
sMVPA% 0.004 -0.01 0.01 0.49 0.01 -0.01 
10MVPA%
 0.01 -0.02 0.05 0.40 0.02 -0.01 
Popliteal        
Artery Diameter SB Breaks -0.01 -0.12 0.10 0.83 0.001 -0.02 
<5min SB Bout -0.06 -0.26 0.13 0.52 0.01 -0.01 
≥5min SB Bout 0.02 -0.14 0.19 0.75 0.002 -0.02 
 True Mean SB 
Bout 
0.01 -0.01 0.04 0.34 0.02 -0.002 
Alpha -5.58 -15.5 4.38 0.26 0.02 0.01 
W50% 0.01 -0.01 0.03 0.47 0.01 -0.01 
PA Bouts -0.01 -0.12 0.10 0.83 0.001 -0.02 
Daily Sum of 
PA Bout Time 
-0.002 -0.01 0.01 0.42 0.01 -0.01 
True Mean PA 
Bout 
-0.03 -0.10 0.04 0.39 0.01 -0.01 
10MVPA Bouts




0.10 -0.20 0.40 0.51 0.01 -0.01 
SB% 0.01 -0.02 0.05 0.33 0.02 -0.001 
Standing% -0.12 -0.22 -0.01 0.02 0.11 0.09 
LIPA% -0.06 -0.15 0.02 0.17 0.04 0.02 
sMVPA% 0.02 -0.06 0.11 0.55 0.01 -0.01 
10MVPA%
 0.14 -0.18 0.47 0.37 0.01 -0.01 
IMT SB Breaks -0.01 -0.02 0.01 0.32 0.02 0.00 
<5min SB Bout -0.003 -0.02 0.02 0.78 0.002 -0.02 
≥5min SB Bout -0.01 -0.03 0.01 0.26 0.02 0.01 
True Mean SB 
Bout 
0.003 -0.001 0.01 0.17 0.04 0.02 
Alpha -1.03 -2.20 0.12 0.07 0.07 0.04 
W50% 0.003 0.00 0.01 0.04 0.09 0.07 
PA Bouts -0.01 -0.02 0.01 0.32 0.02 0.00 
Daily Sum of 
PA Bout Time 
-0.001 -0.001 0.00 0.001 0.15 0.13 
True Mean PA 
Bout 
-0.01 -0.01 -0.001 0.02 0.11 0.09 
10MVPA Bouts




-0.01 -0.04 0.02 0.56 0.01 -0.01 
SB% 0.01 0.001 0.01 0.01 0.13 0.11 
Standing% -0.01 -0.02 0.004 0.17 0.04 0.02 
LIPA% -0.01 -0.02 -0.004 0.01 0.15 0.13 
sMVPA% -0.01 -0.01 0.001 0.09 0.06 0.04 
10MVPA%
 -0.01 -0.04 0.02 0.61 0.01 -0.01 
LOG Blood 
Velocity 
SB Breaks -0.02 -0.05 0.01 0.16 0.04 0.02 
<5min SB Bout -0.01 -0.06 0.04 0.74 0.003 -0.02 




Table A3.1.6 continued. 
LOG Blood 
Velocity 
True Mean SB 
Bout 
0.01 -0.001 0.01 0.07 -0.07 0.05 
Alpha -0.85 -3.57 1.87 0.53 0.01 -0.01 
W50% 0.01 0.00 0.01 0.03 0.09 0.07 
PA Bouts -0.02 -0.05 0.01 0.16 0.04 0.02 
 Daily Sum of 
PA Bout Time 
-0.001 -0.002 0.00 0.13 0.05 0.02 
True Mean PA 
Bout 
-0.01 -0.02 0.01 0.46 0.01 -0.01 
10MVPA Bouts




-0.07 -0.15 0.01 0.06 0.07 0.05 
SB% 0.01 -0.003 0.01 0.17 0.04 0.01 
Standing% -0.01 -0.04 0.01 0.20 0.03 0.01 
LIPA% -0.01 -0.03 0.01 0.50 0.01 -0.01 
sMVPA% -0.01 -0.03 0.01 0.34 0.02 -0.002 
10MVPA%
 -0.07 -0.16 0.01 0.07 0.07 0.04 
LOG Shear 
Rate 
SB Breaks -0.01 -0.05 0.01 0.31 0.02 0.001 
<5min SB Bout 0.01 -0.06 0.06 0.88 0.00 -0.02 
≥5min SB Bout -0.04 -0.09 0.01 0.10 0.06 0.03 
True Mean SB 
Bout 
0.01 -0.01 0.01 0.34 0.02 -0.002 
Alpha 0.08 -3.10 3.27 0.95 0.00 -0.02 
W50% 0.01 -0.003 0.01 0.19 0.03 0.01 
PA Bouts -0.01 -0.05 0.01 0.31 0.02 0.001 
Daily Sum of 
PA Bout Time 
0.00 -0.002 0.001 0.43 0.01 -0.01 
True Mean PA 
Bout 
-0.002 -0.02 0.02 0.86 0.001 -0.02 
10MVPA Bouts




-0.09 -0.18 0.001 0.05 0.08 0.06 
SB% 0.004 -0.01 0.01 0.56 0.01 -0.01 
Standing% 0.002 -0.03 0.03 0.91 0.00 -0.02 
LIPA% 0.002 -0.02 0.03 0.86 0.001 -0.02 
sMVPA% -0.01 -0.04 0.01 0.28 0.02 0.004 
10MVPA%
 -0.10 -0.20 -0.001 0.04 0.08 0.06 
Bold font highlights significant (p≤0.05) bivariate linear regressions. b Change in cardiovascular 
variable per unit increase in GENEA variable. -95%CI Negative 95% confidence interval. +95%CI 
































































Chapter 03: Part 3: Alternative PB heat maps. 
 
 
Figure A3.3.1. The combined influence of SB, LIPA, and Total Week 10MVPA on BMI in older adults. 
Colours represent thresholds of BMI category (kg∙m2). 
 
Figure A3.3.2. The combined influence of SB, LIPA, and Total Week 10MVPA on fasting blood 








Figure A3.3.3. The combined influence of SB, LIPA, and Total Week 10MVPA on fasting blood total 
cholesterol concentration in older adults. Colours represent thresholds of fasting blood total 
cholesterol concentration (mmol∙l-1). 
 
Figure A3.3.4. The combined influence of SB, LIPA, and Total Week 10MVPA on fasting blood 









Figure A3.3.5. The combined influence of SB, LIPA, and Total Week 10MVPA on Systolic BP in older 
adults. Colours represent thresholds of Systolic BP (mmHg). 
 
Figure A3.3.6. The combined influence of SB, LIPA, and Total Week 10MVPA on Diastolic BP in older 









Figure A3.3.7. The combined influence of SB, LIPA, and Total Week 10MVPA on pulse pressure in 
older adults. Colours represent thresholds of pulse pressure (mmHg). 
 
Figure A3.3.8. The combined influence of SB, LIPA, and Total Week 10MVPA on carotid AL artery 









Figure A3.3.9. The combined influence of SB, LIPA, and Total Week 10MVPA on carotid AL far wall 
IMT in older adults. Colours represent thresholds of carotid AL far wall IMT (mm). 
 
Figure A3.3.10. The combined influence of SB, LIPA, and Total Week 10MVPA on resting heart rate 









Figure A3.3.11. The combined influence of SB, LIPA, and Total Week 10MVPA on brachial artery 
diameter in older adults. Colours represent thresholds of brachial artery diameter (mm). 
 
Figure A3.3.12. The combined influence of SB, LIPA, and Total Week 10MVPA on brachial artery far 









Figure A3.3.13. The combined influence of SB, LIPA, and Total Week 10MVPA on popliteal artery 
diameter in older adults. Colours represent thresholds of popliteal artery diameter (mm). 
 
Figure A3.3.14. The combined influence of SB, LIPA, and Total Week 10MVPA on popliteal artery far 









Figure A3.3.15. The combined influence of SB, LIPA, and sMVPA on BMI in older adults. Colours 
represent thresholds of BMI category (kg∙m2). 
 
Figure A3.3.16. The combined influence of SB, LIPA, and sMVPA on fasting blood glucose 










Figure A3.3.17. The combined influence of SB, LIPA, and sMVPA on fasting blood total cholesterol 
concentration in older adults. Colours represent thresholds of fasting blood total cholesterol 
concentration (mmol∙l-1). 
 
Figure A3.3.18. The combined influence of SB, LIPA, and sMVPA on fasting blood triglyceride 









Figure A3.3.19. The combined influence of SB, LIPA, and sMVPA on Systolic BP in older adults. 
Colours represent thresholds of Systolic BP (mmHg). 
 
Figure A3.3.20. The combined influence of SB, LIPA, and sMVPA on Diastolic BP in older adults. 









Figure A3.3.21. The combined influence of SB, LIPA, and sMVPA on pulse pressure in older adults. 
Colours represent thresholds of pulse pressure (mmHg). 
 
Figure A3.3.22. The combined influence of SB, LIPA, and sMVPA on carotid AL artery diameter in 









Figure A3.3.23. The combined influence of SB, LIPA, and sMVPA on carotid AL far wall IMT in older 
adults. Colours represent thresholds of carotid AL far wall IMT (mm). 
 
Figure A3.3.24. The combined influence of SB, LIPA, and sMVPA on resting heart rate in older adults. 









Figure A3.3.25. The combined influence of SB, LIPA, and sMVPA on brachial artery diameter in older 
adults. Colours represent thresholds of brachial artery diameter (mm). 
 
Figure A3.3.26. The combined influence of SB, LIPA, and sMVPA on brachial far wall IMT in older 









Figure A3.3.27. The combined influence of SB, LIPA, and sMVPA on popliteal artery diameter in 
older adults. Colours represent thresholds of popliteal artery diameter (mm). 
 
Figure A3.3.28. The combined influence of SB, LIPA, and sMVPA on popliteal artery far wall IMT in 








Chapter 03: Part 3: MVPA – brachial artery diameter relationship. 
 




Chapter 04: Effect of medication on further ageing. 
 
Figure A4.1. The effect of further ageing on systolic BP when participants are grouped into not 
medicated (○, dotted trend line) and medicated (●, solid trend line). No significant associations. 
 
Figure A4.2. The effect of further ageing on diastolic BP when participants are grouped into not 
medicated (○, dotted trend line) and medicated (●, solid trend line). No significant associations. 
 
Figure A4.3. The effect of further ageing on pulse pressure when participants are grouped into not 




Figure A4.4. The effect of further ageing on resting heart rate when participants are grouped into not 
medicated (○, dotted trend line) and medicated (●, solid trend line). No significant associations. 
 
Figure A4.5. The effect of further ageing on brachial artery diameter when participants are grouped 
into not medicated (○, dotted trend line) and medicated (●, solid trend line). Significant association 
for the medicated group (p=0.02). 
 
Figure A4.6. The effect of further ageing on brachial artery IMT when participants are grouped into 
not medicated (○, dotted trend line) and medicated (●, solid trend line). Significant association for the 




Figure A4.7. The effect of further ageing on carotid artery diameter when participants are grouped 
into not medicated (○, dotted trend line) and medicated (●, solid trend line). No significant 
associations. 
 
Figure A4.8. The effect of further ageing on carotid artery IMT when participants are grouped into 
not medicated (○, dotted trend line) and medicated (●, solid trend line). No significant associations. 
 
Figure A4.9. The effect of further ageing on popliteal artery diameter when participants are grouped 





Figure A4.10. The effect of further ageing on popliteal artery IMT when participants are grouped into 
not medicated (○, dotted trend line) and medicated (●, solid trend line). Significant association for the 




Chapter 05: Part 2: Full ISM results. 
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